<?xml version='1.0' encoding='UTF-8'?>
<chapter id="ch0049">
    <title>33 Mycobacterium: Clinical and Laboratory Characteristics of Rapidly Growing Mycobacteria</title>
    <sect1 id="ch0049s0001">
      <title>33 Mycobacterium: Clinical and Laboratory Characteristics of Rapidly Growing Mycobacteria</title>
      <anchor id="ch0049s0001a0001"/>
      <anchor id="ch0049s0001a0002"/>
      <para role="chapterAuthor"><phrase role="center">BARBARA A. BROWN-ELLIOTT, SUSAN M. HARRINGTON, KOZO MORIMOTO, AND RICHARD J. WALLACE, JR.</phrase>
      </para>
      <sect2 id="ch0049s0001s0001">
        <title>TAXONOMY AND DESCRIPTION OF THE AGENTS</title>
        <anchor id="ch0049s0001s0001a0001"/>
        <anchor id="ch0049s0001s0001a0002"/>
        <para id="ch0049s0001s0001p0001">The rapidly growing mycobacteria (RGM) are generally defined as nontuberculous species that grow mature colonies on laboratory media within 7 days (<link linkend="ch0049s0030s0004li0001">1</link>–<link linkend="ch0049s0030s0004li0003">3</link>). RGM contain long-chain fatty acids, known as mycolic acids, that can be quantitated with chromatographic techniques such as high-performance liquid chromatography (HPLC). Prior to the molecular era, HPLC was used for identification of RGM species in most major reference laboratories. However, this method has been replaced in most laboratories by more definitive molecular and/or proteomic (matrix-assisted desorption ionization–time of flight mass spectrometry, or MALDI-TOF MS) identification methods for more accurate species identification (<link linkend="ch0049s0030s0004li0004">4</link>–<link linkend="ch0049s0030s0004li0006">6</link>).</para>
        <para id="ch0049s0001s0001p0002">Currently, there are almost 200 species of nontuberculous mycobacteria (NTM), among which almost 100 species are RGM. More than half of the RGM species have been described since the early 1990s (<link linkend="ch0049s0030s0004li0007">7</link>). A 2018 publication by Gupta et al. proposed a major revision of the NTM taxonomy based on phylogenetic and comparative genomic assays. The species of the <emphasis>M. abscessus/chelonae</emphasis> group were reclassified as <emphasis>Mycobacteriodes</emphasis>, whereas the remainder of the RGM were reclassified as <emphasis>Mycolicibacterium</emphasis> (<link linkend="ch0049s0030s0004li0008">8</link>). Although the Gupta et al. taxonomic studies are scientifically accurate, in the sense that several clades exist within the mycobacteria, many mycobacteriologists have agreed that the confusion caused by changing the well-known genus <emphasis>Mycobacterium</emphasis> would be a costly and potentially dangerous and destructive decision. Consequently, many mycobacteriologists, especially in the clinical arena, have elected to retain the genus <emphasis>Mycobacterium</emphasis>, which is still considered valid by the Bacteriological Code of taxonomy (<link linkend="ch0049s0030s0004li0009">9</link>, <link linkend="ch0049s0030s0004li0010">10</link>).</para>
        <para id="ch0049s0001s0001p0003">A subsequent investigation published in 2021 used a multifaceted approach for the taxonomic definition of a genus, including the evaluation of 16S rRNA gene similarity, amino acid identity index, average nucleotide identity, alignment fraction, and percentage of conserved proteins, which strongly disputed the proposed division of the mycobacterial genus into five genera. Thus, the investigators advised a reapplication of all species within the genus<emphasis>Mycobacterium</emphasis> with the previously proposed five genera potentially as subgenus complex names (<link linkend="ch0049s0030s0004li0011">11</link>).</para>
        <para id="ch0049s0001s0001p0004">Since 2017, 16 new validated species,<emphasis>M. aquiterrae</emphasis> (<link linkend="ch0049s0030s0004li0012">12</link>), <emphasis>M. aquaticum</emphasis> (<link linkend="ch0049s0030s0004li0013">13</link>), <emphasis>M. eburneum</emphasis> (<link linkend="ch0049s0030s0004li0014">14</link>), <emphasis>M. grossiae</emphasis> (<link linkend="ch0049s0030s0004li0015">15</link>), <emphasis>M. komaniense</emphasis> (<link linkend="ch0049s0030s0004li0016">16</link>), <emphasis>M. kyogaense</emphasis> (<link linkend="ch0049s0030s0004li0017">17</link>), <emphasis>M. lehmannii</emphasis> (<link linkend="ch0049s0030s0004li0018">18</link>), <emphasis>M. malmesburyense</emphasis> (<link linkend="ch0049s0030s0004li0019">19</link>), <emphasis>M. neglectum</emphasis> (<link linkend="ch0049s0030s0004li0020">20</link>), <emphasis>M. neumannii</emphasis> (<link linkend="ch0049s0030s0004li0018">18</link>), <emphasis>M. palauense</emphasis> (<link linkend="ch0049s0030s0004li0020">20</link>), <emphasis>M. stellerae</emphasis> (<link linkend="ch0049s0030s0004li0021">21</link>), <emphasis>M. baixiangningiae</emphasis> (<link linkend="ch0049s0030s0004li0022">22</link>), <emphasis>M. mengxianglii</emphasis> (<link linkend="ch0049s0030s0004li0022">22</link>), <emphasis>M. stephanolepidis</emphasis> (<link linkend="ch0049s0030s0004li0023">23</link>), and <emphasis>M. syngnathidarum</emphasis> (<link linkend="ch0049s0030s0004li0024">24</link>), have been added to the list. The last two species are fish pathogens but currently are not recovered from human clinical samples. <emphasis>M. malmesburyense</emphasis> and <emphasis>M. komaniense</emphasis> have been recovered from bovine nasal swabs, soil, and water in South Africa. Of major importance clinically is the cross-reactive immune response with <emphasis>M. bovis</emphasis> antigens, which could lead to a false diagnosis of bovine tuberculosis (<link linkend="ch0049s0030s0004li0016">16</link>, <link linkend="ch0049s0030s0004li0019">19</link>).</para>
        <para id="ch0049s0001s0001p0005">Of these new species, only two,<emphasis>M. grossiae</emphasis> and <emphasis>M. eburneum</emphasis>, have been recovered from human clinical sources: <emphasis>M. grossiae</emphasis> from human respiratory and blood specimens and <emphasis>M. eburneum</emphasis> from a sputum sample. However, no clinical details were given concerning the patient from whom the <emphasis>M. eburneum</emphasis> isolate was recovered (<link linkend="ch0049s0030s0004li0014">14</link>). Recently, <emphasis>M. eburneum</emphasis> described in 2017 has been merged with a slowly growing mycobacterial species, <emphasis>M. talmoniae</emphasis>. Although first described as an RGM, the growth rate was 7 days for <emphasis>M. eburneum</emphasis> compared to a 7- to 10-day average growth rate for <emphasis>M. talmoniae</emphasis>. Both species contain the 16S rRNA slowly growing mycobacteria genetic signature and are considered to be the same species (<link linkend="ch0049s0030s0004li0025">25</link>).</para>
        <para id="ch0049s0001s0001p0006">There are currently six major groups or complexes of RGM, based on pigmentation and genetic relatedness (<anchor id="ch0049s0001s0001a0003"/><link linkend="ch0049s0001s0001a0005">Table 1</link>). The first group of nonpigmented pathogenic species includes 11 taxa, some of which once belonged to the third biovariant of the <emphasis>M. fortuitum</emphasis> group (<link linkend="ch0049s0001s0001a0005">Table 1</link>) (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0026">26</link>–<link linkend="ch0049s0030s0004li0029">29</link>).</para>
        <anchor id="ch0049s0001s0001a0004"/>
        <beginpage pagenum="658"/>
        <table id="ch0049s0001s0001t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0049s0001s0001a0005"/><link linkend="ch0049s0001s0001a0003">TABLE 1</link></phrase></emphasis> Six major groups of pathogenic RGM
</title>
          
          <tgroup cols="2">
            <tbody>
              <row>
                <entry><phrase role="center">Group or taxon</phrase>
                </entry>
                <entry><phrase role="center">Species within group or taxon</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>Mycobacterium fortuitum</emphasis> group</entry>
                <entry><emphasis>M. fortuitum, M. peregrinum, M. setense, M. septicum</emphasis>,<superscript><emphasis><anchor id="ch0049s0001s0001a0006"/><link linkend="ch0049s0001s0001a0008">a</link></emphasis></superscript> <emphasis>M. porcinum</emphasis>,<superscript><emphasis><link linkend="ch0049s0001s0001a0008">a</link></emphasis></superscript> <emphasis>M. houstonense</emphasis>,<superscript><emphasis><link linkend="ch0049s0001s0001a0008">a</link></emphasis></superscript> <emphasis>M. boenickei</emphasis>,<superscript><emphasis><link linkend="ch0049s0001s0001a0008">a</link></emphasis></superscript> <emphasis>M. brisbanense</emphasis>,<superscript><emphasis><link linkend="ch0049s0001s0001a0008">a</link></emphasis></superscript> <emphasis>M. neworleansense</emphasis>,<superscript><emphasis><link linkend="ch0049s0001s0001a0008">a</link></emphasis></superscript> <emphasis>M. senegalense/conceptionense/farcinogenes</emphasis><emphasis>,</emphasis><superscript><emphasis><anchor id="ch0049s0001s0001a0007"/><link linkend="ch0049s0001s0001a0009">b</link></emphasis></superscript><emphasis> M. syngnathidarum</emphasis></entry>
              </row>
              <row>
                <entry><emphasis>M. chelonae/M. abscessus</emphasis> group</entry>
                <entry><emphasis>M. chelonae, M. immunogenum, M. salmoniphilum, M. franklinii, M. saopaulense, M. stephanoleptidis,</emphasis> the <emphasis>Mycobacterium abscessus</emphasis> species including <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> (formerly <emphasis>M. abscessus</emphasis>), <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense, M. abscessus</emphasis> subsp. <emphasis>bolletii</emphasis></entry>
              </row>
              <row>
                <entry><emphasis>M. mucogenicum</emphasis> group</entry>
                <entry><emphasis>M. mucogenicum, M. aubagnense, M. phocaicum</emphasis>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. smegmatis</emphasis> group</entry>
                <entry><emphasis>M. smegmatis, M. goodii</emphasis>
                </entry>
              </row>
              <row>
                <entry>Early-pigmented RGM</entry>
                <entry><emphasis>M. neoaurum, M. canariasense, M. cosmeticum, M. monacense, M. bacteremicum, M. grossiae</emphasis>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. mageritense/M. wolinskyi</emphasis> group</entry>
                <entry><emphasis>M. mageritense, M. wolinskyi</emphasis>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0001a0008"/><link linkend="ch0049s0001s0001a0006">a</link></emphasis></superscript>Includes the former third-biovariant complex.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0001a0009"/><link linkend="ch0049s0001s0001a0007">b</link></emphasis></superscript>Appear to be synonyms of each other (<link linkend="ch0049s0030s0004li0025">25</link>).</para>
        <para id="ch0049s0001s0001p0007">The second group of nonpigmented RGM is the<emphasis>M. chelonae/M. abscessus</emphasis> complex listed in <link linkend="ch0049s0001s0001a0005">Table 1</link> (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0030">30</link>–<link linkend="ch0049s0030s0004li0033">33</link>). Importantly, the <emphasis>M. abscessus</emphasis> species has been subdivided into three subspecies collectively (<emphasis>sensu lato</emphasis>) referred to as “<emphasis>M. abscessus</emphasis> species.” The former species <emphasis>M. abscessus</emphasis> is now designated <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis>. Two previously described species, <emphasis>M. massiliense</emphasis> and <emphasis>M. bolletii</emphasis>, which had been combined and proposed to form another subspecies of <emphasis>M. abscessus</emphasis> designated as <emphasis>M. abscessus</emphasis> subsp. <emphasis>bolletii</emphasis>, were reexamined and found by genomic sequence data to represent two separate subspecies (<link linkend="ch0049s0030s0004li0034">34</link>, <link linkend="ch0049s0030s0004li0035">35</link>). The previously combined designation (i.e., <emphasis>M. abscessus</emphasis> subsp. <emphasis>bolletii</emphasis>) was controversial since no functional <emphasis>erm</emphasis> gene is present in isolates previously named <emphasis>M. massiliense</emphasis>, in contrast to the case for isolates previously called <emphasis>M. bolletii</emphasis>, with a functional <emphasis>erm</emphasis> gene conferring inducible macrolide resistance. Thus, the 2012 descriptions of the genomic sequences of <emphasis>M. abscessus</emphasis> subsp. <emphasis>bolletii</emphasis> (previously <emphasis>M. bolletii</emphasis>) and <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> (previously <emphasis>M. massiliense</emphasis>) helped to resolve questions surrounding the species and provided information to better discriminate between the subspecies (<link linkend="ch0049s0030s0004li0036">36</link>–<link linkend="ch0049s0030s0004li0038">38</link>).</para>
        <para id="ch0049s0001s0001p0008">A 2017 phylogenetic study of NTM species by Tortoli and colleagues revealed, by genome-to-genome comparisions, that<emphasis>M. farcinogenes, M. conceptionense</emphasis>, and <emphasis>M. senegalense</emphasis> were all very closely related and that their pairwise ANI values (98.3 to 99.4) suggested that these three currently recognized species may be variants of the same species (<link linkend="ch0049s0030s0004li0039">39</link>). Thus, although <emphasis>M. farcinogenes</emphasis> is phenotypically a slowly growing NTM, current molecular identification schema place it within the <emphasis>M. fortuitum</emphasis> group (<link linkend="ch0049s0030s0004li0025">25</link>). Later genomic evidence lists these three species as synomyms of each other (<link linkend="ch0049s0030s0004li0025">25</link>). Additionally, a new member of the group similar to <emphasis>M. chelonae, M. stephanolepidis</emphasis>, is a fish pathogen (<link linkend="ch0049s0030s0004li0023">23</link>).</para>
        <para id="ch0049s0001s0001p0009">Two subspecies of<emphasis>M. chelonae</emphasis> have also been recently recognized, <emphasis>M. chelonae</emphasis> subsp. <emphasis>bovis</emphasis> (validly published, but an illegitimate name in need of replacement) (<ulink url="https://lpsn.dsmz.de/subspecies/mycobacterium-chelonae-bovis">https://lpsn.dsmz.de/subspecies/mycobacterium-chelonae-bovis</ulink>) and <emphasis>M. chelonae</emphasis> subsp. <emphasis>gwakanae</emphasis> (<link linkend="ch0049s0030s0004li0040">40</link>, <link linkend="ch0049s0030s0004li0041">41</link>). Both subspecies have been isolated in Korea. <emphasis>M. chelonae</emphasis> subsp. <emphasis>bovis</emphasis> has been isolated from Korean native bovine species (Hanwoo, <emphasis>Bos taurus coreanas</emphasis>) (<link linkend="ch0049s0030s0004li0041">41</link>), while <emphasis>M. chelonae</emphasis> subsp. <emphasis>gwakanae</emphasis> has been isolated from sputum samples in Korean patients with pulmonary disease coinfected with <emphasis>M. yongonense</emphasis> (<link linkend="ch0049s0030s0004li0041">41</link>).</para>
        <para id="ch0049s0001s0001p0010">A third nonpigmented group, the<emphasis>M. mucogenicum</emphasis> group, currently includes three species, as noted in <link linkend="ch0049s0001s0001a0005">Table 1</link> (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0031">31</link>, <link linkend="ch0049s0030s0004li0042">42</link>).</para>
        <para id="ch0049s0001s0001p0011">The fourth group, the<emphasis>M. smegmatis</emphasis> group, is currently composed of the two late-pigmented species, i.e., <emphasis>M. smegmatis</emphasis> and <emphasis>M. goodii</emphasis> (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0027">27</link>, <link linkend="ch0049s0030s0004li0043">43</link>).</para>
        <para id="ch0049s0001s0001p0012">The fifth group of RGM includes the early-pigmented species, which traditionally have been difficult to identify by conventional (phenotypic) laboratory methods. Proven pathogens in this group include<emphasis>M. neoaurum</emphasis> and <emphasis>M. bacteremicum</emphasis> (<link linkend="ch0049s0001s0001a0005">Table 1</link>), which have been associated with mycobacteremia in patients with catheter infections, and <emphasis>M. iranicum</emphasis>, which has been recovered from five respiratory samples, a hand wound, and two cerebrospinal fluid samples (<link linkend="ch0049s0030s0004li0044">44</link>–<link linkend="ch0049s0030s0004li0046">46</link>). Several newly described early-pigmented species, including <emphasis>M. canariasense, M. cosmeticum, M. monacense</emphasis>, and <emphasis>M. grossiae</emphasis>, appear to be clinically significant (<link linkend="ch0049s0030s0004li0005">5</link>, <link linkend="ch0049s0030s0004li0046">46</link>). <emphasis>M. cosmeticum</emphasis> has been described from granulomatous lesions associated with mesotherapy clinics and nail salons. There are several previously listed environmental (nonpathogenic) species as well as species described since 2017 including <emphasis>M. aquiterrae, M. lehmanii, M. neumanii, M. komaniense, M. baixiangningiae, M. mengxianglii</emphasis>, and <emphasis>M. stellerae</emphasis> (<link linkend="ch0049s0030s0004li0012">12</link>, <link linkend="ch0049s0030s0004li0016">16</link>, <link linkend="ch0049s0030s0004li0018">18</link>, <link linkend="ch0049s0030s0004li0021">21</link>, <link linkend="ch0049s0030s0004li0022">22</link>). Current studies based on DNA sequence analysis have identified the presence of a sixth, nonpigmented pathogenic group composed of <emphasis>M. mageritense</emphasis> and <emphasis>M. wolinskyi</emphasis> (<link linkend="ch0049s0030s0004li0006">6</link>, <link linkend="ch0049s0030s0004li0032">32</link>).</para>
        <para id="ch0049s0001s0001p0013">The introduction of the new species noted above within the RGM emphasizes the importance of molecular identification to the species level and questions the meaningfulness of the current “group” classifications, especially for the<emphasis>M. fortuitum</emphasis> group. However, because previous data (prior to the reliance on genetic testing) and publications use this “group” nomenclature, these designations are retained in this chapter for ease of discussion (<link linkend="ch0049s0030s0004li0001">1</link>). As more information is obtained using advanced molecular technology and more laboratories adopt newer methodologies, the group designations may become even more obsolete.</para>
      </sect2>
      <sect2 id="ch0049s0001s0002">
        <title>CLINICAL SIGNIFICANCE</title>
        <anchor id="ch0049s0001s0002a0001"/>
        <anchor id="ch0049s0001s0002a0002"/>
        <para id="ch0049s0001s0002p0001">The RGM are opportunistic pathogens that cause disease in a variety of clinical settings. The three major clinically important species of RGM, responsible for approximately 80% of mycobacterial disease in humans, are the<emphasis>M. fortuitum</emphasis> group (including <emphasis>M. fortuitum, M. porcinum, M. senegalense</emphasis>, and other less commonly encountered species) (see <anchor id="ch0049s0001s0002a0003"/><link linkend="ch0049s0001s0002a0008">Table 2</link>), the <emphasis>M. chelonae</emphasis> complex, and the <emphasis>M. abscessus</emphasis> species, including <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus, M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis>, and <emphasis>M. abscessus</emphasis> subsp. <emphasis>bolletii</emphasis> (<link linkend="ch0049s0030s0004li0029">29</link>, <link linkend="ch0049s0030s0004li0047">47</link>, <link linkend="ch0049s0030s0004li0048">48</link>). Other potentially pathogenic and clinically significant RGM species are also provided in <anchor id="ch0049s0001s0002a0004"/><link linkend="ch0049s0001s0002a0033">Table 3</link> (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0005">5</link>, <link linkend="ch0049s0030s0004li0006">6</link>, <link linkend="ch0049s0030s0004li0026">26</link>, <link linkend="ch0049s0030s0004li0027">27</link>, <link linkend="ch0049s0030s0004li0031">31</link>–<link linkend="ch0049s0030s0004li0033">33</link>, <link linkend="ch0049s0030s0004li0043">43</link>, <link linkend="ch0049s0030s0004li0046">46</link>, <link linkend="ch0049s0030s0004li0049">49</link>, <link linkend="ch0049s0030s0004li0050">50</link>). Infections caused by the <emphasis>M. abscessus</emphasis> species are often more challenging to treat than those due to other species because of multidrug resistance as well as delayed diagnosis. When a bacterial infection is suspected, but the routine culture test is negative, culture for mycobacteria should be initiated to result in timely diagnosis. Because of the relatively rapid growth of RGM, they may on occasion be detected from samples processed for bacterial culture prior to being finalized, often appearing in 2 to 3 days, unlike for slowly growing mycobacterial species.</para>
        <anchor id="ch0049s0001s0002a0005"/>
        <beginpage pagenum="659"/>
        <anchor id="ch0049s0001s0002a0006"/>
        <beginpage pagenum="660"/>
        <anchor id="ch0049s0001s0002a0007"/>
        <beginpage pagenum="661"/>
        <table id="ch0049s0001s0002t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0049s0001s0002a0008"/><link linkend="ch0049s0001s0002a0003">TABLE 2</link></phrase></emphasis> Currently recognized species of RGM<superscript><emphasis><anchor id="ch0049s0001s0002a0009"/><link linkend="ch0049s0001s0002a0021">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="5">
            <tbody>
              <row>
                <entry><phrase role="center">Species</phrase>
                </entry>
                <entry><phrase role="center">Established clinical significance</phrase>
                </entry>
                <entry><phrase role="center">Pigmentation</phrase>
                </entry>
                <entry><phrase role="center">Unique phenotype</phrase>
                </entry>
                <entry><phrase role="center">Unique (complete) 16S rRNA gene sequence</phrase>
                </entry>
              </row>
              <row>
                <entry>Common human pathogens</entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis></entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis></entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. chelonae</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. fortuitum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. abscessus</emphasis> subsp. <emphasis>bolletii</emphasis></entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. porcinum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. senegalense</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry>Less common human pathogens (&lt;20 clinical isolates or cases)</entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><emphasis>M. bacteremicum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. boenickei</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. canariasense</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. cosmeticum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. franklinii</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. goodii</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. houstonense</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0049s0001s0002a0010"/>
                      <link linkend="ch0049s0001s0002a0022">b</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. immunogenum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. mageritense</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. mucogenicum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. neoaurum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. peregrinum</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0049s0001s0002a0011"/>
                      <link linkend="ch0049s0001s0002a0023">c</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. phocaicum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. smegmatis</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry>Rare human pathogens (&lt;10 cases or isolates)</entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><emphasis>M. aubagnense</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. brisbanense</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. brumae</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. celeriflavum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. elephantis</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. grossiae</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. iranicum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry>“<emphasis>M. lacticola</emphasis>”<superscript><emphasis><anchor id="ch0049s0001s0002a0012"/><link linkend="ch0049s0001s0002a0024">d</link></emphasis></superscript></entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Unknown</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. monacense</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. moriokaense</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. neworleansense</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. novocastrense</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. saopaulense</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0049s0001s0002a0013"/>
                      <link linkend="ch0049s0001s0002a0025">e</link>
                    </emphasis>
                  </superscript>
                  <superscript>
                    <emphasis>,</emphasis>
                  </superscript>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0049s0001s0002a0014"/>
                      <link linkend="ch0049s0001s0002a0026">f</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. septicum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. setense</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. wolinskyi</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry>Unproven human pathogens</entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><emphasis>M. agri</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. aichiense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. alvei</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. anyangense</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0049s0001s0002a0015"/>
                      <link linkend="ch0049s0001s0002a0027">g</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">ND<superscript><emphasis><anchor id="ch0049s0001s0002a0016"/><link linkend="ch0049s0001s0002a0028">h</link></emphasis></superscript></phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. aquaticum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. aquiterrae</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. arabiense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. arcueilense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. aromaticivorans</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. aurum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. austroafricanum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. baixiangningiore</emphasis>
                  <superscript>
                    <emphasis>
                      <link linkend="ch0049s0001s0002a0027">g</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. bourgelati</emphasis>
                  <superscript>
                    <emphasis>
                      <link linkend="ch0049s0001s0002a0027">g</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. chitae</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. chlorophenolicum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. chubuense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. confluentis</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. crocinum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. diernhoferi</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry>Unproven human pathogens</entry>
                <entry/>
                <entry/>
                <entry/>
                <entry/>
              </row>
              <row>
                <entry><emphasis>M. duvalii</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. eburneum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. fallax</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0049s0001s0002a0017"/>
                      <link linkend="ch0049s0001s0002a0029">i</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. flavescens</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. fluoranthenivorans</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0049s0001s0002a0018"/>
                      <link linkend="ch0049s0001s0002a0030">j</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. frederiksbergense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. gadium</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. gilvum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. hassiacum</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0049s0001s0002a0019"/>
                      <link linkend="ch0049s0001s0002a0031">k</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. helvum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. hippocampi</emphasis>
                  <superscript>
                    <emphasis>
                      <link linkend="ch0049s0001s0002a0026">f</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. hodleri</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0049s0001s0002a0020"/>
                      <link linkend="ch0049s0001s0002a0032">l</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. holsaticum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. insubricum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. komaniense</emphasis>
                  <superscript>
                    <emphasis>
                      <link linkend="ch0049s0001s0002a0027">g</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. komossense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. kyogaense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. lehmanii</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. litorale</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. llatzerense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. lutetiense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. madagascariense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. malmesburyense</emphasis>
                  <superscript>
                    <emphasis>
                      <link linkend="ch0049s0001s0002a0027">g</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. mengxianglii</emphasis>
                  <superscript>
                    <emphasis>
                      <link linkend="ch0049s0001s0002a0027">g</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. montmartrense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. murale</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. neglectum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. neumannii</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. obuense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. oryzae</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. palauense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. pallens</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. parafortuitum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. phlei</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. poriferae</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">ND<superscript><emphasis><link linkend="ch0049s0001s0002a0028">h</link></emphasis></superscript></phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. psychrotolerans</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. pyrenivorans</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. rhodesiae</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. rufum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. rutilum</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. salmoniphilum</emphasis>
                  <superscript>
                    <emphasis>
                      <link linkend="ch0049s0001s0002a0026">f</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. sarraceniae</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. sediminis</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. sphagni</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. stellerae</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. stephanolepidis</emphasis>
                  <superscript>
                    <emphasis>
                      <link linkend="ch0049s0001s0002a0026">f</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. syngnathidarum</emphasis>
                  <superscript>
                    <emphasis>
                      <link linkend="ch0049s0001s0002a0026">f</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. thermoresistibile</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. tokaiense</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. vaccae</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. vanbaalenii</emphasis>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
                <entry><phrase role="center">No</phrase>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0021"/><link linkend="ch0049s0001s0002a0009">a</link></emphasis></superscript>From reference <link linkend="ch0049s0030s0004li0039">39</link>.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0022"/><link linkend="ch0049s0001s0002a0010">b</link></emphasis></superscript><emphasis>M. houstonense</emphasis> is 100% identical by full 16S rRNA gene sequence to <emphasis>M. farcinogenes</emphasis>, a slowly growing species currently grouped with RGM.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0023"/><link linkend="ch0049s0001s0002a0011">c</link></emphasis></superscript><emphasis>M. peregrinum</emphasis> (type I) is 100% identical to <emphasis>M. septicum</emphasis>.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0024"/><link linkend="ch0049s0001s0002a0012">d</link></emphasis></superscript>“<emphasis>M. lacticola</emphasis>” is currently a nonvalidated species.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0025"/><link linkend="ch0049s0001s0002a0013">e</link></emphasis></superscript>Turns agar brown.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0026"/><link linkend="ch0049s0001s0002a0014">f</link></emphasis></superscript>Pathogenic for marine animals.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0027"/><link linkend="ch0049s0001s0002a0015">g</link></emphasis></superscript>Pathogenic for cattle or antelope (<emphasis>M. baixiangningiore</emphasis> and <emphasis>M. mengxianglii</emphasis> are listed under genus <emphasis>Mycolicibacterium</emphasis> in the LPSN).</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0028"/><link linkend="ch0049s0001s0002a0016">h</link></emphasis></superscript>ND, not done.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0029"/><link linkend="ch0049s0001s0002a0017">i</link></emphasis></superscript>RGM at 30°C and slowly growing <emphasis>Mycobacterium</emphasis> at 37°C.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0030"/><link linkend="ch0049s0001s0002a0018">j</link></emphasis></superscript>The 16S rRNA gene sequence is identical to that of the unvalidated species “<emphasis>M. hackensackense</emphasis>.”</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0031"/><link linkend="ch0049s0001s0002a0019">k</link></emphasis></superscript>Grows at 65°C.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0049s0001s0002a0032"/><link linkend="ch0049s0001s0002a0020">l</link></emphasis></superscript>Grows on or degrades a variety of organic substrates.</para>
        <table id="ch0049s0001s0002t0002"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0049s0001s0002a0033"/><link linkend="ch0049s0001s0002a0004">TABLE 3</link></phrase></emphasis> Commonly encountered clinically significant nonpigmented RGM species with identical 16S rRNA gene first 500-bp sequences
</title>
          
          <tgroup cols="2">
            <tbody>
              <row>
                <entry><phrase role="center">Species/subspecies</phrase>
                </entry>
                <entry><phrase role="center">Separated by <emphasis>rpoB</emphasis> gene sequence</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus, M. chelonae, M. abscessus</emphasis> subsp. <emphasis>massiliense, M. franklinii, M. abscessus</emphasis> subsp. <emphasis>bolletii</emphasis><superscript><link linkend="ch0049s0001s0002a0038"><emphasis>a</emphasis></link></superscript><anchor id="ch0049s0001s0002a0034"/></entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. senegalense, M. conceptionense</emphasis>,<superscript><link linkend="ch0049s0001s0002a0039"><emphasis>b</emphasis></link></superscript><anchor id="ch0049s0001s0002a0035"/> <emphasis>M. houstonense, M. fortuitum, M. farcinogenes</emphasis><superscript><link linkend="ch0049s0001s0002a0041"><emphasis>d</emphasis></link></superscript><anchor id="ch0049s0001s0002a0036"/></entry>
                <entry><phrase role="center">Yes<superscript><link linkend="ch0049s0001s0002a0040"><emphasis>c</emphasis></link></superscript></phrase>
                  <anchor id="ch0049s0001s0002a0037"/>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. mucogenicum, M. phocaicum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>M. peregrinum, M. septicum</emphasis>
                </entry>
                <entry><phrase role="center">Yes</phrase>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><link linkend="ch0049s0001s0002a0034"><emphasis>a</emphasis></link></superscript><anchor id="ch0049s0001s0002a0038"/>Multilocus sequence analysis may be needed to definitively identify the <emphasis>M. abscessus</emphasis> species to subspecies (<link linkend="ch0049s0030s0004li0038">38</link>, <link linkend="ch0049s0030s0004li0159">159</link>).</para>
        <para role="table-footnote"><superscript><link linkend="ch0049s0001s0002a0035"><emphasis>b</emphasis></link></superscript><anchor id="ch0049s0001s0002a0039"/><emphasis>M. conceptionense</emphasis> has been determined to be the same species as <emphasis>M. senegalense</emphasis> by whole-genome sequencing (<link linkend="ch0049s0030s0004li0039">39</link>).</para>
        <para role="table-footnote"><superscript><link linkend="ch0049s0001s0002a0037"><emphasis>c</emphasis></link></superscript><anchor id="ch0049s0001s0002a0040"/>Rare exception when gene transfer occurs.</para>
        <para role="table-footnote"><superscript><link linkend="ch0049s0001s0002a0036"><emphasis>d</emphasis></link></superscript><anchor id="ch0049s0001s0002a0041"/><emphasis>M. farcinogenes</emphasis> is a slowly growing <emphasis>Mycobacterium</emphasis> species, NOT an RGM (<link linkend="ch0049s0030s0004li0039">39</link>).</para>
      </sect2>
    </sect1>
    <sect1 id="ch0049s0002">
      <title>Skin and Soft Tissue Infections</title>
      <anchor id="ch0049s0002a0001"/>
      <anchor id="ch0049s0002a0002"/>
      <para id="ch0049s0002p0001">The major mechanism for acquiring NTM-associated skin and soft tissue infections (SSTIs) is direct contact with contaminated material or water through traumatic injury, procedure-related wounds, or environmental exposure. Secondary involvement of SSTIs during disseminated disease may also occur (<link linkend="ch0049s0030s0004li0051">51</link>). Although these patients are generally healthy, drug-induced immune suppression leads to increased risk for this type of infection. In addition, SSTIs are associated with important stigma, deformity, and disability. The clinical picture of traumatic and procedure-related wound infection ranges from localized cellulitis, nonhealing ulcers, chronic nodular lesions, and abscesses to progressive tenosynovitis. Osteomyelitis can also ensue depending on the severity and wound type, such as with open fracture (<link linkend="ch0049s0030s0004li0052">52</link>). (See following section on “Bone and Joint Infections.”) The majority of infections occur 4 to 6 weeks following wounds or procedures and generally exhibit local redness and swelling with spontaneous drainage. Sinus tract formations and intermittent drainage are commonly observed (<link linkend="ch0049s0030s0004li0053">53</link>). Metal puncture wounds (48%) and injuries from motor vehicle accidents (26%) are the most common antecedent injuries, and approximately 40% of injury sites involve the foot or leg (<link linkend="ch0049s0030s0004li0054">54</link>).</para>
      <para id="ch0049s0002p0002">Although any of the more than 30 pathogenic RGM species listed in<link linkend="ch0049s0001s0002a0008">Table 2</link> can cause disease, <emphasis>M. fortuitum</emphasis> is the most common SSTI species among RGM, and patients infected with the <emphasis>M. fortuitum</emphasis> group (including the species noted in <link linkend="ch0049s0001s0002a0008">Table 2</link>) have usually undergone a surgical procedure or experienced penetrating trauma, such as open fracture at the infected site. In contrast, patients infected with <emphasis>M. chelonae</emphasis> or the <emphasis>M. abscessus</emphasis> species tend to be older and are more likely to have an underlying health condition, and usually have multiple (disseminated) cutaneous lesions, as opposed to those with single (localized) lesions due to <emphasis>M. fortuitum</emphasis> (<link linkend="ch0049s0030s0004li0055">55</link>). (See section on “Disseminated Cutaneous Disease.”) <emphasis>M. chelonae</emphasis> may be responsible for sporadic cases of localized wound infections following trauma or medical or surgical procedures, including needle injections.</para>
      <sect2 id="ch0049s0002s0001">
        <title>Outbreaks Related to Footbaths (Nail Salons) and Tattooing</title>
        <anchor id="ch0049s0002s0001a0001"/>
        <anchor id="ch0049s0002s0001a0002"/>
        <para id="ch0049s0002s0001p0001">Starting in 2000, an outbreak of furunculosis (infection of hair follicles) on the lower extremities caused by<emphasis>M. fortuitum</emphasis> was described for 32 otherwise healthy patients who were patrons of a nail salon in California (footbaths precede pedicures at nail salons) (<link linkend="ch0049s0030s0004li0056">56</link>). The organism was also cultured from contaminated footbaths and from inlet suction screens containing hair and other debris, and the recovered isolates were indistinguishable by pulsed-field gel electrophoresis (PFGE). Leg shaving prior to the footbath and pedicure was identified as a significant risk factor (<link linkend="ch0049s0030s0004li0056">56</link>). The follow-up report revealed that most of the cases could be treated with oral antibiotics without surgical intervention, and more than two antibiotics tailored to the organism were recommended. Other species, including the <emphasis>M. abscessus</emphasis> species and <emphasis>M. mageritense</emphasis>, were subsequently recovered from cases in California, North Carolina, and Georgia (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0057">57</link>, <link linkend="ch0049s0030s0004li0058">58</link>).</para>
        <para id="ch0049s0002s0001p0002">In late 2011 and early 2012, an outbreak of 19 cases of<emphasis>M. chelonae</emphasis> associated with tattoo ink was reported in New York (<link linkend="ch0049s0030s0004li0059">59</link>). This was the largest documented outbreak of this type involving <emphasis>M. chelonae</emphasis>. Reported skin lesions were mainly restricted to the gray ink color, suggesting that infection might have occurred through a specific premixed tattoo ink. A total of 114 reported cases were analyzed in a systematic review (<link linkend="ch0049s0030s0004li0060">60</link>); <emphasis>M. chelonae</emphasis> was the most common, with other RGM species, such as <emphasis>M. immunogenum</emphasis>, the <emphasis>M. abscessus</emphasis> species, and <emphasis>M. fortuitum</emphasis>, also reported. Because tattooing has become very popular, the incidence rate and number of reported cases may have been underestimated. Fractionated CO<subscript>2</subscript> laser cosmetic resurfacing has also been associated with RGM infections (<link linkend="ch0049s0030s0004li0061">61</link>). However, in a report from North Carolina, isolates, the <emphasis>M. abscessus</emphasis> species isolates and <emphasis>M. chelonae</emphasis> isolates did not match those obtained from the clinic, suggesting that the infection was acquired post procedure.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0049s0003">
      <title>Bone and Joint Infections</title>
      <anchor id="ch0049s0003a0001"/>
      <anchor id="ch0049s0003a0002"/>
      <para id="ch0049s0003p0001">RGM may also cause bone and joint infections. Similar to bacterial disease, osteomyelitis may occur after open bone fractures and puncture wounds. The most common scenario is an open fracture of the femur, often followed by orthopedic surgical procedures. This type of infection may be due to disseminated-type disease. Moreover, the causative species may vary depending on the clinical setting, but the pathogen most frequently recovered in this setting is the<emphasis>M. fortuitum</emphasis> group, including the rare species <emphasis>M. houstonense, M. boenickei</emphasis>, and <emphasis>M. setense</emphasis> (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0026">26</link>, <link linkend="ch0049s0030s0004li0062">62</link>). One species in the <emphasis>M. smegmatis</emphasis> group, <emphasis>M. goodii</emphasis>, and one species in the <emphasis>M. mageritense/wolinskyi</emphasis> group, <emphasis>M. wolinskyi</emphasis>, have also been associated with osteomyelitis (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0043">43</link>). Bone involvement secondary to a puncture wound is likely the second major cause of osteomyelitis, and such infections most commonly involve the <emphasis>M. fortuitum</emphasis> group (<link linkend="ch0049s0030s0004li0001">1</link>). An increasing cause of bone and joint infections are prosthetic knee and joint infections caused by <emphasis>M. fortuitum</emphasis> and <emphasis>M. chelonae</emphasis> (<link linkend="ch0049s0030s0004li0062">62</link>).</para>
      <para id="ch0049s0003p0002">These bone and joint infections usually occur in immunocompetent patients who have an apparent predisposing trauma or penetrating injury or who have undergone surgical procedures. Nevertheless, vertebral osteomyelitis (VO) is unusual in such patients; indeed, approximately half of VO cases develop in immunocompromised patients, and 85% of cases do not have any direct inoculation events (<link linkend="ch0049s0030s0004li0063">63</link>). In these cases, blood-borne infection is suspected, especially in immunosuppressed patients. An outbreak of septic arthritis due to <emphasis>M. abscessus</emphasis>. subsp. <emphasis>massiliense</emphasis> among patients who had intra-articular injections of a steroid mixed with an analgesic at a single clinic was reported in South Korea (<link linkend="ch0049s0030s0004li0064">64</link>).</para>
      <anchor id="ch0049s0003a0003"/>
      <beginpage pagenum="662"/>
    </sect1>
    <sect1 id="ch0049s0004">
      <title>Pulmonary Infections</title>
      <anchor id="ch0049s0004a0001"/>
      <anchor id="ch0049s0004a0002"/>
      <para id="ch0049s0004p0001">Chronic lung infections with RGM, most often in nonsmoking older women with bronchiectasis, are sometimes associated with the<emphasis>M. avium</emphasis> complex (MAC). The <emphasis>M. abscessus</emphasis> species is the causative agent in approximately 80% of cases of pulmonary disease due to RGM, but geographical variations have been noted (<link linkend="ch0049s0030s0004li0047">47</link>). <emphasis>M. abscessus</emphasis> is also the most intractable NTM species; radiological findings are the same as for MAC disease, with a fibrocavitary type and nodular-bronchiectatic type disease (<link linkend="ch0049s0030s0004li0065">65</link>). The proportion of the three subspecies (<emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus, M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis>, or <emphasis>M. abscessus</emphasis> subsp. <emphasis>bolletii</emphasis>) is dependent on the country or region (<link linkend="ch0049s0030s0004li0066">66</link>–<link linkend="ch0049s0030s0004li0069">69</link>). At present, there is no explanation for the apparently variable geographic distribution of <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> strains in the population with respiratory disease. Data show a relatively higher proportion (44 to 56%) in Asian countries than in the United States (28%), and European countries, such as the Netherlands (21%) (<link linkend="ch0049s0030s0004li0066">66</link>, <link linkend="ch0049s0030s0004li0067">67</link>, <link linkend="ch0049s0030s0004li0069">69</link>). The proportion and geographical distribution of a point mutation at position 28 (T28C), which results in inactivation of <emphasis>erm</emphasis>(<link linkend="ch0049s0030s0004li0041">41</link>) in <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> and consequential retention of susceptibility to macrolides, are unknown. <emphasis>M. abscessus</emphasis> subsp. <emphasis>bolletii</emphasis> is rarely associated with disease in any of the geographical areas.</para>
      <para id="ch0049s0004p0002">Typically, MAC is the most commonly identified NTM in pulmonary disease, and approximately 20 to 30% of the<emphasis>M. abscessus</emphasis> species cases have previous MAC disease (<link linkend="ch0049s0030s0004li0070">70</link>, <link linkend="ch0049s0030s0004li0071">71</link>). Therefore, subsequent positive culture for the <emphasis>M. abscessus</emphasis> species among MAC pulmonary diseases is not uncommon. Conversely, some patients from whom the <emphasis>M. abscessus</emphasis> species are first cultured also have secondary positive cultures for MAC. There are similarities between patients infected with MAC and with the <emphasis>M. abscessus</emphasis> species, and a common pathogenicity or host susceptibility factor may be involved. Less than 20% of <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> and <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> infections are associated with fibrocavitary-type disease, and there is no difference in the time to progression between the two groups (<link linkend="ch0049s0030s0004li0069">69</link>). Because of a nonfunctional <emphasis>erm</emphasis> gene, patients with <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> are successfully treated with macrolides more often than patients infected with <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> (72 to 80% success rate, in contrast to 25 to 35% for patients with <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis>, usually with a functional <emphasis>erm</emphasis> gene) (<link linkend="ch0049s0030s0004li0067">67</link>–<link linkend="ch0049s0030s0004li0069">69</link>).</para>
      <sect2 id="ch0049s0004s0001">
        <title>Cystic Fibrosis</title>
        <anchor id="ch0049s0004s0001a0001"/>
        <anchor id="ch0049s0004s0001a0002"/>
        <para id="ch0049s0004s0001p0001">Over the past 2 decades, the discovery of drugs that modulate the synthesis and function of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) protein has resulted in the oldest and healthiest CF population in history (<link linkend="ch0049s0030s0004li0072">72</link>). Thus, there is the possibility that improved CF treatment might contribute to the apparent increase in NTM prevalence among patients. Patients with CF also have bronchiectasis, in addition to chronic, recurrent airway and pulmonary parenchymal infections, which may be primary risk factors for susceptibility to NTM disease (<link linkend="ch0049s0030s0004li0073">73</link>). Furthermore, NTM pulmonary disease is associated with a rapid decline in forced expiratory volume in the first second of expiration (FEV1) in CF patients (<link linkend="ch0049s0030s0004li0074">74</link>). In CF patients with a macrolide-resistant <emphasis>M. abscessus</emphasis> species infection, lung transplant decisions are challenging, and the transplant may not be performed (<link linkend="ch0049s0030s0004li0072">72</link>, <link linkend="ch0049s0030s0004li0075">75</link>).</para>
        <para id="ch0049s0004s0001p0002">The<emphasis>M. abscessus</emphasis> species are the second most common group of NTM recovered from CF patients (after MAC, but some centers report a greater frequency), and it may be the most common species associated with clinical disease in this setting (<link linkend="ch0049s0030s0004li0073">73</link>). A 2012 study concluded that CF patients with the <emphasis>M. abscessus</emphasis> species were younger and had more severe disease and more frequent intravenous antimicrobial treatment than those with MAC infection (<link linkend="ch0049s0030s0004li0076">76</link>). The first possible human-to-human transmission of NTM was reported in 2012 in Seattle in CF patients with <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> (<link linkend="ch0049s0030s0004li0077">77</link>). This finding was further investigated, and isolates that genetically matched the strain with possible human-to-human transmission have been detected in several geographic areas outside the United States, including the United Kingdom and South America, which provides preliminary corroborative evidence for the unusual type of transmission (<link linkend="ch0049s0030s0004li0036">36</link>, <link linkend="ch0049s0030s0004li0077">77</link>–<link linkend="ch0049s0030s0004li0079">79</link>). In addition, more than 1,000 <emphasis>M. abscessus</emphasis> species clinical isolates have been obtained from 517 CF patients in Europe, the United States, and Australia. The study reported the isolation of nearly identical clones from various geographically distant locations. Approximately 74% of CF patients worldwide are infected with two <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> clusters or one <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> cluster (<link linkend="ch0049s0030s0004li0080">80</link>). Although these findings suggest the possibility of global spread among CF patients, there are scant reports from areas with few CF patients.</para>
      </sect2>
      <sect2 id="ch0049s0004s0002">
        <title>Chronic Aspiration Syndrome and Miscellaneous Lung Disease</title>
        <anchor id="ch0049s0004s0002a0001"/>
        <anchor id="ch0049s0004s0002a0002"/>
        <para id="ch0049s0004s0002p0001">The<emphasis>M. fortuitum</emphasis> group has been reported as a pathogen in half of cases of chronic aspiration disease secondary to underlying gastroesophageal disorders, such as achalasia (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0047">47</link>). However, <emphasis>M. fortuitum</emphasis> pulmonary disease is rare and often does not require treatment, though cases of extensive disease associated with lipoid pneumonia, as has also been seen in a few cases due to <emphasis>M. chelonae</emphasis> and <emphasis>M. smegmatis</emphasis>, have been reported (<link linkend="ch0049s0030s0004li0081">81</link>, <link linkend="ch0049s0030s0004li0082">82</link>). A rare case of pulmonary disease with <emphasis>M. mageritense</emphasis> was described for a patient with a compromised immune system (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0083">83</link>). Nevertheless, the outbreak of <emphasis>M. porcinum</emphasis> discussed below described the first reported cases of clinically significant pulmonary disease associated with this species, a member of the <emphasis>M. fortuitum</emphasis> group (<link linkend="ch0049s0030s0004li0048">48</link>).</para>
      </sect2>
      <sect2 id="ch0049s0004s0003">
        <title>Hypersensitivity Pneumonitis</title>
        <anchor id="ch0049s0004s0003a0001"/>
        <anchor id="ch0049s0004s0003a0002"/>
        <para id="ch0049s0004s0003p0001">Hypersensitivity pneumonitis among metal grinders working with contaminated metal-working fluids (MWF) in industrial plants has been associated with<emphasis>M. immunogenum</emphasis> (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0047">47</link>). Multiple pseudo-outbreaks associated with this species resulting from contaminated automated bronchoscope cleaning machines and MWF have been reported. This species can grow and remain viable in degraded MWF, and it is resistant to the routine biocides used for disinfection of MWF. Exposure to the contaminated MWF results in an allergic hypersensitivity pneumonitis (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0047">47</link>). To date, this species has not been detected in open lung biopsy specimens from these patients.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0049s0005">
      <title>Central Nervous System Disease</title>
      <anchor id="ch0049s0005a0001"/>
      <anchor id="ch0049s0005a0002"/>
      <anchor id="ch0049s0005a0003"/>
      <para id="ch0049s0005p0001">Although central nervous system disease involving RGM is rare, morbidity and mortality are high.<emphasis>M. fortuitum</emphasis> is the most common species, followed by the <emphasis>M. abscessus</emphasis> species and <emphasis>M. mucogenicum</emphasis> (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0084">84</link>). Meningitis is the typical clinical presentation, manifesting as headache, fever, and neck stiffness. CSF findings usually show low glucose, high protein, and elevated white blood cells (<link linkend="ch0049s0030s0004li0084">84</link>). Acquisition modes include otolaryngological disease, previous neurosurgery, and CNS catheters (i.e., ventriculoperitoneal shunt or epidural catheters). Therefore, if a patient with antecedent trauma or surgery or an immunosuppressed state has a chronic presentation and neutrophilic CSF, RGM infection should be suspected. In general, infections due to the <emphasis>M. abscessus</emphasis> species and <emphasis>M. mucogenicum</emphasis> have high mortality. Early clinical suspicion is critical, with an impact on management and outcome (<link linkend="ch0049s0030s0004li0085">85</link>). A patient infected with <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> who survived was reported in a small case series. Treatment with steroids is recommended in those with substantial meningeal involvement (<link linkend="ch0049s0030s0004li0084">84</link>).</para>
    </sect1>
    <sect1 id="ch0049s0006">
      <title>Ocular Infections</title>
      <anchor id="ch0049s0006a0001"/>
      <anchor id="ch0049s0006a0002"/>
      <para id="ch0049s0006p0001">The spectrum of ocular infections caused by NTM includes keratitis, canaliculitis, scleral buckle infections, conjunctivitis, scleritis, and endophthalmitis (<link linkend="ch0049s0030s0004li0086">86</link>), and the number of RGM ocular infections has been increasing. In a large study that analyzed 100 ophthalmic cases, the majority of patients were infected with RGM (95%), and the causative species were <emphasis>M. chelonae</emphasis> (44%), the <emphasis>M. abscessus</emphasis> species (38%), and the <emphasis>M. fortuitum</emphasis> group (9%) (<link linkend="ch0049s0030s0004li0087">87</link>). With advances in refractive surgery, other descriptions of epidemic and sporadic ocular infections, especially infections following laser-assisted <emphasis>in situ</emphasis> keratomileusis (LASIK) surgery (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0087">87</link>), have increased dramatically since the early 1990s. Endophthalmitis is a severe intraocular infection. Approximately 88% of cases of endophthalmitis occur exogenously due to RGM, and cataract surgery is the most common procedure related to infection (<link linkend="ch0049s0030s0004li0088">88</link>). If patients have a history of previous trauma, previous surgery, or compromised immunity, the possibility of NTM infection should be suspected, especially when refractory to topical antibiotics (<link linkend="ch0049s0030s0004li0089">89</link>). Steroids should be avoided for keratitis treatment. A study that analyzed species involved in ocular infection in Taiwan found that 11 of 24 isolates were <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis>.</para>
    </sect1>
    <sect1 id="ch0049s0007">
      <title>Otitis Media</title>
      <anchor id="ch0049s0007a0001"/>
      <anchor id="ch0049s0007a0002"/>
      <para id="ch0049s0007p0001">The most common NTM ear diseases are chronic otitis media and otomastoiditis caused by<emphasis>M. abscessus</emphasis> species. Ear diseases caused by NTM are common in children, but adult cases are often reported in Asian countries. The entry route of NTM into the middle ear is speculated to involve two distinct routes: a tympanostomy tube with spread to the middle ear through the eustachian tube, and spread via the use of contaminated surgical instruments (<link linkend="ch0049s0030s0004li0090">90</link>). In an outbreak of 17 cases of otitis media in two ear-nose-throat clinics, patients presented with chronic ear drainage with a perforated tympanic membrane and a prior tympanostomy tube (<link linkend="ch0049s0030s0004li0001">1</link>). This is the characteristic scenario of such cases, and mycobacterial infections should be suspected. Sporadic cases of this disease continue to be reported. The key to the disease appears to be the presence of a foreign body (tympanostomy tube) and multidrug resistance. Treatment for the macrolide-resistant <emphasis>M. abscessus</emphasis> species consists of long-term parenteral or intravenous antibiotic combination therapy along with surgical intervention (<link linkend="ch0049s0030s0004li0090">90</link>). Otitis media and otomastoiditis caused by <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> (macrolide susceptible) were described for middle-aged adults with underlying otologic disease. These patients were treated successfully with clarithromycin-containing regimens for up to 9 months (<link linkend="ch0049s0030s0004li0091">91</link>).</para>
    </sect1>
    <sect1 id="ch0049s0008">
      <title>Health Care-Associated Infections</title>
      <anchor id="ch0049s0008a0001"/>
      <anchor id="ch0049s0008a0002"/>
      <para id="ch0049s0008p0001">Health care-associated disease with RGM has been reported most commonly for<emphasis>M. fortuitum, M. chelonae</emphasis>, the <emphasis>M. abscessus</emphasis> species, and <emphasis>M. mucogenicum</emphasis>, though any species may be involved. Most infections occur following contamination with tap water (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0092">92</link>, <link linkend="ch0049s0030s0004li0093">93</link>). Types of infections include postsurgical wound infections, catheter sepsis, infections following hemodialysis, postinjection abscesses, and otitis media following tympanostomy tube replacement (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0093">93</link>). Both sporadic cases and localized outbreaks have occurred. Cosmetic procedure-associated infections caused by liposuction, liposculpture, acupuncture, and mesotherapy have also occurred (<link linkend="ch0049s0030s0004li0093">93</link>–<link linkend="ch0049s0030s0004li0096">96</link>). Because some cosmetic procedures include surgical intervention and are performed at a health care facility, the differences between health care- and cosmetic procedure-associated infections are sometimes obscure and can be included in this category (<link linkend="ch0049s0030s0004li0097">97</link>, <link linkend="ch0049s0030s0004li0098">98</link>).</para>
      <para id="ch0049s0008p0002">Two recent outbreaks involving<emphasis>M. abscessus</emphasis> infections following pulpotomy in pediatric dental clinics have been published (<link linkend="ch0049s0030s0004li0097">97</link>, <link linkend="ch0049s0030s0004li0098">98</link>), including a report of 24 school-aged children in Atlanta, Georgia, with inducibly macrolide-resistant <emphasis>M. abscessus</emphasis> species. Twelve children received antibiotics, one child underwent lymph node resection, and 11 children needed postsurgical antibiotics following incomplete surgical excision or presence of pulmonary nodules. Five children experienced serious adverse events during treatment including nephrotoxicity, ototoxicity, neutropenia, and rash. An epidemiological investigation suggested the outbreak was associated with the use of tap water during pulpotomy. After a change to treated distilled water, no other cases have been reported (<link linkend="ch0049s0030s0004li0097">97</link>).</para>
      <para id="ch0049s0008p0003">The second and largest odontogenic outbreak to date identified 71 pediatric patients (22 confirmed and 49 probable) in Orange County, California. All case patients required surgical procedures and 26 of 70 hospitalized patients required more than one surgery. Tissue samples from 19 of 22 patients grew<emphasis>M. abscessus</emphasis>; 1 of 22 was identified as <emphasis>M. chelonae</emphasis>, and 2 of 22 were acid-fast bacteria unable to be identified from culture. Similar to the Georgia cases, adverse events were common and the outbreak was associated with the use of nonsterile water. Following the outbreak, a new California law was passed which specified the use of nonsterile water or water without appropriate antibacterial properties as “unprofessional conduct.” All patients recovered despite extensive jaw debridements and pulmonary involvement (<link linkend="ch0049s0030s0004li0098">98</link>).</para>
      <para id="ch0049s0008p0004">More than 2,000 cases of surgical-site infections after video-laparoscopic and arthroscopic surgical procedures caused by RGM were reported by the Brazilian national agency from 2003 to 2008 (<link linkend="ch0049s0030s0004li0099">99</link>), and analyses of more than 150 strains from different states revealed that they belong to a single <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> strain (BRA100) (<link linkend="ch0049s0030s0004li0100">100</link>, <link linkend="ch0049s0030s0004li0101">101</link>). Additionally, it was noteworthy that the strain was resistant to 2% glutaraldehyde disinfectants used for disinfecting surgical equipment between surgeries (<link linkend="ch0049s0030s0004li0099">99</link>, <link linkend="ch0049s0030s0004li0102">102</link>). Reports of surgically related infections decreased after 2008 after control measures were implemented by the Brazilian authority, but additional infections were reported in a different area of Brazil in 2010 (<link linkend="ch0049s0030s0004li0103">103</link>). Interestingly, some studies have indicated a molecular relationship between the BRA100 clone and strains from Taiwan, Malaysia, the United Kingdom, and the United States.</para>
      <anchor id="ch0049s0008a0003"/>
      <beginpage pagenum="664"/>
      <para id="ch0049s0008p0005">Outbreaks of NTM wound infections, especially with the<emphasis>M. abscessus</emphasis> species, have occurred among “lipotourists” from the United States who travel abroad to undergo cosmetic surgery. From 2003 to 2004, 20 U.S. tourists who underwent abdominoplasty in the Dominican Republic developed <emphasis>M. abscessus</emphasis> species postsurgical infections (<link linkend="ch0049s0030s0004li0094">94</link>); 8 who underwent surgery in the same clinic were infected with identical isolates. The remaining patients who carried different strains of the <emphasis>M. abscessus</emphasis> species underwent surgery in different clinics but otherwise had clinical presentations and demographic characteristics similar to those of the other patients (<link linkend="ch0049s0030s0004li0094">94</link>).</para>
      <para id="ch0049s0008p0006">Biomesotherapy, a therapy used (mostly outside of the U.S.) for pain management and general well-being, which includes injection of unregulated supplements and homeopathic formulations, has also been associated with outbreaks of<emphasis>M. chelonae</emphasis> and the <emphasis>M. abscessus</emphasis> species (<link linkend="ch0049s0030s0004li0104">104</link>, <link linkend="ch0049s0030s0004li0105">105</link>). In addition to true outbreaks, numerous health care-associated pseudo-outbreaks have been described. Contaminated or malfunctioning equipment, including bronchoscopes and automated endoscope cleaning machines, as well as contaminated laboratory reagents and ice, have been implicated (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0093">93</link>, <link linkend="ch0049s0030s0004li0104">104</link>).</para>
      <para id="ch0049s0008p0007">A 2013–2014 outbreak of<emphasis>M. abscessus</emphasis> species at a tertiary care hospital in the southeastern United States involved infections in lung transplant patients following surgery. Multiple interventions in patient care, including institution of sterile water for consumption, oral care, and bathing, and water engineering were implemented, and the outbreak subsided. Molecular strain typing by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing identified two clonal strains of the <emphasis>M. abscessus</emphasis> species among clinical isolates, one of which was isolated from the hospital water supply in a new medical tower (<link linkend="ch0049s0030s0004li0106">106</link>).</para>
      <para id="ch0049s0008p0008">A 2014 cluster of six surgical site infections following cardiothoracic surgery due to<emphasis>M. wolinskyi</emphasis> were reported from a single academic medical center. No single point source of infection or environmental source was identified, but a self-contained heater/cooler unit used in cardiothoracic surgeries and a cold-air blaster were suspected as potential sources of infection. Removal of the units resulted in an end of the outbreak (<link linkend="ch0049s0030s0004li0107">107</link>). A similar outbreak in France was also investigated with implementation of special infection control mediations (<link linkend="ch0049s0030s0004li0108">108</link>). Although outbreaks related to cosmetic procedure-associated infections have been mainly reported in South American countries, any country may be involved and have inherent risks.</para>
      <sect2 id="ch0049s0008s0001">
        <title>Catheter-Related Infections</title>
        <anchor id="ch0049s0008s0001a0001"/>
        <anchor id="ch0049s0008s0001a0002"/>
        <para id="ch0049s0008s0001p0001">Central catheter-associated infections are the most common health care-associated infections due to RGM (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0048">48</link>, <link linkend="ch0049s0030s0004li0051">51</link>, <link linkend="ch0049s0030s0004li0078">78</link>). Indeed, they are the most common cause of RGM bacteremia, but the disease may also present as local wound drainage as part of an exit site or tunnel infection (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0051">51</link>, <link linkend="ch0049s0030s0004li0078">78</link>, <link linkend="ch0049s0030s0004li0081">81</link>). Thus, symptoms range from local manifestations of catheter infection sites to systemic inflammatory responses. <emphasis>M. mucogenicum, M. fortuitum</emphasis>, the <emphasis>M. abscessus</emphasis> species, and the pigmented species <emphasis>M. bacteremicum</emphasis> (<link linkend="ch0049s0030s0004li0044">44</link>) are the most common pathogens in central line-associated bloodstream infection (CLABSI). Notably, <emphasis>M. mucogenicum</emphasis> is indistinguishable from <emphasis>M. phocaicum</emphasis> by 16S rRNA sequencing analysis because the sequences are completely identical. Rare RGM, such as <emphasis>M. neoaurum, M. canariasense</emphasis>, and <emphasis>M. phocaicum</emphasis>, have also been reported to cause catheter-related infections. An outbreak of <emphasis>M. phocaicum</emphasis> and <emphasis>M. mucogenicum</emphasis> was described for five patients with central venous catheters in an oncology unit in a Texas hospital (<link linkend="ch0049s0030s0004li0093">93</link>).</para>
        <para id="ch0049s0008s0001p0002">Peritoneal catheter infection can involve the catheter insertion site, the tunnelling tract, and the peritoneum. Peritonitis leads to a high rate of catheter withdrawal and relatively high mortality. Because a low percentage of patients stop peritoneal dialysis when a catheter is removed before developing peritonitis, it is recommended that the catheter be removed when exit site infection occurs. Other types of infection due to ventriculoperitoneal shunts and shunts for hemodialysis have also been reported.</para>
      </sect2>
      <sect2 id="ch0049s0008s0002">
        <title>Prosthetic Devices</title>
        <anchor id="ch0049s0008s0002a0001"/>
        <anchor id="ch0049s0008s0002a0002"/>
        <para id="ch0049s0008s0002p0001">Prosthetic device infections, including prosthetic heart valves, artificial knees and hips, lens implants, and metal rods inserted into the vertebrae to stabilize bones following fractures, have been described (<link linkend="ch0049s0030s0004li0062">62</link>). Again, <emphasis>M. fortuitum</emphasis> is the most common pathogen, but any pathogenic RGM, including the <emphasis>M. smegmatis</emphasis> group, can be associated with this type of infection (<link linkend="ch0049s0030s0004li0062">62</link>).</para>
      </sect2>
      <sect2 id="ch0049s0008s0003">
        <title>Transplant Patients</title>
        <anchor id="ch0049s0008s0003a0001"/>
        <anchor id="ch0049s0008s0003a0002"/>
        <para id="ch0049s0008s0003p0001">In transplant patients, infections caused by RGM are more of a problem in hematopoietic stem cell transplantation (HSCT) than in solid-organ transplantation and are often caused by<emphasis>M. fortuitum</emphasis>, the <emphasis>M. abscessus</emphasis> species, <emphasis>M. chelonae, M. mucogenicum</emphasis>, and rarely <emphasis>M. neoaurum</emphasis> (<link linkend="ch0049s0030s0004li0109">109</link>). The risk of NTM infection in HSCT patients is 50 to 600 times higher than that in the general population (<link linkend="ch0049s0030s0004li0109">109</link>), with a wide range of onset times from 1 to 35 months after transplantation (<link linkend="ch0049s0030s0004li0110">110</link>). The most common manifestation of RGM infection in HSCT patients is central venous catheter infection. In solid-organ transplant patients, skin and soft-tissue infections are commonly associated with surgical sites and long-term intravenous or peritoneal catheters (<link linkend="ch0049s0030s0004li0111">111</link>).</para>
      </sect2>
      <sect2 id="ch0049s0008s0004">
        <title>Surgical Wound Infections</title>
        <anchor id="ch0049s0008s0004a0001"/>
        <anchor id="ch0049s0008s0004a0002"/>
        <para id="ch0049s0008s0004p0001">Surgical wound infections due to RGM are a well-recognized clinical entity. In the 1970s and 1980s, multiple outbreaks of disease occurred, and these were most commonly associated with augmentation mammoplasty and coronary artery bypass surgery (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0093">93</link>, <link linkend="ch0049s0030s0004li0112">112</link>). (See “Health Care-Associated Infections,” above.) Infections following these types of surgery are now less common, although a cluster of 12 cases of post-augmentation mammoplasty surgical site infections due to <emphasis>M. fortuitum</emphasis> and <emphasis>M. porcinum</emphasis> was reported between 2002 and 2004 in Brazil (<link linkend="ch0049s0030s0004li0112">112</link>). More often, however, these infections now occur following other types of cosmetic surgeries, such as liposuction, breast reconstruction following mastectomy, and other types of prosthetic surgeries, such as knee replacements.</para>
        <para id="ch0049s0008s0004p0002">In a 1989 report (<link linkend="ch0049s0030s0004li0018">18</link>), approximately 80% of RGM wound isolates related to cardiac surgery were from seven southern coastal states, including Texas, Louisiana, Georgia, Maryland, Alabama, Florida, and South Carolina. A second report, published in the same year, showed that 92% of 37 identified cases of surgical wound infection following augmentation mammoplasty were also from patients in southern coastal states, with the majority located in Texas, Florida, and North Carolina, suggesting that the disease risk was highest in the southeastern United States (<link linkend="ch0049s0030s0004li0001">1</link>).</para>
        <para id="ch0049s0008s0004p0003">Recovery of<emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> and <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> has been reported from outbreaks of infections associated with laparoscopic surgeries and cosmetic surgeries in Brazil, the Dominican Republic, and Korea (<link linkend="ch0049s0030s0004li0093">93</link>, <link linkend="ch0049s0030s0004li0094">94</link>, <link linkend="ch0049s0030s0004li0096">96</link>). These and other recent reports suggest that, although few studies have identified these newer subspecies in invasive infections, they may have been misclassified in previous studies (<link linkend="ch0049s0030s0004li0113">113</link>).</para>
        <anchor id="ch0049s0008s0004a0003"/>
        <beginpage pagenum="665"/>
        <para id="ch0049s0008s0004p0004">A 2015 study involved 19 patients who developed postsurgical wound infections following caesarean sections, hernioplasty, diagnostic laproscopy, laproscopic cholecystectomy, and reduction mammoplasty in India (<link linkend="ch0049s0030s0004li0114">114</link>). Although the isolates were identified using only biochemical testing and growth rate, the organisms present in the cultures included those of the <emphasis>M. fortuitum</emphasis> and the <emphasis>M. abscessus/chelonae</emphasis> groups.</para>
        <para id="ch0049s0008s0004p0005">All of the patients, except two who were lost to follow-up and two who relapsed following repeated incision and drainage and exploratory surgery, recovered following draining of abscesses and resection of any nodules along with antibiotic treatment with amikacin and clarithromycin (<link linkend="ch0049s0030s0004li0114">114</link>).</para>
        <para id="ch0049s0008s0004p0006">In 2016, Wu and colleagues reported<emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> in four postpartum women following caesarean sections in Taiwan from 2009 to 2012 (<link linkend="ch0049s0030s0004li0115">115</link>). All four patients recovered following regimens of macrolides, amikacin, imipenem/cilastin, and tigecycline without surgical intervention. These two studies along with earlier reports highlight the importance of combining surgical and combination antibiotic therapy for wound infections due to the RGM. As stated previously, many of the other surgical wound infections involved outbreak situations and are discussed in “Health Care-Associated Infections,” above.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0049s0009">
      <title>Infections Associated with Anti-IFN-γ Autoantibodies</title>
      <anchor id="ch0049s0009a0001"/>
      <anchor id="ch0049s0009a0002"/>
      <para id="ch0049s0009p0001">NTM infections involving neutralizing anti-IFN-γ autoantibodies, known as “adult-onset immunodeficiency,” were first described in 2004 (<link linkend="ch0049s0030s0004li0116">116</link>, <link linkend="ch0049s0030s0004li0117">117</link>). The IFN-γ–IL-12 pathway plays an essential role in the host immune response to intracellular pathogens (<link linkend="ch0049s0030s0004li0118">118</link>). Most of the patients were immunocompetent Asian adults who presented with disseminated infections along with lymph node swelling. A review found that the mean age of onset was 52 ± 13.7 years; 64 patients (58%) were female, who were younger than the males in the study (48.8 ± 11.5 versus 56.3 ± 15.2 years) (<link linkend="ch0049s0030s0004li0119">119</link>). Less than half of the cases also had a history of other opportunistic infections (e.g., salmonellosis, cryptococcosis, penicilliosis, and histoplasmosis) because of blockage of the IFN-γ–IL-12 pathway. Reactive dermatitis, such as Sweet’s syndrome and erythema nodosum, is also commonly reported, especially in RGM cases. The most common organs involved are the lymph nodes (79%), followed by the bones/joints (34%), lungs (32%), blood (24%), skin (18%), and bone marrow (11%). RGM (the <emphasis>M. abscessus</emphasis> species, <emphasis>M. fortuitum</emphasis>, and <emphasis>M. chelonae</emphasis>) were frequently isolated from more than half of the cases, even though <emphasis>M. avium</emphasis> is common in AIDS patients with disseminated NTM infection. It remains unclear whether these patients are more susceptible to RGM or if the findings merely reflected the environment of the susceptible host. Lymph node lesions and reactive dermatitis are more common in patients with RGM infection. Indeterminate results of the QuantiFERON TB test suggest antibody positivity in the serum (<link linkend="ch0049s0030s0004li0119">119</link>).</para>
      <para id="ch0049s0009p0002">A rare type of disseminated infection due to RGM in immune-competent hosts presenting with lymphadenopathy was recently described in patients from Thailand (<link linkend="ch0049s0030s0004li0120">120</link>). These patients were ultimately shown to have anti-IFN-γ auto antibodies (<link linkend="ch0049s0030s0004li0120">120</link>).</para>
    </sect1>
    <sect1 id="ch0049s0010">
      <title>Disseminated Cutaneous Disease</title>
      <anchor id="ch0049s0010a0001"/>
      <anchor id="ch0049s0010a0002"/>
      <para id="ch0049s0010p0001">For unknown reasons, disseminated cutaneous disease is rare for all taxonomic groups other than the<emphasis>M. abscessus/M. chelonae</emphasis> group, even in immune-compromised patients, including those with AIDS (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0047">47</link>, <link linkend="ch0049s0030s0004li0121">121</link>).</para>
      <para id="ch0049s0010p0002">In contrast, disseminated cutaneous disease due to both<emphasis>M. abscessus</emphasis> species (less frequently seen) and <emphasis>M. chelonae</emphasis> is more common and serious. Disease typically presents as multiple, chronic, painful red nodules, usually involving the lower extremities, in chronically immunosuppressed patients receiving corticosteroids (organ transplant recipients, patients with rheumatoid arthritis, and/or other autoimmune disorders or immunosuppressive therapy) (<link linkend="ch0049s0030s0004li0055">55</link>), and the disease has no apparent portal of entry. Also, as with <emphasis>M. chelonae</emphasis>, patients with disseminated cutaneous infection due to <emphasis>M. abscessus</emphasis> species rarely have detectable bacteremia and/or endocarditis but usually present with multiple, draining, painful cutaneous nodules, usually in the lower extremities (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0047">47</link>). These lesions then drain spontaneously, with the drainage usually being acid-fast bacillus smear positive. With disease due to <emphasis>M. chelonae</emphasis>, almost all patients are immunosuppressed, usually from low-dose corticosteroid therapy. Although the disease is presumably a consequence of hematogenous spread, bacteremia is rarely identified in this clinical setting. A portal of entry for the infection is rarely evident (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0047">47</link>). In a series of 100 clinical isolates from skin and soft tissue, 53% were from patients with disseminated cutaneous infections (<link linkend="ch0049s0030s0004li0001">1</link>).</para>
      <sect2 id="ch0049s0010s0001">
        <title>COLLECTION, TRANSPORT, AND STORAGE OF SPECIMENS</title>
        <anchor id="ch0049s0010s0001a0001"/>
        <anchor id="ch0049s0010s0001a0002"/>
        <para id="ch0049s0010s0001p0001">Details of standard methods are included in<ulink url="ch0046#ch0046s0001">chapter 30</ulink> of this <emphasis>Manual</emphasis>. Transport of specimens is accomplished by using leakproof containers and proper safety protocols. Specimens for detection of RGM should be delivered to the laboratory in a timely manner, following appropriate shipping and handling regulations for shipping biological or infectious materials (<link linkend="ch0049s0030s0004li0122">122</link>).</para>
      </sect2>
      <sect2 id="ch0049s0010s0002">
        <title>DIRECT EXAMINATION</title>
        <anchor id="ch0049s0010s0002a0001"/>
        <anchor id="ch0049s0010s0002a0002"/>
      </sect2>
    </sect1>
    <sect1 id="ch0049s0011">
      <title>Microscopy</title>
      <anchor id="ch0049s0011a0001"/>
      <anchor id="ch0049s0011a0002"/>
      <para id="ch0049s0011p0001">The use of mycobacterial smears is a rapid and reasonably sensitive step in the diagnosis of RGM disease. Gram stains showing faintly staining, “ghost-like” beaded Gram-positive bacilli are often helpful in establishing a diagnosis of mycobacteriosis. Ziehl-Neelsen or Kinyoun staining may also be useful. However, the use of smears alone is not sufficient for species identification. A large study found that NTM, including RGM, are likely to be detected by fluorochrome staining of specimens, especially those from patients at low risk for AIDS in areas where lung disease is endemic (<link linkend="ch0049s0030s0004li0122">122</link>, <link linkend="ch0049s0030s0004li0123">123</link>). Further details of the staining procedures are found in <ulink url="ch0046#ch0046s0001">chapter 30</ulink> of this <emphasis>Manual</emphasis>.</para>
    </sect1>
    <sect1 id="ch0049s0012">
      <title>Nucleic Acid Detection</title>
      <anchor id="ch0049s0012a0001"/>
      <anchor id="ch0049s0012a0002"/>
      <para id="ch0049s0012p0001">Currently, there are no commercial nucleic acid detection systems available for direct detection of NTM. An indirect method could be identifying an acid-fast bacillus smear-positive sample that is negative by a nucleic acid amplification test specific for<emphasis>M. tuberculosis</emphasis>, but this does not distinguish between RGM and the slowly growing NTM.</para>
      <anchor id="ch0049s0012a0003"/>
      <beginpage pagenum="666"/>
    </sect1>
    <sect1 id="ch0049s0013">
      <title>Laboratory-Developed Tests</title>
      <anchor id="ch0049s0013a0001"/>
      <anchor id="ch0049s0013a0002"/>
      <para id="ch0049s0013p0001">PCR amplification and sequencing has been used to detect and identify NTM in specimens from sterile sites, but these tests are generally limited to larger, reference laboratories. Culture-independent methods for detection of NTM from specimens containing mixed microbiota are uncommon. A few small studies conducted among CF patients have focused on detection of<emphasis>M. abscessus</emphasis> and MAC. Published methods have included a multiprobe real-time PCR assay using <emphasis>hsp65</emphasis> with melt analysis to distinguish common mycobacterial species (<link linkend="ch0049s0030s0004li0124">124</link>), quantitative PCR using an <emphasis>rpoB</emphasis> target (<link linkend="ch0049s0030s0004li0125">125</link>), and PCR amplification of 16S rRNA followed by next-generation sequencing (<link linkend="ch0049s0030s0004li0126">126</link>). The glycopeptidolipids and mycolic acids of the mycobacterial cell wall, complex CF sputum specimen matrices, and relatively low mycobacterial organism burden may make detection of <emphasis>M. abscessus</emphasis> in CF specimens more challenging than nonmycobacerial species. Analytical sensitivity might be enhanced by incorporating bead-beating with 0.1-mm zirconium beads in the extraction process (<link linkend="ch0049s0030s0004li0126">126</link>). Unfortunately, sensitivity for detection of the <emphasis>M. abscessus</emphasis> species has generally not been better than smear (<link linkend="ch0049s0030s0004li0124">124</link>, <link linkend="ch0049s0030s0004li0126">126</link>).</para>
      <para id="ch0049s0013p0002">Whole-genome analysis and bioinformatics were used to identify molecular targets incorporated in a one-step multiplex PCR assay that has been described to detect five clinically significant NTM species, including<emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> and <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> (<link linkend="ch0049s0030s0004li0127">127</link>). This assay is highly sensitive and specific for the <emphasis>M. abscessus</emphasis> species in culture, but is not yet evaluated from clinical specimens. A multiplex assay for the specific detection of the most common RGM was developed for use with the BD MAX platform (Becton Dickinson Diagnostic Systems, Sparks, MD), which automates extraction, PCR, and detection. The assay incorporates ITS sequences for detection of the <emphasis>M. abscessus</emphasis> species and <emphasis>M. chelonae</emphasis>, and <emphasis>rpoB</emphasis> for the <emphasis>M. fortuitum</emphasis> complex. It was evaluated with previously frozen clinical specimens from respiratory, wound, and other sources. Overall sensitivity compared to culture was 90% and specificity was 98% (<link linkend="ch0049s0030s0004li0128">128</link>).</para>
      <para id="ch0049s0013p0003">Metagenomic approaches for the detection of mycobacteria in clinical specimens are being developed, but are currently only available in research or large reference laboratories. Furthermore, results are usually reported on a research-use-only basis, as validation of such methods is complex. Barriers to implementation in clinical laboratories include dealing with the large proportion of human DNA sequences that may be present in comparison to bacterial DNA, the expense of the equipment, and the high level of computational skill required to analyze the sequencing datasets. Nevertheless, metagenomics has successfully been used to detect<emphasis>M. abscessus</emphasis> mixed with other pathogen(s) in bronchoalveolar lavage fluid (<link linkend="ch0049s0030s0004li0129">129</link>, <link linkend="ch0049s0030s0004li0130">130</link>). Future advancements in metagenomics are likely to make these methods more achievable for clinical laboratories.</para>
      <sect2 id="ch0049s0013s0001">
        <title>ISOLATION PROCEDURES</title>
        <anchor id="ch0049s0013s0001a0001"/>
        <anchor id="ch0049s0013s0001a0002"/>
        <para id="ch0049s0013s0001p0001">Primary isolation of RGM optimally requires culture at 28 to 30°C rather than 35°C, especially for recovery of<emphasis>M. chelonae</emphasis> and <emphasis>M. immunogenum</emphasis> (<link linkend="ch0049s0030s0004li0001">1</link>). Direct examination and isolation procedures are detailed in <ulink url="ch0046#ch0046s0001">chapter 30</ulink> of this <emphasis>Manual</emphasis>.</para>
        <para id="ch0049s0013s0001p0002">Recovery of RGM from routine blood culture systems does not appear to be problematic. However, no large comparative studies of commercial systems have been performed to date.</para>
      </sect2>
      <sect2 id="ch0049s0013s0002">
        <title>IDENTIFICATION</title>
        <anchor id="ch0049s0013s0002a0001"/>
        <anchor id="ch0049s0013s0002a0002"/>
      </sect2>
    </sect1>
    <sect1 id="ch0049s0014">
      <title>Biochemical Testing</title>
      <anchor id="ch0049s0014a0001"/>
      <anchor id="ch0049s0014a0002"/>
      <para id="ch0049s0014p0001">As previously stated, the RGM are defined as NTM that grow mature colonies within 7 days (most species grow within 3 to 4 days) (<link linkend="ch0049s0030s0004li0001">1</link>). Until the advent of more modern molecular techniques, traditional laboratory identification of the RGM was based primarily upon growth rate, pigmentation, colonial morphology, and a select battery of biochemical tests (<link linkend="ch0049s0030s0004li0001">1</link>). These standard tests included tests of arylsulfatase production, tolerance to 5% NaCl, nitrate reductase activity, iron uptake, and carbohydrate utilization. All members of the <emphasis>M. fortuitum</emphasis> group and the <emphasis>M. chelonae/M. abscessus</emphasis> group exhibit a strongly positive arylsulfatase reaction at 3 days. The <emphasis>M. smegmatis</emphasis> group (<emphasis>M. smegmatis</emphasis> and <emphasis>M. goodii</emphasis>) and <emphasis>M. wolinskyi</emphasis> have similar growth rates but do not exhibit arylsulfatase activity at 3 days (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0043">43</link>). Approximately 95% of the isolates of <emphasis>M. smegmatis</emphasis> and 80% of <emphasis>M. goodii</emphasis> isolates develop a late (7 to 10 days) yellow-orange pigmentation (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0043">43</link>).</para>
      <para id="ch0049s0014p0002">We recommend that biochemical testing of the RGM should be replaced by molecular genetic or proteomic methods (i.e., DNA sequencing or MALDI-TOF MS). Moreover, although biochemical testing is recommended by some journals when describing a new species as part of a polyphasic identification algorithm, strict quality control should be exercised, because these tests are not routinely performed.</para>
    </sect1>
    <sect1 id="ch0049s0015">
      <title>Antimicrobial Susceptibility Tests for Taxonomic Identification</title>
      <anchor id="ch0049s0015a0001"/>
      <anchor id="ch0049s0015a0002"/>
      <para id="ch0049s0015p0001">Other adjunctive nonmolecular tests, including antimicrobial susceptibility tests, have been utilized for preliminary identification of the RGM (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0131">131</link>). They are less commonly used with the advent of molecular techniques, but they can help to provide species confirmation in conjunction with molecular genetic or proteomic results. As a screening tool, isolates of the <emphasis>M. fortuitum</emphasis> group and the <emphasis>M. chelonae/M. abscessus</emphasis> group can be differentiated by the use of a polymyxin B (300 IU) disk diffusion method. Generally, isolates of the <emphasis>M. fortuitum</emphasis> group exhibit a partial or clear zone of inhibition (≥10 mm) around the polymyxin disk, whereas isolates of the <emphasis>M. chelonae/M. abscessus</emphasis> group show no zone of inhibition (<link linkend="ch0049s0030s0004li0001">1</link>).</para>
      <para id="ch0049s0015p0002">Moreover,<emphasis>M. chelonae</emphasis> and the <emphasis>M. abscessus</emphasis> species also have different antimicrobial susceptibility patterns. One major difference between the two species is resistance to cefoxitin. Isolates of <emphasis>M. chelonae</emphasis> generally have cefoxitin MICs of ≥256 μg/ml, whereas the modal MIC for isolates of the <emphasis>M. abscessus</emphasis> species is 32 to 64 μg/ml (<link linkend="ch0049s0030s0004li0001">1</link>). Furthermore, isolates of <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis>, but not <emphasis>M. chelonae</emphasis> or <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis>, have an inducible <emphasis>erm</emphasis> gene similar to the gene in <emphasis>M. fortuitum</emphasis>, which conveys macrolide resistance (<link linkend="ch0049s0030s0004li0132">132</link>, <link linkend="ch0049s0030s0004li0133">133</link>).</para>
      <para id="ch0049s0015p0003">Isolates of the<emphasis>M. abscessus</emphasis> species also have lower amikacin MICs and are resistant to tobramycin, whereas tobramycin is more active than amikacin with <emphasis>M. chelonae</emphasis>. Additionally, isolates of <emphasis>M. chelonae</emphasis> are more susceptible <emphasis>in vitro</emphasis> to some of the newer antibiotics, including linezolid and moxifloxacin, than are isolates of the <emphasis>M. abscessus</emphasis> species (<link linkend="ch0049s0030s0004li0134">134</link>).</para>
      <para id="ch0049s0015p0004">It should still be emphasized that although the aforementioned testing is helpful, molecular genetic or proteomic identification is necessary for definitive identification of all NTM, including RGM (<link linkend="ch0049s0030s0004li0131">131</link>).</para>
      <anchor id="ch0049s0015a0003"/>
      <beginpage pagenum="667"/>
      <sect2 id="ch0049s0015s0001">
        <title>HPLC Identification</title>
        <anchor id="ch0049s0015s0001a0001"/>
        <anchor id="ch0049s0015s0001a0002"/>
        <para id="ch0049s0015s0001p0001">HPLC analysis of the mycobacterial cell wall mycolic acid content is still routinely used in some large reference or public health department laboratories to identify slowly growing isolates of NTM, but it has been problematic with RGM (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0135">135</link>). HPLC can be helpful for placing RGM isolates into groups or complexes, but it is not specific enough to identify most species with a high degree of accuracy, and data are missing on some of the newer species.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0049s0016">
      <title>Molecular Identification Methods</title>
      <anchor id="ch0049s0016a0001"/>
      <anchor id="ch0049s0016a0002"/>
      <sect2 id="ch0049s0016s0001">
        <title>Nucleic Acid Probes</title>
        <anchor id="ch0049s0016s0001a0001"/>
        <anchor id="ch0049s0016s0001a0002"/>
        <para id="ch0049s0016s0001p0001">The INNO-LiPA multiplex probe assay (Fujirebio Diagnostics, Inc., Belgium) is based on the principle of reverse hybridization (<link linkend="ch0049s0030s0004li0136">136</link>). Although the assay has not received U.S. FDA clearance, it can identify both rapidly and slowly growing mycobacterial species. Biotinylated DNA obtained by PCR amplification of the 16S-23S internal transcribed spacer (ITS) is hybridized with specific oligonucleotide probes immobilized as parallel lines on membrane strips. The main advantage of this system is that a large variety of species may be identified by a single assay, without the need to select an appropriate probe. One limitation of the assay is that it fails to differentiate isolates of closely related species, such as <emphasis>M. chelonae</emphasis> and the <emphasis>M. abscessus</emphasis> species (<link linkend="ch0049s0030s0004li0136">136</link>). Identification of the <emphasis>M. fortuitum</emphasis> group should be interpreted with caution as cross-reactivity may be detected with species of the <emphasis>M. fortuitum</emphasis> group and several species, such as <emphasis>M. thermoresistibile, M. agri</emphasis>, and <emphasis>M. alvei</emphasis>, that are rarely found in clinical samples (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0136">136</link>). Additionally, rare isolates of <emphasis>M. smegmatis</emphasis> have been reported that react with the <emphasis>M. fortuitum</emphasis> probe and not with the <emphasis>M. smegmatis</emphasis> probe (<link linkend="ch0049s0030s0004li0136">136</link>, <link linkend="ch0049s0030s0004li0137">137</link>).</para>
        <para id="ch0049s0016s0001p0002">A similar commercial PCR method that targets the 23S rRNA gene, the GenoType<emphasis>Mycobacterium</emphasis> assay (Hain Lifescience GmbH, Nehren, Germany), provides probes in two kits. The CM (“Common Mycobacteria”) kit identifies common RGM such as <emphasis>M. chelonae, M. abscessus</emphasis> complex, and the <emphasis>M. fortuitum</emphasis> group. Several less common species are identified with the AS (“Additional Species”) kit (<link linkend="ch0049s0030s0004li0138">138</link>, <link linkend="ch0049s0030s0004li0139">139</link>). In addition, the recently developed GenoType NTM-DR kit contains probes that distinguish subspecies within the <emphasis>M. abscessus</emphasis> group and includes targets for characterization of aminoglycoside and macrolide resistance (<link linkend="ch0049s0030s0004li0140">140</link>, <link linkend="ch0049s0030s0004li0141">141</link>). The INNO-LiPA and GenoType line probe systems are widely used in Europe for NTM identification.</para>
      </sect2>
    </sect1>
    <sect1 id="ch0049s0017">
      <title>Sequence Analysis</title>
      <anchor id="ch0049s0017a0001"/>
      <anchor id="ch0049s0017a0002"/>
      <para id="ch0049s0017p0001">Nucleic acid sequence analysis has been performed for the identification of mycobacteria for several years. This identification tool has been useful for the discrimination of most of the newly described species of RGM (<link linkend="ch0049s0030s0004li0118">118</link>, <link linkend="ch0049s0030s0004li0142">142</link>, <link linkend="ch0049s0030s0004li0143">143</link>).</para>
      <para id="ch0049s0017p0002">Sequencing remains a complex and often cost-prohibitive expense for some routine clinical laboratories, which also may not have an adequate volume of isolates to warrant sequencing. Therefore, the consensus is that not all laboratories should attempt to incorporate sequencing into their laboratory routine. Moreover, requests for sequencing should instead be sent to a qualified reference laboratory with skill and experience in the method (<link linkend="ch0049s0030s0004li0143">143</link>, <link linkend="ch0049s0030s0004li0144">144</link>).</para>
    </sect1>
    <sect1 id="ch0049s0018">
      <title>Partial 16S rRNA Gene Sequence Analysis</title>
      <anchor id="ch0049s0018a0001"/>
      <anchor id="ch0049s0018a0002"/>
      <para id="ch0049s0018p0001">Generally, the identification of mycobacteria, including RGM, focuses on two main hypervariable domains, known as region A and region B, located at the 5′ end of the 16S rRNA gene. These regions correspond to<emphasis>Escherichia coli</emphasis> positions 129 to 267 and 430 to 500, respectively. Hypervariable region A, especially, contains most of the species-specific sequence variations (so-called “signature sequences”) in mycobacterial species, and sequencing of this region allows taxonomic identification of most mycobacteria, including many species of RGM (<link linkend="ch0049s0030s0004li0006">6</link>, <link linkend="ch0049s0030s0004li0118">118</link>).</para>
      <para id="ch0049s0018p0002">Although not yet FDA cleared, a commercial gene sequencing system, the MicroSeq 500 16S rDNA bacterial sequencing kit (ThermoFisher, Carlsbad, CA), analyzes the first 500-bp sequence and compares the sequence with those in a commercially prepared database. The use of this commercial system alone cannot differentiate some major species of RGM, such as<emphasis>M. chelonae</emphasis> and the <emphasis>M. abscessus</emphasis> species, which require sequencing of other regions or other genes for identification (see <link linkend="ch0049s0001s0002a0033">Table 3</link>) (<link linkend="ch0049s0030s0004li0131">131</link>, <link linkend="ch0049s0030s0004li0142">142</link>, <link linkend="ch0049s0030s0004li0143">143</link>, <link linkend="ch0049s0030s0004li0145">145</link>). For this reason, clinical laboratories have supplemented the commercial database with additional sequences from their own in-house libraries or GenBank (<ulink url="https://www.ncbi.nlm.nih.gov/genbank">https://www.ncbi.nlm.nih.gov/genbank</ulink>).</para>
      <para id="ch0049s0018p0003">The currently commercially available partial 16S rRNA gene sequencing system (MicroSeq first 500 bp) has a number of large gaps for identification of RGM. For example, isolates of two major RGM pathogens,<emphasis>M. chelonae</emphasis> and the <emphasis>M. abscessus</emphasis> species, require sequencing of sites outside the first 500 bp, as they are identical in this region but differ at other 16S rRNA gene sites (in the 3′ region) (<link linkend="ch0049s0030s0004li0118">118</link>, <link linkend="ch0049s0030s0004li0142">142</link>) (see <anchor id="ch0049s0018a0003"/><link linkend="ch0049s0018a0004">Table 4</link>). To ensure accurate identification, at least 300 bp of quality sequence should be compared between the reference and query sequences and should cover at least one region of the gene where variations are to be expected. Therefore, most clinical laboratories currently sequence between 450 and 480 bp in order to provide an adequate sequence (<link linkend="ch0049s0030s0004li0118">118</link>, <link linkend="ch0049s0030s0004li0144">144</link>).</para>
      <para id="ch0049s0018p0004">In general, members of the genus<emphasis>Mycobacterium</emphasis> are closely related to each other, and closely related species may differ by only a few base pairs, or none at all. For example, <emphasis>M. goodii</emphasis>, which is difficult to distinguish from <emphasis>M. smegmatis</emphasis> phenotypically except by susceptibility pattern, has only a four-base difference in the entire 16S rRNA gene (<link linkend="ch0049s0030s0004li0043">43</link>).</para>
      <para id="ch0049s0018p0005">A quality-controlled database is indispensable for the evaluation and accurate identification of unknown strains (<link linkend="ch0049s0030s0004li0143">143</link>). The laboratorian should also recognize that sequence analysis is an important component in a polyphasic approach to the identification of unknown strains. While in some instances, molecular analysis-based identifications without conventional testing may be adequate, more often there are cases in which the broader picture must be reviewed. This includes exclusion of mixed cultures, and key phenotypic tests, including colonial morphology, pigmentation, and growth rate, are necessary, especially for the differentiation of closely related species (<link linkend="ch0049s0030s0004li0131">131</link>, <link linkend="ch0049s0030s0004li0143">143</link>).</para>
      <table id="ch0049s0018t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0049s0018a0004"/><link linkend="ch0049s0018a0003">TABLE 4</link></phrase></emphasis> <emphasis>erm</emphasis> gene designations in commonly encountered RGM species
</title>
        
        <tgroup cols="2">
          <tbody>
            <row>
              <entry><phrase role="center">Designation (reference)</phrase>
              </entry>
              <entry><phrase role="center">Species/subspecies</phrase>
              </entry>
            </row>
            <row>
              <entry><emphasis>erm</emphasis> gene</entry>
              <entry/>
            </row>
            <row>
              <entry><emphasis>erm</emphasis> (<link linkend="ch0049s0030s0004li0038">38</link>)</entry>
              <entry><emphasis>M. goodii, M. smegmatis</emphasis>
              </entry>
            </row>
            <row>
              <entry><emphasis>erm</emphasis> (<link linkend="ch0049s0030s0004li0039">39</link>)</entry>
              <entry><emphasis>M. fortuitum, M. boenickei, M. houstonense, M. neworleansense, M. porcinum</emphasis>
              </entry>
            </row>
            <row>
              <entry><emphasis>erm</emphasis> (<link linkend="ch0049s0030s0004li0040">40</link>)</entry>
              <entry><emphasis>M. mageritense, M. wolinskyi</emphasis>
              </entry>
            </row>
            <row>
              <entry><emphasis>erm</emphasis> (<link linkend="ch0049s0030s0004li0041">41</link>)</entry>
              <entry><emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> and subsp. <emphasis>bolletii</emphasis></entry>
            </row>
            <row>
              <entry>Absent or nonfunctional<emphasis>erm</emphasis> gene</entry>
              <entry><emphasis>M. chelonae, M. immunogenum, M. mucogenicum</emphasis> complex (<emphasis>M. mucogenicum, M. phocaicum, M. aubagnense</emphasis>), <emphasis>M. senegalense, M. peregrinum, M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis></entry>
            </row>
            <row>
              <entry/>
              <entry>Approximately 20% of<emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis></entry>
            </row>
          </tbody>
        </tgroup>
      </table>
      <para id="ch0049s0018p0006">The lack of consensus on standard reporting criteria or a cutoff value has been a major obstacle in interpretation of sequence data (<link linkend="ch0049s0030s0004li0143">143</link>, <link linkend="ch0049s0030s0004li0144">144</link>). Reporting criteria, such as (i) distinct species, (ii) “related” to a species, and (iii) “most closely related to” a species, depending upon the amount of sequence difference between the unknown isolate and the 16S rRNA gene database entries (<link linkend="ch0049s0030s0004li0145">145</link>), have been recommended but not validated (<link linkend="ch0049s0030s0004li0118">118</link>, <link linkend="ch0049s0030s0004li0143">143</link>). Although 100% identity is mandatory for signature sequences, one or a few mismatches at other positions may be acceptable for identification to the species level (<link linkend="ch0049s0030s0004li0144">144</link>).</para>
      <anchor id="ch0049s0018a0005"/>
      <beginpage pagenum="668"/>
    </sect1>
    <sect1 id="ch0049s0019">
      <title>Sequencing of the hsp65 Gene</title>
      <anchor id="ch0049s0019a0001"/>
      <anchor id="ch0049s0019a0002"/>
      <para id="ch0049s0019p0001">Although the 65-kDa heat shock protein gene (<emphasis>hsp65</emphasis>) is highly conserved among species of mycobacteria, it exhibits more interspecies and intraspecies polymorphisms than those in the 16S rRNA gene sequence (<link linkend="ch0049s0030s0004li0146">146</link>, <link linkend="ch0049s0030s0004li0147">147</link>). This variability can be advantageous for the development of other strategies for the identification of genetically related species of RGM (<link linkend="ch0049s0030s0004li0146">146</link>). Most sequencing or restriction fragment length polymorphism analyses have utilized a 441-bp sequence identified by Telenti et al. (<link linkend="ch0049s0030s0004li0147">147</link>), often referred to as the Telenti fragment.</para>
      <para id="ch0049s0019p0002">Studies based on DNA sequencing have demonstrated interspecies allelic diversity within the RGM. Detailed studies of several RGM species, including<emphasis>M. peregrinum, M. porcinum, M. senegalense, M. chelonae</emphasis>, and the <emphasis>M. abscessus</emphasis> species, have shown 4 to 6 sequence variants (sequevars) per species that differ by 4 to 6 nucleotides within the 441-bp Telenti fragment (<link linkend="ch0049s0030s0004li0147">147</link>, <link linkend="ch0049s0030s0004li0148">148</link>). PCR restriction fragment analysis of <emphasis>hsp65</emphasis> was an early valuable molecular tool for the identification of RGM but has generally been replaced with the more widespread availability of gene sequencing.</para>
      <para id="ch0049s0019p0003">Additionally, unlike 16S rRNA gene sequencing, the<emphasis>hsp65</emphasis> sequencing method can differentiate isolates of the <emphasis>M. abscessus</emphasis> species from those of <emphasis>M. chelonae</emphasis> (they differ by almost 30 bp in the 441-bp <emphasis>hsp65</emphasis> sequence, compared to only 4 bp in the entire 1,500-bp 16S rRNA gene sequence) (<link linkend="ch0049s0030s0004li0148">148</link>). In contrast to sequencing with the 16S rRNA gene, sequencing with the <emphasis>hsp65</emphasis> gene can discriminate even RGM species with a high degree of 16S rRNA gene similarity, such as <emphasis>M. fortuitum, M. septicum, M. peregrinum, M. houstonense</emphasis>, and <emphasis>M. senegalense</emphasis>.</para>
      <para id="ch0049s0019p0004">As with other sequencing methods, a constraint of<emphasis>hsp65</emphasis> gene sequencing has been that few sequences of newer RGM species are available in databases, and detailed sequencing of older species (i.e., multiple strains) has not been done, such that only one sequence per species is generally available. Since whole-genome sequencing is now recommended for newly described species, sequences for <emphasis>hsp65</emphasis>, as well as other targets described below, are generally available for at least a limited number of strains. However, development of a comprehensive database and in-house validation continue to be essential (<link linkend="ch0049s0030s0004li0006">6</link>, <link linkend="ch0049s0030s0004li0143">143</link>, <link linkend="ch0049s0030s0004li0148">148</link>).</para>
    </sect1>
    <sect1 id="ch0049s0020">
      <title>rpoB Sequence Analysis</title>
      <anchor id="ch0049s0020a0001"/>
      <anchor id="ch0049s0020a0002"/>
      <para id="ch0049s0020p0001">Initial studies using<emphasis>rpoB</emphasis> (the gene encoding the β-subunit of RNA polymerase) sequencing for description of species were based upon partial <emphasis>rpoB</emphasis> gene sequence analysis, comprising only about 20% of the entire gene length. Other investigators have suggested that species identification of a variety of RGM species is possible using a 340- to 360-bp region, but extensive variation may require development of more species-specific probes (<link linkend="ch0049s0030s0004li0031">31</link>, <link linkend="ch0049s0030s0004li0032">32</link>, <link linkend="ch0049s0030s0004li0149">149</link>, <link linkend="ch0049s0030s0004li0150">150</link>).</para>
      <para id="ch0049s0020p0002">The utility of<emphasis>rpoB</emphasis> was emphasized in a 2004 study by Adekambi and Drancourt that compared the phylogenetic relationships among 19 RGM species, including the major pathogens in this group, by comparing <emphasis>rpoB</emphasis> to several different sequence targets, including the 16S rRNA gene, <emphasis>hsp65, sodA</emphasis>, and <emphasis>recA</emphasis>. All 19 species showed good discrimination with <emphasis>rpoB</emphasis> (<link linkend="ch0049s0030s0004li0151">151</link>, <link linkend="ch0049s0030s0004li0152">152</link>).</para>
      <para id="ch0049s0020p0003">Not only has the<emphasis>rpoB</emphasis> sequence been useful for the identification of established species, but it has also helped to enable the discrimination of species that cannot be differentiated by the 16S rRNA gene or the <emphasis>hsp65</emphasis> sequence alone. Newly described species that are usually differentiated by <emphasis>rpoB</emphasis> sequencing include <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense, M. phocaicum</emphasis>, and <emphasis>M. aubagnense</emphasis> (<link linkend="ch0049s0030s0004li0031">31</link>–<link linkend="ch0049s0030s0004li0033">33</link>). However, recent studies have shown that multilocus sequencing is necessary to definitively identify <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> (<link linkend="ch0049s0030s0004li0030">30</link>, <link linkend="ch0049s0030s0004li0034">34</link>, <link linkend="ch0049s0030s0004li0153">153</link>).</para>
    </sect1>
    <sect1 id="ch0049s0021">
      <title>Sequence Analysis of Other Gene Targets</title>
      <anchor id="ch0049s0021a0001"/>
      <anchor id="ch0049s0021a0002"/>
      <para id="ch0049s0021p0001">Other molecular targets for taxonomic identification, including the 32-kDa protein gene, the superoxide dismutase gene (<emphasis>sodA</emphasis>), the 16S-23S rRNA ITS, <emphasis>dnaJ, secA1</emphasis>, and <emphasis>recA</emphasis>, have been suggested for mycobacterial identification utilizing either PCR-restriction fragment length analysis (PRA) or direct sequencing (<link linkend="ch0049s0030s0004li0153">153</link>, <link linkend="ch0049s0030s0004li0154">154</link>). However, preliminary data suggest that these gene sequences may be more variable than <emphasis>hsp65</emphasis>, and, to date, they have been utilized less commonly for the laboratory identification of the species of RGM (<link linkend="ch0049s0030s0004li0032">32</link>, <link linkend="ch0049s0030s0004li0153">153</link>, <link linkend="ch0049s0030s0004li0154">154</link>).</para>
      <para id="ch0049s0021p0002">Moreover, a major limitation of all sequence-based testing is the lack of sufficient databases (<link linkend="ch0049s0030s0004li0032">32</link>, <link linkend="ch0049s0030s0004li0131">131</link>, <link linkend="ch0049s0030s0004li0143">143</link>). Additionally, a multigenic approach for taxonomic evaluation of species has been suggested widely by investigators and was proposed by an <emphasis>ad hoc</emphasis> committee for the reevaluation of the species definition in bacteriology (<link linkend="ch0049s0030s0004li0155">155</link>). As whole-genome sequence data are increasingly available, sequence data from less common targets and more mycobacterial species, including those newly described, can be used to build databases and understand mycobacterial diversity.</para>
      <para id="ch0049s0021p0003">The 2010 studies by Kim et al. used<emphasis>erm</emphasis>(<link linkend="ch0049s0030s0004li0041">41</link>) gene sequences to differentiate <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> from <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> and <emphasis>M. abscessus</emphasis> subsp. <emphasis>bolletii</emphasis> (<link linkend="ch0049s0030s0004li0156">156</link>). The results of species identification using <emphasis>erm</emphasis>(<link linkend="ch0049s0030s0004li0041">41</link>) were concordant with those of multilocus sequence analysis including <emphasis>rpoB, hsp65, sodA</emphasis>, and the 16S-23S ITS (<link linkend="ch0049s0030s0004li0156">156</link>). However, Blauwendraat et al. reported that sequencing of <emphasis>sodA</emphasis> provides little value in species differentiation (<link linkend="ch0049s0030s0004li0157">157</link>). <anchor id="ch0049s0021a0003"/>Table 5 shows the <emphasis>erm</emphasis> gene designations for some of the commonly encountered RGM pathogens.</para>
    </sect1>
    <sect1 id="ch0049s0022">
      <title>Multilocus Sequence Analysis</title>
      <anchor id="ch0049s0022a0001"/>
      <anchor id="ch0049s0022a0002"/>
      <para id="ch0049s0022p0001">A 2009 study by Macheras et al. has shown the inaccuracy of single-target sequencing for differentiation of species within the<emphasis>M. abscessus</emphasis> species (i.e., <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis>, the former species <emphasis>M. massiliense</emphasis>, and the former species <emphasis>M. bolletii</emphasis>) (<link linkend="ch0049s0030s0004li0038">38</link>). The previous strategy, using only <emphasis>rpoB</emphasis> sequencing for identification of subspecies within the <emphasis>M. abscessus</emphasis> species, appears to be unacceptable due to the composite genetic structure, which suggests that genetic exchanges among members of the group led to legitimate recombination events among homologous housekeeping genes in a large number of isolates of the <emphasis>M. abscessus</emphasis> species studied thus far (<link linkend="ch0049s0030s0004li0038">38</link>, <link linkend="ch0049s0030s0004li0153">153</link>, <link linkend="ch0049s0030s0004li0158">158</link>).</para>
      <anchor id="ch0049s0022a0003"/>
      <beginpage pagenum="669"/>
      <para id="ch0049s0022p0002">These studies also emphasize the need for multiple-gene sequencing in the definition of species (<link linkend="ch0049s0030s0004li0038">38</link>). A 2011 study by Macheras et al. suggested the use of eight housekeeping gene sequences (4,071 bp), including <emphasis>argH, cya, glpK, gnd, murC, pgm, pta</emphasis>, and <emphasis>purH</emphasis> (<link linkend="ch0049s0030s0004li0159">159</link>). Their work also brings into question the previous criteria for differentiation of species based on &gt;3% <emphasis>rpoB</emphasis> sequence divergence between two RGM species (<link linkend="ch0049s0030s0004li0159">159</link>). Furthermore, their work substantiates later studies asserting that <emphasis>M. massiliense</emphasis> and <emphasis>M. bolletii</emphasis> are not different species (<link linkend="ch0049s0030s0004li0034">34</link>, <link linkend="ch0049s0030s0004li0039">39</link>).</para>
      <para id="ch0049s0022p0003">Recently, whole-genome sequencing (WGS) has been utilized for MLST. One approach extended MLST analysis by combining<emphasis>hsp65, rpoB, erm</emphasis> (<link linkend="ch0049s0030s0004li0041">41</link>), and genes for resistance detection with housekeeping genes, yielding results for identification, resistance detection, and discrimatory strain typing for the <emphasis>M. abscessus</emphasis> species (<link linkend="ch0049s0030s0004li0160">160</link>). As the cost of sequencing decreases and data analysis is simplified, WGS schemes may be within reach for routine use by clinical laboratories.</para>
    </sect1>
    <sect1 id="ch0049s0023">
      <title>Pyrosequencing</title>
      <anchor id="ch0049s0023a0001"/>
      <anchor id="ch0049s0023a0002"/>
      <para id="ch0049s0023p0001">Pyrosequencing technology (Biotage, Uppsala, Sweden) is based on the detection of pyrophosphate during DNA synthesis. During sequencing, visible light is produced that is proportional to the number of incorporated nucleotides.</para>
      <para id="ch0049s0023p0002">The method uses short (20- to 30-bp) sequences and is not as discriminating as traditional Sanger sequencing, but it is an attractive and less expensive alternative. Another advantage of the pyrosequencing technology is its commercial availability, although it has not yet been FDA cleared. As with other sequencing methods, the major limitation is the quality of the databases for interpretation and comparison of sequences (<link linkend="ch0049s0030s0004li0161">161</link>). In a 2005 study of 50 RGM isolates (<emphasis>M. chelonae/M. abscessus</emphasis> and <emphasis>M. mucogenicum</emphasis>), using the hypervariable region of 16S rDNA, consensus sequences were obtained for 40 isolates compared to traditional sequencing results. Of 10 isolates of <emphasis>M. fortuitum</emphasis>, 3 had identical sequences that matched those of <emphasis>M. fortuitum/M. peregrinum</emphasis>, and the remaining 7 isolates matched <emphasis>M. fortuitum</emphasis> (<link linkend="ch0049s0030s0004li0162">162</link>). Chikamatsu et al. evaluated a collection of 72 RGM type strains including 43 species of unproven pathogenicity using two sequencing primers within hypervariable region A. Thirty-four (47.2%) were identified to species, 30 (41.6%) were distinguished to the group or complex level, and 8 (11.1%) could not be identified, generally due to poor-quality sequence data (<link linkend="ch0049s0030s0004li0163">163</link>). To date, this method has provided reliable and rapid identification of a variety of RGM species (<link linkend="ch0049s0030s0004li0162">162</link>).</para>
      <para id="ch0049s0023p0003">Investigators have proposed the use of a segment of the<emphasis>rpoB</emphasis> gene in conjunction with pyrosequencing to determine the sequence of a 60-bp portion of the <emphasis>rpoB</emphasis> gene. The sequence, located at positions 1105 to 1219 (including primer sequences) in variable region II according to the numbering of Adekambi et al. (<link linkend="ch0049s0030s0004li0031">31</link>), successfully identified 99/100 isolates of <emphasis>M. abscessus</emphasis> and <emphasis>M. chelonae</emphasis> (<link linkend="ch0049s0030s0004li0164">164</link>).</para>
    </sect1>
    <sect1 id="ch0049s0024">
      <title>Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry</title>
      <anchor id="ch0049s0024a0001"/>
      <anchor id="ch0049s0024a0002"/>
      <para id="ch0049s0024p0001">MALDI-TOF MS is a reliable and rapid technological advance for the identification of NTM, including the RGM. MALDI-TOF MS produces unique spectral fingerprints based on extracted proteins. Moreover, MALDI-TOF MS provides a less expensive and less labor-intensive procedural alternative to gene sequencing for identification of the RGM (<link linkend="ch0049s0030s0004li0165">165</link>). Recent studies report the use of MALDI-TOF MS in conjunction with enhanced libraries, and extraction procedures can differentiate the most clinically relevant species of RGM (<link linkend="ch0049s0030s0004li0004">4</link>, <link linkend="ch0049s0030s0004li0165">165</link>, <link linkend="ch0049s0030s0004li0166">166</link>).</para>
      <para id="ch0049s0024p0002">Currently, the major commercial MALDI-TOF MS systems are the Bruker Biotyper (Bruker Daltonics, Billerica, MA) and bioMérieux VITEK MS (bioMérieux, Durham, NC). These systems contain a spectral database and identification algorithms for the detection of conserved and microbe-specific protein spectra patterns in whole-cell mass spectra (<link linkend="ch0049s0030s0004li0166">166</link>–<link linkend="ch0049s0030s0004li0168">168</link>). The most time-consuming portion of this method is the inactivation and protein extraction step. Most of the compiled data are based upon extraction from colonies on solid media. Numerous protocols for preparation of proteins can be found in the earliest literature. Saleeb et al. optimized the extraction process with the addition of bead-beating to disrupt the mycobacterial cell wall. This step proved to be advantageous for achieving quality spectra for some mycobacteria, particularly strains of the <emphasis>M. abscessus</emphasis> species and <emphasis>M. fortuitum</emphasis> (<link linkend="ch0049s0030s0004li0169">169</link>). The Bruker and bioMérieux commercial systems have refined the recommended extraction procedures for use with their systems, and both recommend a bead-beating step with either a vortex mixer or bead-beating apparatus (<link linkend="ch0049s0030s0004li0170">170</link>–<link linkend="ch0049s0030s0004li0172">172</link>). Importantly, the extraction protocol used may be method- and database-specific. Confidence score and identification rate have been reported to be negatively impacted when the extraction method differs from the one used to establish the database (<link linkend="ch0049s0030s0004li0165">165</link>, <link linkend="ch0049s0030s0004li0172">172</link>). However, shortened extraction protocols using Adaptive Focused Acoustics (AFA; Covaris, Woburn, MA), sonication, and bead-based homogenization prior to analysis with the Bruker MicroFlex LT system have also provided results for RGM equivalent to or better than those with manufacturer-recommended procedures (<link linkend="ch0049s0030s0004li0173">173</link>–<link linkend="ch0049s0030s0004li0175">175</link>).</para>
      <para id="ch0049s0024p0003">The most recent version of the bioMérieux database (v3.2 Knowledge Base) has been FDA approved for<emphasis>in vitro</emphasis> diagnostic use and contains 162 unique RGM isolates representing the 6 most common species or species groups. Nine additional species that are not clinically validated are included in the database. There are essentially no differences between the current IVD v3.2 and IVD v3.0 databases with respect to RGM; the SARAMIS v4.16 library (bioMérieux, Marcy l’Étoile, France) adds several RGM species that are unproven human pathogens (<link linkend="ch0049s0030s0004li0176">176</link>). For the VITEK MS, a reliable species identification has been established at a confidence score of &gt;90% (<link linkend="ch0049s0030s0004li0176">176</link>). A recent multicentered study of the VITEK MS system using the 3.0 database showed that the system could correctly identify 98% of 202 RGM to the species or complex level (<link linkend="ch0049s0030s0004li0171">171</link>).</para>
      <para id="ch0049s0024p0004">The most recent version of the Bruker MBT mycobacterial library v7.0 is RUO. Reference spectra were added to the library to improve recognition of species diversity and natural variability within the<emphasis>Mycobacterium</emphasis> genus. The database currently contains 182 mycobacterial species, with over 90 RGM represented. In addition to the species in database v6.0, the latest database adds four mycobacterial species, only one of which may rarely be a human RGM pathogen. A confidence score of ≥1.8 is recommended by the manufacturer for high-confidence species identification (<link linkend="ch0049s0030s0004li0177">177</link>).</para>
      <para id="ch0049s0024p0005">A few studies have compared the Bruker and bioMérieux systems, but various extraction methods, early versions of the databases, and different interpretations of confidence scores were used, leading to some ambiguity when compared to current practices (<link linkend="ch0049s0030s0004li0165">165</link>, <link linkend="ch0049s0030s0004li0172">172</link>, <link linkend="ch0049s0030s0004li0178">178</link>). Recently, Brown-Elliott et al. conducted a multicentered comparison study using the manufacturer-recommended extraction methods and versions 3.0 and 5.0 of the bioMérieux and Bruker databases, respectively (<link linkend="ch0049s0030s0004li0004">4</link>). The findings of this study were generally consistent with earlier evalutions. A confidence score of ≥1.8 was used for acceptable identification to the species level with the Bruker Biotyper. Others have found that lowering the acceptable score improves the rate of identification to species with little sacrifice in accuracy, and applying an acceptable score of ≥1.8 is common practice for users of this system (<link linkend="ch0049s0030s0004li0166">166</link>, <link linkend="ch0049s0030s0004li0172">172</link>, <link linkend="ch0049s0030s0004li0179">179</link>). The Biotyper system identified 115/125 (92%) and the VITEK MS system identified 124/125 (99.2%) RGM to at least the group or complex level. Importantly, both systems can distinguish the <emphasis>M. abscessus</emphasis> species from <emphasis>M. chelonae</emphasis> and accurately identify the <emphasis>M. abscessus</emphasis> species. Neither system identifies <emphasis>M. abscessus</emphasis> subspecies with the software used for routine identification. The Biotyper could not distinguish <emphasis>M. mucogenicum</emphasis> from <emphasis>M. phocaicum</emphasis>, and the VITEK MS identified all <emphasis>M. phocaicum</emphasis> as <emphasis>M. mucogenicum</emphasis>. Thus, neither system can distinguish members of the <emphasis>M. mucogenicum</emphasis> group. The Bruker system was better able to identify to the species level within the <emphasis>M. fortuitum</emphasis> complex, identifying 20/20 <emphasis>M. fortuitum</emphasis> subsp. <emphasis>fortuitum</emphasis>, 1/1 <emphasis>M. neworleansense</emphasis>, 1/8 <emphasis>M. senegalense</emphasis>/<emphasis>conceptionense</emphasis>, and 9/10 <emphasis>M. porcinum</emphasis>. One <emphasis>M. porcinum</emphasis> was misidentified as <emphasis>M. abscessus</emphasis>. VITEK MS reported all 39 isolates within the <emphasis>M. fortuitum</emphasis> group correctly to the group level. Identification of <emphasis>M. fortuitum</emphasis> group organisms to species may be clinically significant, because some species lack a functional <emphasis>erm</emphasis> gene and will likely be susceptible to macrolide antibiotics. The Biotyper correctly identified only 8/15 <emphasis>M. chelonae</emphasis> and misidentified 6/15 <emphasis>M. chelonae</emphasis> as <emphasis>M. salmoniphilum</emphasis>. Similarity of spectra for <emphasis>M. chelonae</emphasis> and <emphasis>M. salmoniphilum</emphasis> or <emphasis>M. stephanolepidis</emphasis> (neither of which are recognized pathogens) is a limitation recognized in software v7.0 release notes. In previous studies using earlier versions of the Biotyper library, some <emphasis>M. chelonae</emphasis> have produced low scores, prompting laboratories to supplement libraries with regional strains to improve accuracy of identification (<link linkend="ch0049s0030s0004li0165">165</link>, <link linkend="ch0049s0030s0004li0169">169</link>, <link linkend="ch0049s0030s0004li0172">172</link>). The VITEK MS successfully identified all <emphasis>M. chelonae</emphasis>. Both systems were able to identify <emphasis>M. immunogenum</emphasis> and <emphasis>M. mageritense</emphasis>, with VITEK MS misidentifying 1/9 isolates of <emphasis>M. immunogenum</emphasis> as <emphasis>M. abscessus</emphasis> (<link linkend="ch0049s0030s0004li0004">4</link>).</para>
      <anchor id="ch0049s0024a0003"/>
      <beginpage pagenum="670"/>
      <para id="ch0049s0024p0006">A third system, the ASTA MicroIDSys Elite, manufactured by ASTA (Suwon-si, Korea, and recently in the U.S. also) has recently emerged in the international market. Using the ASTA MycoDB v2.0 database for analysis of spectra, 25/26 (96.2%) RGM type strains were identified to the species or complex (<emphasis>M. fortuitum</emphasis>/<emphasis>M. porcinum</emphasis>). One <emphasis>M. holsaticum</emphasis> was misidentified as <emphasis>M. fortuitum</emphasis> complex. MicroIDSys identified 45/51 (88.2%) organisms to the species/complex from primary culture MGIT liquid media (Becton Dickinson, Sparks, MD) with 2 misidentifications (<link linkend="ch0049s0030s0004li0180">180</link>).</para>
      <para id="ch0049s0024p0007">Identification of mycobacteria in clinical samples from liquid media plays an important role in achieving rapid results but may be challenging due to the low levels of mycobacterial biomass in the medium when MALDI-TOF MS is employed (<link linkend="ch0049s0030s0004li0181">181</link>). Additionally, there has been concern that identification from liquid media is hindered by clinical specimen and media components. Several investigators have demonstrated successful identification of RGM to species or complex using seeded media studies (<link linkend="ch0049s0030s0004li0170">170</link>, <link linkend="ch0049s0030s0004li0179">179</link>). To address concerns related to the medium and specimen, Miller et al. conducted reagent interference and simulated sputum studies. They demonstrated that supplemented liquid media, digestion and decontamination reagents, contaminating bacteria, and sputum should not generate interfering peaks in spectral analysis. Furthermore, 139/140 (99.3%) samples spiked with RGM were accurately identified with no misidentifications (<link linkend="ch0049s0030s0004li0182">182</link>). Extending incubation 24 to 72 hours beyond the time at which an automated system first detects growth, extracting from up to 3 ml of liquid medium, pipetting from the biomass at the bottom of the culture tube, and addition of a 0.5% SDS wash step are approaches that may improve the rate of successful identification from clinical cultures (<link linkend="ch0049s0030s0004li0180">180</link>, <link linkend="ch0049s0030s0004li0183">183</link>, <link linkend="ch0049s0030s0004li0184">184</link>).</para>
      <para id="ch0049s0024p0008">Just as for genetic sequencing methods, the importance of an extensive database for MALDI-TOF MS cannot be overemphasized (<link linkend="ch0049s0030s0004li0172">172</link>). Although databases have improved, some users are supplementing the available commercial databases with their own in-house-developed databases to allow species-level differentiation of NTM and account for regional diversity within a species (<link linkend="ch0049s0030s0004li0169">169</link>). MALDI-TOF MS methods for mycobacteria have continued to advance, but further development is needed. Routine identification of the <emphasis>M. abscessus</emphasis> subspecies remains challenging. Attempts to develop a method to identify subspecies by using single-peak analysis have been hampered by geographic differences in strains and gene transfer between subspecies. A set of standard peaks that can be used to distinguish the three subspecies has not been defined, leaving sequence analysis of multiple targets as the best method for identification at this time (<link linkend="ch0049s0030s0004li0185">185</link>, <link linkend="ch0049s0030s0004li0186">186</link>).</para>
      <para id="ch0049s0024p0009">Future developments suggested for MALDI-TOF MS might include further refinement of the databases; possible typing of organisms; detection of the absence or presence of specific proteins associated with virulence and antimicrobial resistance; and development of methods for direct detection and identification from clinical samples (<link linkend="ch0049s0030s0004li0168">168</link>).</para>
      <sect2 id="ch0049s0024s0001">
        <title>TYPING SYSTEMS</title>
        <anchor id="ch0049s0024s0001a0001"/>
        <anchor id="ch0049s0024s0001a0002"/>
      </sect2>
    </sect1>
    <sect1 id="ch0049s0025">
      <title>Pulsed-Field Gel Electrophoresis</title>
      <anchor id="ch0049s0025a0001"/>
      <anchor id="ch0049s0025a0002"/>
      <para id="ch0049s0025p0001">Pulsed-field gel electrophoresis (PFGE) is the most widely used method for molecular strain typing of the RGM. Although PFGE has never been standardized for RGM, most investigators concur that small (2 or 3 bands) differences between isolates indicate that the isolates are closely related, differences of 4 to 6 bands indicate that the strains are possibly related, and differences of ≥7 bands indicate that the isolates are genetically different (<link linkend="ch0049s0030s0004li0027">27</link>, <link linkend="ch0049s0030s0004li0187">187</link>). Because unrelated strains of most RGM contain highly diverse PFGE patterns, this technique has been useful in epidemiological investigations including an extended outbreak of the <emphasis>M. abscessus</emphasis> species in a tertiary care hospital from 2013 to 2015 (<link linkend="ch0049s0030s0004li0106">106</link>). With the addition of thiourea as a modification of the original method, it is now possible to obtain reliable results by PFGE for all species of RGM, including isolates previously affected by DNA degradation (<link linkend="ch0049s0030s0004li0188">188</link>, <link linkend="ch0049s0030s0004li0189">189</link>). Recent studies have shown that DNA smear patterns of previous isolates are correlated with the presence of the <emphasis>dnd</emphasis> locus, which contains a DNA degradation gene (<link linkend="ch0049s0030s0004li0190">190</link>).</para>
    </sect1>
    <sect1 id="ch0049s0026">
      <title>Random Amplified Polymorphic DNA PCR</title>
      <anchor id="ch0049s0026a0001"/>
      <anchor id="ch0049s0026a0002"/>
      <para id="ch0049s0026p0001">In the random amplified polymorphic DNA PCR (RAPD-PCR) method, using one arbitrary primer and low-stringency conditions, the primer hybridizes to both strands of template DNA, where it is matched or partially matched, resulting in strain-specific heterogeneous DNA products. Zhang and colleagues applied the RAPD-PCR or arbitrarily primed PCR analysis method to compare strains of<emphasis>M. abscessus</emphasis> species (<link linkend="ch0049s0030s0004li0188">188</link>). They were able to confirm several previous observations about prior health care-related RGM outbreaks, including a 1988 epidemic of otitis media due to aminoglycoside-resistant <emphasis>M. abscessus</emphasis> species in children with prior tympanostomy tubes, as well as a cardiac surgery outbreak (<link linkend="ch0049s0030s0004li0001">1</link>, <link linkend="ch0049s0030s0004li0093">93</link>, <link linkend="ch0049s0030s0004li0188">188</link>).</para>
      <anchor id="ch0049s0026a0003"/>
      <beginpage pagenum="671"/>
    </sect1>
    <sect1 id="ch0049s0027">
      <title>VNTR Analysis</title>
      <anchor id="ch0049s0027a0001"/>
      <anchor id="ch0049s0027a0002"/>
      <para id="ch0049s0027p0001">The development of strain typing methods using VNTR would be valuable for helping to explain differences between isolates from chronic new infections and relapse infections. Blauwendraat and colleagues also indicated that the method would show whether cross-infection occurs and, moreover, enable prospective studies of strains of the<emphasis>M. abscessus</emphasis> species correlated with clinical outcomes (<link linkend="ch0049s0030s0004li0157">157</link>). In 2012, Wong et al. (<link linkend="ch0049s0030s0004li0191">191</link>) described a VNTR typing assay (MavA) using 18 tandem repeats in the <emphasis>M. abscessus</emphasis> genomic sequence, which was found to be superior to multilocus sequencing, with 100% typeability, 100% locus stability, and 100% reproducibility. More recently, VNTR typing has also been useful to identify outbreak strains of the <emphasis>M. abscessus</emphasis> species in a tertiary care hospital (<link linkend="ch0049s0030s0004li0106">106</link>).</para>
    </sect1>
    <sect1 id="ch0049s0028">
      <title>Repetitive-Sequence-Based PCR</title>
      <anchor id="ch0049s0028a0001"/>
      <anchor id="ch0049s0028a0002"/>
      <para id="ch0049s0028p0001">A commercial system (although not yet FDA cleared), DiversiLab (bioMérieux, Durham, NC), is available for strain typing of organisms, including mycobacteria, by using repetitive elements interspersed throughout the genome. The system electrophoretically separates repetitive-sequence-based PCR (rep-PCR) amplicons on microfluidic chips to provide computer-generated readouts. The discriminative power has been reported to equal or exceed that of standard restriction fragment length polymorphism analysis for some species of mycobacteria, with a smaller sample size than that for standard PFGE and in a much shorter time frame (<link linkend="ch0049s0030s0004li0153">153</link>, <link linkend="ch0049s0030s0004li0192">192</link>). Limitations of the system include the lack of an extensive established database and the cost of the system.</para>
    </sect1>
    <sect1 id="ch0049s0029">
      <title>Enterobacterial Repetitive Intergenic Consensus PCR (ERIC PCR)</title>
      <anchor id="ch0049s0029a0001"/>
      <anchor id="ch0049s0029a0002"/>
      <para id="ch0049s0029p0001">Enterobacterial repetitive consensus sequences are repetitive elements distributed along the bacterial chromosome, at intergenic regions of polycistronic operons or flanking open reading frames. The method was evaluated with isolates of the<emphasis>M. abscessus/M. chelonae</emphasis> species and with isolates of <emphasis>M. fortuitum</emphasis>. Typing of isolates by ERIC PCR works in mycobacteria as a RAPD-PCR because the presence of ERIC repeats has never been demonstrated in available <emphasis>Mycobacterium</emphasis> genomes, and amplification with appropriate ERIC primers can occur in the absence of genuine ERIC sequences. In a study of outbreak strains of <emphasis>M. abscessus</emphasis> in Brazil, ERIC PCR showed higher discriminatory power than PFGE for typing of strains that had shown smear patterns with PFGE without thiourea, although this method was not as discriminatory when testing isolates of <emphasis>M. fortuitum</emphasis> (<link linkend="ch0049s0030s0004li0112">112</link>).</para>
    </sect1>
    <sect1 id="ch0049s0030">
      <title>Whole-Genome Sequencing</title>
      <anchor id="ch0049s0030a0001"/>
      <anchor id="ch0049s0030a0002"/>
      <para id="ch0049s0030p0001">WGS has emerged as a specialized method for studying genetic variation and performing population genomics studies on nontuberculous mycobacteria (NTM), including some species (primarily the<emphasis>M. abscessus</emphasis> species) in the RGM. This method has allowed us to identify genetic factors that characterize the species diversity and specificity of RGM and has provided insight into aspects of survival in the environment, such as resistance to antibiotics, as well as the evolutionary process and general pathogenicity of strains and species (<link linkend="ch0049s0030s0004li0193">193</link>–<link linkend="ch0049s0030s0004li0198">198</link>). It has also been instrumental in facilitating our understanding of the epidemiological features and global relatedness of the <emphasis>M. abscessus</emphasis> species. In a series of studies, epidemiological analyses of the <emphasis>M. abscessus</emphasis> species have been conducted at different scales, including outbreaks within a single hospital (<link linkend="ch0049s0030s0004li0078">78</link>, <link linkend="ch0049s0030s0004li0199">199</link>), nationwide (<link linkend="ch0049s0030s0004li0200">200</link>–<link linkend="ch0049s0030s0004li0202">202</link>), and even the intercontinental spread of this pathogen (<link linkend="ch0049s0030s0004li0080">80</link>, <link linkend="ch0049s0030s0004li0203">203</link>). Importantly, WGS has provided the first evidence of possible person-to-person transmission of <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> (<link linkend="ch0049s0030s0004li0078">78</link>, <link linkend="ch0049s0030s0004li0079">79</link>). However, there are cases that show high genetic relatedness between clinical isolates despite the fact that there is no epidemiological link between patients (<link linkend="ch0049s0030s0004li0199">199</link>, <link linkend="ch0049s0030s0004li0204">204</link>), highlighting that tracking patient-to-patient transmission solely based on WGS analysis of clinical isolates should be approached with caution and that epidemiological support is still needed at present. A gold standard method for analyzing the transmission dynamics of the <emphasis>M. abscessus</emphasis> species based on WGS data has not yet been established, and further studies are needed. Using WGS data for geographically diverse <emphasis>M. abscessus</emphasis> species clinical isolates, Bryant and colleagues revealed that the majority of isolates formed dense clusters with low genetic diversity, with two <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> and one <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> clones dominating the worldwide distribution (<link linkend="ch0049s0030s0004li0080">80</link>). Although this study also revealed that clustered strains are more virulent and more likely to acquire drug resistance than nonclustered strains, the genetic factors that cause this and the characteristics of each cluster are not yet clear. At present, most of these epidemiological findings have been obtained from the analysis of clinical isolates derived from patients with cystic fibrosis in Western countries, and there are few examples of analyses from other regions and in non-CF patients. WGS not only provides epidemiological insights but also is an emerging tool for the development of molecular diagnostic assays. Based on the findings from WGS analysis of the <emphasis>M. abscessus</emphasis> species clinical isolates, researchers have recently developed a method of discriminating subspecies and mutations associated with drug resistance: subspecies identification by amplification of genomic regions associated with each of the three subspecies (<link linkend="ch0049s0030s0004li0205">205</link>, <link linkend="ch0049s0030s0004li0206">206</link>). Furthermore, by amplifying genomic region-associated strains that are susceptible to macrolide antibiotics, which are the key drug used to treat <emphasis>M. abscessus</emphasis> species infections, this method is able to differentiate macrolide-susceptible populations among the <emphasis>M. abscessus</emphasis> species clinical isolates with ease and high accuracy (<link linkend="ch0049s0030s0004li0206">206</link>). Future molecular biological and epidemiological studies and molecular assay development will be based on the findings from WGS. In this context, WGS is undoubtedly an important tool for the genetic characterization of NTMs, including RGM, even though the bioinformatics skills needed to analyze WGS data have not yet been fully embraced by researchers in clinical and reference laboratories, most likely due to cost and lack of availability of bioinformatics experts to interpret findings in a meaningful way.</para>
      <sect2 id="ch0049s0030s0001">
        <title>SEROLOGIC TESTS</title>
        <anchor id="ch0049s0030s0001a0001"/>
        <anchor id="ch0049s0030s0001a0002"/>
        <para id="ch0049s0030s0001p0001">Serologic classification of mycobacteria has been attempted, starting in 1925 with<emphasis>M. avium</emphasis> complex. However, serotyping has not been suitable for routine species identification of mycobacteria including the RGM, and early studies served to emphasize the complexity of the antigenic composition of mycobacteria, with many antigens shared by more than one species (<link linkend="ch0049s0030s0004li0207">207</link>).</para>
        <anchor id="ch0049s0030s0001a0003"/>
        <beginpage pagenum="672"/>
      </sect2>
      <sect2 id="ch0049s0030s0002">
        <title>ANTIMICROBIAL SUSCEPTIBILITIES</title>
        <anchor id="ch0049s0030s0002a0001"/>
        <anchor id="ch0049s0030s0002a0002"/>
        <para id="ch0049s0030s0002p0001">Several different methods have been used for susceptibility testing of RGM for clinical purposes. These methods include agar disk diffusion, broth microdilution, agar disk elution, and Etest. Each method has proved useful, but none of the methods were well standardized until 2003 with the publication of the CLSI guidelines (<link linkend="ch0049s0030s0004li0208">208</link>). In the M24A document, the CLSI recommended broth microdilution as the reference method for susceptibility testing of the RGM, and it continues to be recommended in the latest edition (<link linkend="ch0049s0030s0004li0209">209</link>, <link linkend="ch0049s0030s0004li0210">210</link>). Ten antimicrobials, including amikacin, cefoxitin, ciprofloxacin, clarithromycin, doxycycline, linezolid, imipenem, trimethoprim-sulfamethoxazole, tigecycline, and tobramycin, have been recommended for minimal inhibitory concentration (MIC) testing, and breakpoints have been established for all but one (tigecycline) of these agents. Breakpoints for two other antimicrobial agents, meropenem and minocycline, are also the same as imipenem and doxycycline, respectively (<link linkend="ch0049s0030s0004li0210">210</link>). Tigecycline MICs should be reported without interpretation since there are currently no standardized breakpoints for this agent (<link linkend="ch0049s0030s0004li0210">210</link>).</para>
        <para id="ch0049s0030s0002p0002">MICs are optimally read after incubation at 30°C for 3 days. A few RGM species, including some species within the<emphasis>M. fortuitum</emphasis> group, may be readable at 48 hours, but most of the clinically relevant species, including the <emphasis>M. abscessus/chelonae</emphasis> species, do not have adequate growth until 3 to 5 days. The CLSI recommends not reporting MICs (except for clarithromycin) after 5 days due to possible drug degradation (<link linkend="ch0049s0030s0004li0209">209</link>). Clarithromycin MICs should be read initially at 3 to 5 days and again at up to 14 days in order to phenotypically demonstrate inducible macrolide resistance by the <emphasis>erm</emphasis> gene. The principle of this testing is discussed briefly below and in detail in <ulink url="ch0097#ch0097s0001">chapter 79</ulink>. Several additional newer antimicrobials, including omadacycline, eravacycline, tedizolid, bedaquiline, clofazimine, and β-lactamase inhibitor antimicrobials, are undergoing evaluations. However, these have not yet been addressed by the CLSI. These are discussed in more detail in <ulink url="ch0097#ch0097s0001">chapter 79</ulink>.</para>
        <para id="ch0049s0030s0002p0003">Several specific recommendations about test results have also been made. Tobramycin should only be reported for isolates of<emphasis>M. chelonae</emphasis>. Any RGM isolate with an amikacin MIC of ≥64 μg/ml should be retested and/or sent to a reference laboratory in order to confirm resistance (although mutational resistance involving the 16S rRNA gene does occur). Also, if any isolate of the <emphasis>M. fortuitum</emphasis> group has an imipenem MIC of &gt;8 μg/ml, this test should also be repeated with careful attention paid to inoculum density and a maximum incubation time of 3 days because of the instability of imipenem over time.</para>
        <para id="ch0049s0030s0002p0004">Another caveat is that the MICs of sulfamethoxazole and trimethoprim-sulfamethoxazole are read using 80% inhibition of growth as the susceptibility endpoint, not 100% inhibition as is used for the other antimicrobials. Overinoculation of the MIC panels is often most obvious with sulfonamides. An inexperienced laboratorian may interpret the sulfonamide MIC as resistant when in reality the inoculum may be too heavy. Rarely, isolates of the<emphasis>M. fortuitum</emphasis> group are resistant to sulfonamides. If an isolate in this group is found resistant, a repeat test with lower inoculum is warranted (<link linkend="ch0049s0030s0004li0209">209</link>).</para>
        <para id="ch0049s0030s0002p0005">The recent finding of the presence of a functional<emphasis>erm</emphasis> gene that induces macrolide resistance in many isolates of the <emphasis>M. fortuitum</emphasis> group and <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis>, but not <emphasis>M. chelonae</emphasis> or <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis>, has also changed the manner in which clarithromycin reporting should be done (<link linkend="ch0049s0030s0004li0132">132</link>, <link linkend="ch0049s0030s0004li0133">133</link>, <link linkend="ch0049s0030s0004li0211">211</link>, <link linkend="ch0049s0030s0004li0212">212</link>). The significance of the finding of these genes has not yet been assessed in clinical trials. However, a landmark study in Korea among 64 patients with <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> and 81 patients with <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> lung disease showed that approximately 80% of the patients with <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis> could be successfully treated with a macrolide-containing multidrug regimen, in contrast to only about 20% of the patients with <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> (<link linkend="ch0049s0030s0004li0069">69</link>). The investigators suggested that inducible resistance to clarithromycin could explain the decreased efficacy of clarithromycin-containing antibiotic regimens against <emphasis>M. abscessus</emphasis> lung disease (<link linkend="ch0049s0030s0004li0069">69</link>).</para>
        <para id="ch0049s0030s0002p0006">Following recent<emphasis>in vitro erm</emphasis> gene studies, it is possible to report isolates (e.g., most strains of <emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus, M. porcinum</emphasis>, and <emphasis>M. abscessus</emphasis> subsp. <emphasis>bolletii</emphasis>) as macrolide resistant, obviating the need for a 14-day incubation if the isolate has been identified by molecular methods (i.e., gene sequencing) as a species or subspecies with a known functional <emphasis>erm</emphasis> gene. Similarly, species or subspecies with no functional <emphasis>erm</emphasis> gene, including <emphasis>M. senegalense, M. peregrinum, M. chelonae, M. immunogenum</emphasis>, the <emphasis>M. mucogenicum</emphasis> group, and <emphasis>M. abscessus</emphasis> subsp. <emphasis>massiliense</emphasis>, may be reported as clarithromycin susceptible (<link linkend="ch0049s0030s0004li0132">132</link>, <link linkend="ch0049s0030s0004li0133">133</link>, <link linkend="ch0049s0030s0004li0210">210</link>–<link linkend="ch0049s0030s0004li0215">215</link>). See <link linkend="ch0049s0018a0004">Table 4</link>.</para>
        <para id="ch0049s0030s0002p0007">Further details of the antimicrobial susceptibility method and guidance for patient therapy may be found in<ulink url="ch0097#ch0097s0001">chapter 79</ulink> of this <emphasis>Manual</emphasis>.</para>
      </sect2>
      <sect2 id="ch0049s0030s0003">
        <title>EVALUATION, INTERPRETATION, AND REPORTING OF RESULTS</title>
        <anchor id="ch0049s0030s0003a0001"/>
        <anchor id="ch0049s0030s0003a0002"/>
        <para id="ch0049s0030s0003p0001">Dramatic taxonomic changes, largely attributed to the advent of molecular testing, have occurred over the past 10 to 20 years. Multiple new species have been introduced, and some former subspecies have attained species status. Of the more than 100 validly published species of RGM, approximately one-third have been described within the past 10 years.</para>
        <para id="ch0049s0030s0003p0002">The recommended species and subspecies identification methods are evolving, with declining interest and efficiency of phenotypic testing and HPLC and increasing availability and accuracy of molecular methods and MALDI-TOF MS. Phenotypic tests have limited utility and are best applied in conjunction with molecular methods. Currently, molecular and/or proteomic methods are preferred and are generally the only way to identify many newer species or subspecies. Laboratories in which molecular testing is unavailable should consider referring RGM isolates to a reference laboratory with molecular capabilities (<link linkend="ch0049s0030s0004li0131">131</link>).</para>
        <para id="ch0049s0030s0003p0003">The major species of RGM (see<link linkend="ch0049s0001s0001a0005">Table 1</link>) each have different drug susceptibility patterns and different virulence in different clinical settings. The diagnostic priorities in terms of disease include bloodstream infection (usually catheter sepsis), disseminated or posttraumatic wound infection, and pulmonary disease (especially in the setting of bronchiectasis). For example, <emphasis>M. mucogenicum</emphasis> is a recognized cause of catheter sepsis, but because of its common presence in tap water the species is usually considered a contaminant in sputum. The most common RGM isolated from pulmonary specimens and associated with disease is the <emphasis>M. abscessus</emphasis> species. However, other RGM such as <emphasis>M. fortuitum</emphasis>, which is rarely considered a pathogen except in the setting of achalasia or lipoid pneumonia, may also be recovered from respiratory samples. The pathogenic potential of the RGM is generally related to clinical findings (unexplained fever, dimorphic inflammatory lesions, etc.), immune status of the patient, number of positive cultures, quantity of organisms in the sample recovery from smear-positive samples, and sources of the recovered species (<link linkend="ch0049s0030s0004li0047">47</link>). Some established and newly described species have been identified from environmental samples but as yet not identified as human or animal pathogens (<link linkend="ch0049s0030s0004li0122">122</link>). These factors emphasize the necessity to perform species-level identification and susceptibility testing on clinically significant isolates of RGM. Furthermore, isolates recovered from a single sample are less likely to be significant than those from multiple samples.</para>
        <anchor id="ch0049s0030s0003a0003"/>
        <beginpage pagenum="673"/>
        <para id="ch0049s0030s0003p0004">When species identification of a clinically significant isolate is not available (i.e., susceptibility may be finalized prior to identification of species), MICs should be reported for antimicrobials as recommended by the CLSI. An identification such as “Rapidly growing<emphasis>Mycobacterium</emphasis> sp.” may be acceptable until identification has been performed. However, the report should include a comment that tobramycin is reported only for <emphasis>M. chelonae</emphasis> (<link linkend="ch0049s0030s0004li0209">209</link>).</para>
        <para id="ch0049s0030s0003p0005">As previously commented in this chapter, the nomenclature designation of the collective<emphasis>M. abscessus</emphasis> (formerly complex) is currently “the <emphasis>M. abscessus</emphasis> species,” and laboratory reporting should reflect this change, especially in preliminary reporting when the subspecies is unknown.</para>
        <para id="ch0049s0030s0003p0006">When MIC results are reported, an interpretation of MIC values (i.e., “susceptible,” “intermediate,” or “resistant”) should be given for each antimicrobial for which there are recommended breakpoints (<link linkend="ch0049s0030s0004li0209">209</link>). For agents such as tigecycline for which no breakpoints have been recommended, an MIC value with a notation that “no CLSI breakpoints have been established for this species” should accompany the report. Moreover, because of the documented lack of efficacy for the use of first-line tuberculosis drugs (i.e., ethambutol, rifampin, isoniazid), laboratories should not routinely report MICs for these agents against RGM (<link linkend="ch0049s0030s0004li0131">131</link>). Other antimicrobials including tedizolid, omadacycline, eravacycline, bedaquiline, and clofazimine have also been studied against the RGM, and details are included in <ulink url="ch0097#ch0097s0001">chapter 79</ulink> of this <emphasis>Manual</emphasis>. Furthermore, for cultures that remain positive for the same species after 6 months of appropriate antimicrobial therapy, confirmation of species identification by molecular methods and repeat antimicrobial susceptibility testing is warranted (<link linkend="ch0049s0030s0004li0209">209</link>).</para>
        <para id="ch0049s0030s0003p0007">Although recent advances in antimicrobial therapies, including the new macrolides, fluoroquinolones, oxazolidinones, tigecycline, and more recently omadacycline and eravacycline (<link linkend="ch0049s0030s0004li0216">216</link>, <link linkend="ch0049s0030s0004li0217">217</link>), have enhanced the therapeutic options and improved the prognosis for RGM disease, there is still a compelling need for the development of more efficient, effective, and safe oral antimicrobials for treatment.</para>
        <para id="ch0049s0030s0003p0008">For example, most<emphasis>M. abscessus</emphasis> subsp. <emphasis>abscessus</emphasis> lung disease is still generally considered incurable with the currently available antimicrobials. Susceptibility testing of the RGM is necessary in order to select optimal antimicrobial therapy and to monitor the development of mutational drug resistance that may occur with the prolonged therapy required for RGM disease.</para>
      </sect2>
      <sect2 id="ch0049s0030s0004">
        <title>REFERENCES</title>
        <anchor id="ch0049s0030s0004a0001"/>
        <anchor id="ch0049s0030s0004a0002"/>
        <itemizedlist mark="none" role="biblioEntryList">
          <listitem id="ch0049s0030s0004li0001" role="bibliographyEntry">
            <para>1.<emphasis role="strong">Brown-Elliott BA, Wallace RJ Jr.</emphasis> 2002. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">15:</emphasis>716–746.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0002" role="bibliographyEntry">
            <para>2.<emphasis role="strong">Forbes BA, Hall GS, Miller MB, Novak SM, Rowlinson M-C, Salfinger M, Somoskövi A, Warshauer DM, Wilson ML.</emphasis> 2018. Practice guidelines for clinical microbiology laboratories: mycobacteria. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">31:</emphasis>e00038–e17.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0003" role="bibliographyEntry">
            <para>3.<emphasis role="strong">Euzéby JP.</emphasis> 1997. List of bacterial names with standing in nomenclature: a folder available on the internet. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">47:</emphasis>590–592.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0004" role="bibliographyEntry">
            <para>4.<emphasis role="strong">Brown-Elliott BA, Fritsche TR, Olson BJ, Vasireddy S, Vasireddy R, Iakhiaeva E, Alame D, Wallace RJ Jr, Branda JA.</emphasis> 2019. Comparison of two commercial matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for identification of nontuberculous mycobacteria. <emphasis><citetitle>Am J Clin Pathol</citetitle></emphasis> <emphasis role="strong">152:</emphasis>527–536.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0005" role="bibliographyEntry">
            <para>5.<emphasis role="strong">Tortoli E.</emphasis> 2014. Microbiological features and clinical relevance of new species of the genus <emphasis><citetitle>Mycobacterium</citetitle></emphasis>. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">27:</emphasis>727–752.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0006" role="bibliographyEntry">
            <para>6.<emphasis role="strong">Tortoli E.</emphasis> 2003. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">16:</emphasis>319–354.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0007" role="bibliographyEntry">
            <para>7.<emphasis role="strong">Forbes BA.</emphasis> 2017. Mycobacterial taxonomy. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">55:</emphasis>380–383.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0008" role="bibliographyEntry">
            <para>8.<emphasis role="strong">Gupta RS, Lo B, Son J.</emphasis> 2018. Phylogenomics and comparative genomic studies robustly support division of the genus <emphasis><citetitle>Mycobacterium</citetitle></emphasis> into an emended genus <emphasis><citetitle>Mycobacterium</citetitle></emphasis> and four novel genera. <emphasis><citetitle>Front Microbiol</citetitle></emphasis> <emphasis role="strong">9:</emphasis>67.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0009" role="bibliographyEntry">
            <para>9.<emphasis role="strong">Tindall BJ.</emphasis> 1999. Misunderstanding the bacteriological code. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>1313–1316.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0010" role="bibliographyEntry">
            <para>10.<emphasis role="strong">Tortoli E, Brown-Elliott BA, Chalmers JD, Cirillo DM, Daley CL, Emler S, Floto RA, Garcia MJ, Hoefsloot W, Koh W-J, Lange C, Loebinger M, Maurer FP, Morimoto K, Niemann S, Richter E, Turenne CY, Vasireddy R, Vasireddy S, Wagner D, Wallace RJ Jr, Wengenack N, van Ingen J.</emphasis> 2019. Same meat, different gravy: ignore the new names of mycobacteria. <emphasis><citetitle>Eur Respir J</citetitle></emphasis> <emphasis role="strong">54:</emphasis>1900795.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0011" role="bibliographyEntry">
            <para>11.<emphasis role="strong">Meehan CJ, Barco RA, Loh YE, Cogneau S, Rigouts L.</emphasis> 2021. Reconstituting the genus <emphasis><citetitle>Mycobacterium</citetitle></emphasis>. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">71:</emphasis>004922.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0012" role="bibliographyEntry">
            <para>12.<emphasis role="strong">Lee J-C, Whang KS.</emphasis> 2017. <emphasis><citetitle>Mycobacterium aquiterrae</citetitle></emphasis> sp. nov., a rapidly growing bacterium isolated from groundwater. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">67:</emphasis>4104–4110.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0013" role="bibliographyEntry">
            <para>13.<emphasis role="strong">Hashemi Shahraki A, Trovato A, Droz S, Haidarieh P, Borroni E, Mirsaeidi M, Mannino R, Hashemzadeh M, Mariottini A, Cirillo DM, Tortoli E.</emphasis> 2017. <emphasis><citetitle>Mycobacterium aquaticum</citetitle></emphasis> sp. nov., a rapidly growing species isolated from haemodialysis water. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">67:</emphasis>3279–3282.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0014" role="bibliographyEntry">
            <para>14.<emphasis role="strong">Nouioui I, Carro L, Teramoto K, Igual JM, Jando M, Del Carmen Montero-Calasanz M, Sutcliffe I, Sangal V, Goodfellow M, Klenk H-P.</emphasis> 2017. <emphasis><citetitle>Mycobacterium eburneum</citetitle></emphasis> sp. nov., a non-chromogenic, fast-growing strain isolated from sputum. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">67:</emphasis>3174–3181.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0015" role="bibliographyEntry">
            <para>15.<emphasis role="strong">Paniz-Mondolfi AE, Greninger AL, Ladutko L, Brown-Elliott BA, Vasireddy R, Jakubiec W, Vasireddy S, Wallace RJ Jr, Simmon KE, Dunn BE, Jackoway G, Vora SB, Quinn KK, Qin X, Campbell S.</emphasis> 2017. <emphasis><citetitle>Mycobacterium grossiae</citetitle></emphasis> sp. nov., a rapidly growing, scotochromogenic species isolated from human clinical respiratory and blood culture specimens. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">67:</emphasis>4345–4351.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0016" role="bibliographyEntry">
            <para>16.<emphasis role="strong">Gcebe N, Rutten VPMG, van Pittius NG, Naicker B, Michel AL.</emphasis> 2018. <emphasis><citetitle>Mycobacterium komaniense</citetitle></emphasis> sp. nov., a rapidly growing non-tuberculous <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species detected in South Africa. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">68:</emphasis>1526–1532.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0017" role="bibliographyEntry">
            <para>17.<emphasis role="strong">Nouioui I, Brunet LR, Simpson D, Klenk H-P, Goodfellow M.</emphasis> 2018. Description of a novel species of fast growing mycobacterium: <emphasis><citetitle>Mycobacterium kyogaense</citetitle></emphasis> sp. nov., a scotochromogenic strain received as <emphasis><citetitle>Mycobacterium vaccae</citetitle></emphasis>. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">68:</emphasis>3726–3734.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0018" role="bibliographyEntry">
            <anchor id="ch0049s0030s0004a0003"/>
            <para>18.<emphasis role="strong">Nouioui I, Sangal V, Carro L, Teramoto K, Jando M, Montero-Calasanz MDC, Igual JM, Sutcliffe I, Goodfellow M, Klenk HP.</emphasis> 2017. Two novel species of rapidly growing mycobacteria: <emphasis><citetitle>Mycobacterium lehmannii</citetitle></emphasis> sp. nov. and <emphasis><citetitle>Mycobacterium neumannii</citetitle></emphasis> sp. nov. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">67:</emphasis>4948–4955.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0019" role="bibliographyEntry">
            <para>19.<emphasis role="strong">Gcebe N, Rutten V, van Pittius NG, Naicker B, Michel A.</emphasis> 2017. <emphasis><citetitle>Mycobacterium malmesburyense</citetitle></emphasis> sp. nov., a non-tuberculous species of the genus <emphasis><citetitle>Mycobacterium</citetitle></emphasis> revealed by multiple gene sequence characterization. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">67:</emphasis>832–838.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0020" role="bibliographyEntry">
            <para>20.<emphasis role="strong">Nouioui I, Carro L, Sangal V, Jando M, Igual JM, Goodfellow M, Klenk H-P.</emphasis> 2018. Formal description of <emphasis><citetitle>Mycobacterium neglectum</citetitle></emphasis> sp. nov. and <emphasis><citetitle>Mycobacterium palauense</citetitle></emphasis> sp. nov., rapidly growing actinobacteria. <emphasis><citetitle>Antonie van Leeuwenhoek</citetitle></emphasis> <emphasis role="strong">111:</emphasis>1209–1223.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0021" role="bibliographyEntry">
            <para>21.<emphasis role="strong">Nouioui I, Sangal V, Cortés-Albayay C, Jando M, Igual JM, Klenk HP, Zhang YQ, Goodfellow M.</emphasis> 2019. <emphasis><citetitle>Mycolicibacterium stellerae</citetitle></emphasis> sp. nov., a rapidly growing scotochromogenic strain isolated from <emphasis><citetitle>Stellera chamaejasme</citetitle></emphasis>. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">69:</emphasis>3465–3471.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0022" role="bibliographyEntry">
            <para>22.<emphasis role="strong">Cheng Y, Lei W, Wang X, Tian Z, Liu H, Yang J, Lu S, Lai XH, Pu J, Huang Y, Zhang S, Yang C, Lian X, Bai Y, Wan K, Wang S, Xu J.</emphasis> 2021. <emphasis><citetitle>Mycolicibacterium baixiangningiae</citetitle></emphasis> sp. nov. and <emphasis><citetitle>Mycolicibacterium mengxianglii</citetitle></emphasis> sp. nov., two new rapidly growing mycobacterial species. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">71</emphasis>.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0023" role="bibliographyEntry">
            <para>23.<emphasis role="strong">Fukano H, Wada S, Kurata O, Katayama K, Fujiwara N, Hoshino Y.</emphasis> 2017. <emphasis><citetitle>Mycobacterium stephanolepidis</citetitle></emphasis> sp. nov., a rapidly growing species related to <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis>, isolated from marine teleost fish, <emphasis><citetitle>Stephanolepis cirrhifer</citetitle></emphasis>. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">67:</emphasis>2811–2817.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0024" role="bibliographyEntry">
            <para>24.<emphasis role="strong">Fogelson SB, Camus AC, Lorenz W, Phillips A, Bartlett P, Sanchez S.</emphasis> 2018. <emphasis><citetitle>Mycobacterium syngnathidarum</citetitle></emphasis> sp. nov., a rapidly growing mycobacterium identified in syngnathid fish. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">68:</emphasis>3696–3700.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0025" role="bibliographyEntry">
            <para>25.<emphasis role="strong">Tortoli E, Meehan CJ, Grottola A, Fregni Serpini G, Fabio A, Trovato A, Pecorari M, Cirillo DM.</emphasis> 2019. Genome-based taxonomic revision detects a number of synonymous taxa in the genus <emphasis><citetitle>Mycobacterium</citetitle></emphasis>. <emphasis><citetitle>Infect Genet Evol</citetitle></emphasis> <emphasis role="strong">75:</emphasis>103983.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0026" role="bibliographyEntry">
            <para>26.<emphasis role="strong">Schinsky MF, Morey RE, Steigerwalt AG, Douglas MP, Wilson RW, Floyd MM, Butler WR, Daneshvar MI, Brown-Elliott BA, Wallace RJJ, McNeil MM, Brenner DJ, Brown JM.</emphasis> 2004. Taxonomic variation in the <emphasis><citetitle>Mycobacterium fortuitum</citetitle></emphasis> third biovariant complex: description of <emphasis><citetitle>Mycobacterium boenickei</citetitle></emphasis> sp. nov., <emphasis><citetitle>Mycobacterium houstonense</citetitle></emphasis> sp. nov., <emphasis><citetitle>Mycobacterium neworleansense</citetitle></emphasis> sp. nov. and <emphasis><citetitle>Mycobacterium brisbanense</citetitle></emphasis> sp. nov. and recognition of <emphasis><citetitle>Mycobacterium porcinum</citetitle></emphasis> from human clinical isolates. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>1653–1667.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0027" role="bibliographyEntry">
            <para>27.<emphasis role="strong">Wallace RJ Jr, Brown-Elliott BA, Hall L, Roberts G, Wilson RW, Mann LB, Crist CJ, Chiu SH, Dunlap R, Garcia MJ, Bagwell JT, Jost KC Jr.</emphasis> 2002. Clinical and laboratory features of <emphasis><citetitle>Mycobacterium mageritense</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">40:</emphasis>2930–2935.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0028" role="bibliographyEntry">
            <para>28.<emphasis role="strong">Wallace RJ Jr, Brown-Elliott BA, Brown J, Steigerwalt AG, Hall L, Woods G, Cloud J, Mann L, Wilson R, Crist C, Jost KC Jr, Byrer DE, Tang J, Cooper J, Stamenova E, Campbell B, Wolfe J, Turenne C.</emphasis> 2005. Polyphasic characterization reveals that the human pathogen <emphasis><citetitle>Mycobacterium peregrinum</citetitle></emphasis> type II belongs to the bovine pathogen species <emphasis><citetitle>Mycobacterium senegalense</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">43:</emphasis>5925–5935.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0029" role="bibliographyEntry">
            <para>29.<emphasis role="strong">Wallace RJ Jr, Brown-Elliott BA, Wilson RW, Mann L, Hall L, Zhang Y, Jost KC Jr, Brown JM, Kabani A, Schinsky MF, Steigerwalt AG, Crist CJ, Roberts GD, Blacklock Z, Tsukamura M, Silcox V, Turenne C.</emphasis> 2004. Clinical and laboratory features of <emphasis><citetitle>Mycobacterium porcinum</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>5689–5697.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0030" role="bibliographyEntry">
            <para>30.<emphasis role="strong">Leao SC, Tortoli E, Viana-Niero C, Ueki SYM, Lima KV, Lopes ML, Yubero J, Menendez MC, Garcia MJ.</emphasis> 2009. Characterization of mycobacteria from a major Brazilian outbreak suggests that revision of the taxonomic status of members of the <emphasis><citetitle>Mycobacterium chelonae-M. abscessus</citetitle></emphasis> group is needed. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">47:</emphasis>2691–2698.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0031" role="bibliographyEntry">
            <para>31.<emphasis role="strong">Adékambi T, Berger P, Raoult D, Drancourt M.</emphasis> 2006. <emphasis><citetitle>rpoB</citetitle></emphasis> gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of <emphasis><citetitle>Mycobacterium bolletii</citetitle></emphasis> sp. nov., <emphasis><citetitle>Mycobacterium phocaicum</citetitle></emphasis> sp. nov. and <emphasis><citetitle>Mycobacterium aubagnense</citetitle></emphasis> sp. nov. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">56:</emphasis>133–143.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0032" role="bibliographyEntry">
            <para>32.<emphasis role="strong">Adékambi T, Colson P, Drancourt M.</emphasis> 2003. <emphasis><citetitle>rpoB</citetitle></emphasis>-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">41:</emphasis>5699–5708.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0033" role="bibliographyEntry">
            <para>33.<emphasis role="strong">Adékambi T, Reynaud-Gaubert M, Greub G, Gevaudan MJ, La Scola B, Raoult D, Drancourt M.</emphasis> 2004. Amoebal coculture of “<emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis>” sp. nov. from the sputum of a patient with hemoptoic pneumonia. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>5493–5501.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0034" role="bibliographyEntry">
            <para>34.<emphasis role="strong">Leao SC, Tortoli E, Euzéby JP, Garcia MJ.</emphasis> 2011. Proposal that <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis> and <emphasis><citetitle>Mycobacterium bolletii</citetitle></emphasis> be united and reclassified as <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subsp. <emphasis><citetitle>bolletii</citetitle></emphasis> comb. nov., designation of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subsp. <emphasis><citetitle>abscessus</citetitle></emphasis> subsp. nov. and emended description of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis>. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">61:</emphasis>2311–2313.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0035" role="bibliographyEntry">
            <para>35.<emphasis role="strong">Tortoli E, Kohl TA, Brown-Elliott BA, Trovato A, Leão SC, Garcia MJ, Vasireddy S, Turenne CY, Griffith DE, Philley JV, Baldan R, Campana S, Cariani L, Colombo C, Taccetti G, Teri A, Niemann S, Wallace RJ Jr, Cirillo DM.</emphasis> 2016. Emended description of <emphasis><citetitle>Mycobacterium abscessus</citetitle>, <citetitle>Mycobacterium abscessus</citetitle></emphasis> subsp. <emphasis><citetitle>abscessus</citetitle></emphasis> and <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subsp. <emphasis><citetitle>bolletii</citetitle></emphasis> and designation of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subsp. <emphasis><citetitle>massiliense</citetitle></emphasis> comb. nov. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">66:</emphasis>4471–4479.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0036" role="bibliographyEntry">
            <para>36.<emphasis role="strong">Tettelin H, Sampaio EP, Daugherty SC, Hine E, Riley DR, Sadzewicz L, Sengamalay N, Shefchek K, Su Q, Tallon LJ, Conville P, Olivier KN, Holland SM, Fraser CM, Zelazny AM.</emphasis> 2012. Genomic insights into the emerging human pathogen <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis>. <emphasis><citetitle>J Bacteriol</citetitle></emphasis> <emphasis role="strong">194:</emphasis>5450.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0037" role="bibliographyEntry">
            <para>37.<emphasis role="strong">Choo SW, Wong YL, Tan JL, Ong CS, Wong GJ, Ng KP, Ngeow YF.</emphasis> 2012. Annotated genome sequence of <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis> strain M154, belonging to the recently created taxon <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subsp. <emphasis><citetitle>bolletii</citetitle></emphasis> comb. nov. <emphasis><citetitle>J Bacteriol</citetitle></emphasis> <emphasis role="strong">194:</emphasis>4778.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0038" role="bibliographyEntry">
            <para>38.<emphasis role="strong">Macheras E, Roux A-L, Ripoll F, Sivadon-Tardy V, Gutierrez C, Gaillard J-L, Heym B.</emphasis> 2009. Inaccuracy of single-target sequencing for discriminating species of the <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> group. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">47:</emphasis>2596–2600.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0039" role="bibliographyEntry">
            <para>39.<emphasis role="strong">Tortoli E, Fedrizzi T, Meehan CJ, Trovato A, Grottola A, Giacobazzi E, Serpini GF, Tagliazucchi S, Fabio A, Bettua C, Bertorelli R, Frascaro F, De Sanctis V, Pecorari M, Jousson O, Segata N, Cirillo DM.</emphasis> 2017. The new phylogeny of the genus <emphasis><citetitle>Mycobacterium</citetitle></emphasis>: the old and the news. <emphasis><citetitle>Infect Genet Evol</citetitle></emphasis> <emphasis role="strong">56:</emphasis>19–25.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0040" role="bibliographyEntry">
            <para>40.<emphasis role="strong">Kim B-J, Kim G-N, Kim B-R, Jeon CO, Jeong J, Lee SH, Lim J-H, Lee S-H, Kim CK, Kook Y-H, Kim B-J.</emphasis> 2017. Description of <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis> subsp. <emphasis><citetitle>bovis</citetitle></emphasis> subsp. nov., isolated from cattle (<emphasis><citetitle>Bos taurus coreanae</citetitle></emphasis>), emended description of <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis> and creation of <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis> subsp. <emphasis><citetitle>chelonae</citetitle></emphasis> subsp. nov. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">67:</emphasis>3882–3887.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0041" role="bibliographyEntry">
            <para>41.<emphasis role="strong">Kim B-J, Kim B-R, Jeong J, Lim J-H, Park SH, Lee S-H, Kim CK, Kook Y-H, Kim BJ.</emphasis> 2018. A description of <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis> subsp. <emphasis><citetitle>gwanakae</citetitle></emphasis> subsp. nov., a rapidly growing mycobacterium with a smooth colony phenotype due to glycopeptidolipids. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">68:</emphasis>3772–3780.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0042" role="bibliographyEntry">
            <para>42.<emphasis role="strong">Springer B, Böttger EC, Kirschner P, Wallace RJ Jr.</emphasis> 1995. Phylogeny of the <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis>-like organism based on partial sequencing of the 16S rRNA gene and proposal of <emphasis><citetitle>Mycobacterium mucogenicum</citetitle></emphasis> sp. nov. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">45:</emphasis>262–267.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0043" role="bibliographyEntry">
            <para>43.<emphasis role="strong">Brown BA, Springer B, Steingrube VA, Wilson RW, Pfyffer GE, Garcia MJ, Menendez MC, Rodriguez-Salgado B, Jost KC Jr, Chiu SH, Onyi GO, Böttger EC, Wallace RJ Jr.</emphasis> 1999. <emphasis><citetitle>Mycobacterium wolinskyi</citetitle></emphasis> sp. nov. and <emphasis><citetitle>Mycobacterium goodii</citetitle></emphasis> sp. nov., two new rapidly growing species related to <emphasis><citetitle>Mycobacterium smegmatis</citetitle></emphasis> and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. <emphasis><citetitle>Int J Syst Bacteriol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>1493–1511.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0044" role="bibliographyEntry">
            <para>44.<emphasis role="strong">Brown-Elliott BA, Wallace RJ Jr, Petti CA, Mann LB, McGlasson M, Chihara S, Smith GL, Painter P, Hail D, Wilson R, Simmon KE.</emphasis> 2010. <emphasis><citetitle>Mycobacterium neoaurum</citetitle></emphasis> and <emphasis><citetitle>Mycobacterium bacteremicum</citetitle></emphasis> sp. nov. as causes of mycobacteremia. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">48:</emphasis>4377–4385.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0045" role="bibliographyEntry">
            <para>45.<emphasis role="strong">Simmon KE, Low YY, Brown-Elliott BA, Wallace RJ Jr, Petti CA.</emphasis> 2009. Phylogenetic analysis of <emphasis><citetitle>Mycobacterium aurum</citetitle></emphasis> and <emphasis><citetitle>Mycobacterium neoaurum</citetitle></emphasis> with redescription of <emphasis><citetitle>M. aurum</citetitle></emphasis> culture collection strains. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">59:</emphasis>1371–1375.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0046" role="bibliographyEntry">
            <para>46.<emphasis role="strong">Tortoli E.</emphasis> 2006. The new mycobacteria: an update. <emphasis><citetitle>FEMS Immunol Med Microbiol</citetitle></emphasis> <emphasis role="strong">48:</emphasis>159–178.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0047" role="bibliographyEntry">
            <para>47.<emphasis role="strong">Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America.</emphasis> 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. <emphasis><citetitle>Am J Respir Crit Care Med</citetitle></emphasis> <emphasis role="strong">175:</emphasis>367–416.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0048" role="bibliographyEntry">
            <para>48.<emphasis role="strong">Brown-Elliott BA, Wallace RJ Jr, Tichindelean C, Sarria JC, McNulty S, Vasireddy R, Bridge L, Mayhall CG, Turenne C, Loeffelholz M.</emphasis> 2011. Five-year outbreak of community- and hospital-acquired <emphasis><citetitle>Mycobacterium porcinum</citetitle></emphasis> infections related to public water supplies. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>4231–4238.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0049" role="bibliographyEntry">
            <para>49.<emphasis role="strong">Patel JB, Wallace RJ Jr, Brown-Elliott BA, Taylor T, Imperatrice C, Leonard DGB, Wilson RW, Mann L, Jost KC, Nachamkin I.</emphasis> 2004. Sequence-based identification of aerobic actinomycetes. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>2530–2540.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0050" role="bibliographyEntry">
            <para>50.<emphasis role="strong">Schinsky MF, McNeil MM, Whitney AM, Steigerwalt AG, Lasker BA, Floyd MM, Hogg GG, Brenner DJ, Brown JM.</emphasis> 2000. <emphasis><citetitle>Mycobacterium septicum</citetitle></emphasis> sp. nov., a new rapidly growing species associated with catheter-related bacteraemia. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">50:</emphasis>575–581.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0051" role="bibliographyEntry">
            <para>51.<emphasis role="strong">Lee MR, Sheng WH, Hung CC, Yu CJ, Lee LN, Hsueh PR.</emphasis> 2015. <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> complex infections in humans. <emphasis><citetitle>Emerg Infect Dis</citetitle></emphasis> <emphasis role="strong">21:</emphasis>1638–1646.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0052" role="bibliographyEntry">
            <para>52.<emphasis role="strong">Kothavade RJ, Dhurat RS, Mishra SN, Kothavade UR.</emphasis> 2013. Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria. <emphasis><citetitle>Eur J Clin Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">32:</emphasis>161–188.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0053" role="bibliographyEntry">
            <para>53.<emphasis role="strong">Philley JV, Griffith DE.</emphasis> 2019. Disease caused by <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> and other rapidly growing mycobacteria (RGM), p 369–400. <emphasis><citetitle>In</citetitle></emphasis> Griffith DE (ed), <emphasis><citetitle>Nontuberculous Mycobacterial Disease: A Comprehensive Approach to Diagnosis and Management</citetitle></emphasis>. Humana Press, Cham, Switzerland.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0054" role="bibliographyEntry">
            <para>54.<emphasis role="strong">Wallace RJ Jr, Brown BA, Silcox VA, Tsukamura M, Nash DR, Steele LC, Steingrube VA, Smith J, Sumter G, Zhang YS, Blacklock Z.</emphasis> 1991. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of <emphasis><citetitle>Mycobacterium fortuitum</citetitle></emphasis>. <emphasis><citetitle>J Infect Dis</citetitle></emphasis> <emphasis role="strong">163:</emphasis>598–603.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0055" role="bibliographyEntry">
            <para>55.<emphasis role="strong">Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW.</emphasis> 2006. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. <emphasis><citetitle>Arch Dermatol</citetitle></emphasis> <emphasis role="strong">142:</emphasis>1287–1292.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0056" role="bibliographyEntry">
            <para>56.<emphasis role="strong">Winthrop KL, Albridge K, South D, Albrecht P, Abrams M, Samuel MC, Leonard W, Wagner J, Vugia DJ.</emphasis> 2004. The clinical management and outcome of nail salon-acquired <emphasis><citetitle>Mycobacterium fortuitum</citetitle></emphasis> skin infection. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">38:</emphasis>38–44.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0057" role="bibliographyEntry">
            <para>57.<emphasis role="strong">Vugia DJ, Jang Y, Zizek C, Ely J, Winthrop KL, Desmond E.</emphasis> 2005. Mycobacteria in nail salon whirlpool footbaths, California. <emphasis><citetitle>Emerg Infect Dis</citetitle></emphasis> <emphasis role="strong">11:</emphasis>616–618.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0058" role="bibliographyEntry">
            <para>58.<emphasis role="strong">Stout JE, Gadkowski LB, Rath S, Alspaugh JA, Miller MB, Cox GM.</emphasis> 2011. Pedicure-associated rapidly growing mycobacterial infection: an endemic disease. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">53:</emphasis>787–792.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0059" role="bibliographyEntry">
            <para>59.<emphasis role="strong">Kennedy BS, Bedard B, Younge M, Tuttle D, Ammerman E, Ricci J, Doniger AS, Escuyer VE, Mitchell K, Noble-Wang JA, O’Connell HA, Lanier WA, Katz LM, Betts RF, Mercurio MG, Scott GA, Lewis MA, Goldgeier MH.</emphasis> 2012. Outbreak of <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis> infection associated with tattoo ink. <emphasis><citetitle>N Engl J Med</citetitle></emphasis> <emphasis role="strong">367:</emphasis>1020–1024.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0060" role="bibliographyEntry">
            <para>60.<emphasis role="strong">Mudedla SE, Avendano E, Raman G.</emphasis> 2015. Non-tuberculous mycobacterium skin infections after tattooing in healthy individuals: a systematic review of case reports. <emphasis><citetitle>Dermatol Online J</citetitle></emphasis> <emphasis role="strong">21:</emphasis>13030/qt8mr3r4f0.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0061" role="bibliographyEntry">
            <para>61.<emphasis role="strong">Culton DA, Lachiewicz AM, Miller BA, Miller MB, Mackuen C, Groben P, White B, Cox GM, Stout JE.</emphasis> 2013. Nontuberculous mycobacterial infection after fractionated CO(<subscript>2</subscript>) laser resurfacing. <emphasis><citetitle>Emerg Infect Dis</citetitle></emphasis> <emphasis role="strong">19:</emphasis>365–370.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0062" role="bibliographyEntry">
            <para>62.<emphasis role="strong">Eid AJ, Berbari EF, Sia IG, Wengenack NL, Osmon DR, Razonable RR.</emphasis> 2007. Prosthetic joint infection due to rapidly growing mycobacteria: report of 8 cases and review of the literature. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">45:</emphasis>687–694.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0063" role="bibliographyEntry">
            <para>63.<emphasis role="strong">Kim C-J, Kim U-J, Kim HB, Park SW, Oh M-D, Park K-H, Kim NJ.</emphasis> 2016. Vertebral osteomyelitis caused by non-tuberculous mycobacteria: predisposing conditions and clinical characteristics of six cases and a review of 63 cases in the literature. <emphasis><citetitle>Infect Dis (Lond)</citetitle></emphasis> <emphasis role="strong">48:</emphasis>509–516.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0064" role="bibliographyEntry">
            <para>64.<emphasis role="strong">Lee H, Hwang D, Jeon M, Lee E, Kim T, Yu SN, Kim Y, Lee B-I.</emphasis> 2016. Clinical features and treatment outcomes of septic arthritis due to <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis> associated with intra-articular injection: a case report. <emphasis><citetitle>BMC Res Notes</citetitle></emphasis> <emphasis role="strong">9:</emphasis>443.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0065" role="bibliographyEntry">
            <para>65.<emphasis role="strong">Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL.</emphasis> 2020. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">71:</emphasis>905–913.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0066" role="bibliographyEntry">
            <para>66.<emphasis role="strong">van Ingen J, de Zwaan R, Dekhuijzen RP, Boeree MJ, van Soolingen D.</emphasis> 2009. Clinical relevance of <emphasis><citetitle>Mycobacterium chelonae-abscessus</citetitle></emphasis> group isolation in 95 patients. <emphasis><citetitle>J Infect</citetitle></emphasis> <emphasis role="strong">59:</emphasis>324–331.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0067" role="bibliographyEntry">
            <para>67.<emphasis role="strong">Morimoto K, Nakagawa T, Asami T, Morino E, Fujiwara H, Hase I, Tsujimoto Y, Izumi K, Hayashi Y, Matsuda S, Murase Y, Yano R, Takasaki J, Betsuyaku T, Aono A, Goto H, Nishimura T, Sasaki Y, Hoshino Y, Kurashima A, Ato M, Ogawa K, Hasegawa N, Mitarai S.</emphasis> 2018. Clinico-microbiological analysis of 121 patients with pulmonary <emphasis><citetitle>Mycobacteroides abscessus</citetitle></emphasis> complex disease in Japan—an NTM-JRC study with RIT. <emphasis><citetitle>Respir Med</citetitle></emphasis> <emphasis role="strong">145:</emphasis>14–20.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0068" role="bibliographyEntry">
            <para>68.<emphasis role="strong">Koh WJ, Stout JE, Yew WW.</emphasis> 2014. Advances in the management of pulmonary disease due to <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> complex. <emphasis><citetitle>Int J Tuberc Lung Dis</citetitle></emphasis> <emphasis role="strong">18:</emphasis>1141–1148.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0069" role="bibliographyEntry">
            <para>69.<emphasis role="strong">Koh WJ, Jeon K, Lee NY, Kim B-J, Kook Y-H, Lee S-H, Park Y-K, Kim CK, Shin SJ, Huitt GA, Daley CL, Kwon OJ.</emphasis> 2011. Clinical significance of differentiation of <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis> from <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis>. <emphasis><citetitle>Am J Respir Crit Care Med</citetitle></emphasis> <emphasis role="strong">183:</emphasis>405–410.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0070" role="bibliographyEntry">
            <para>70.<emphasis role="strong">Koh WJ, Jeong BH, Kim SY, Jeon K, Park KU, Jhun BW, Lee H, Park HY, Kim DH, Huh HJ, Ki CS, Lee NY, Kim HK, Choi YS, Kim J, Lee SH, Kim CK, Shin SJ, Daley CL, Kim H, Kwon OJ.</emphasis> 2017. Mycobacterial characteristics and treatment outcomes in <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> lung disease. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">64:</emphasis>309–316.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0071" role="bibliographyEntry">
            <para>71.<emphasis role="strong">Griffith DE, Philley JV, Brown-Elliott BA, Benwill JL, Shepherd S, York D, Wallace RJ Jr.</emphasis> 2015. The significance of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subspecies <emphasis><citetitle>abscessus</citetitle></emphasis> isolation during <emphasis><citetitle>Mycobacterium avium</citetitle></emphasis> complex lung disease therapy. <emphasis><citetitle>Chest</citetitle></emphasis> <emphasis role="strong">147:</emphasis>1369–1375.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0072" role="bibliographyEntry">
            <para>72.<emphasis role="strong">Richards CJ, Olivier KN.</emphasis> 2019. Nontuberculous mycobacteria in cystic fibrosis. <emphasis><citetitle>Semin Respir Crit Care Med</citetitle></emphasis> <emphasis role="strong">40:</emphasis>737–750.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0073" role="bibliographyEntry">
            <para>73.<emphasis role="strong">Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee J-H, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, Edwards LJ, Chakraborti S, Knowles MR, Nontuberculous Mycobacteria in Cystic Fibrosis Study Group.</emphasis> 2003. Nontuberculous mycobacteria. I. Multicenter prevalence study in cystic fibrosis. <emphasis><citetitle>Am J Respir Crit Care Med</citetitle></emphasis> <emphasis role="strong">167:</emphasis>828–834.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0074" role="bibliographyEntry">
            <anchor id="ch0049s0030s0004a0004"/>
            <para>74.<emphasis role="strong">Martiniano SL, Sontag MK, Daley CL, Nick JA, Sagel SD.</emphasis> 2014. Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. <emphasis><citetitle>Ann Am Thorac Soc</citetitle></emphasis> <emphasis role="strong">11:</emphasis>36–44.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0075" role="bibliographyEntry">
            <para>75.<emphasis role="strong">Furukawa BS, Flume PA.</emphasis> 2018. Nontuberculous mycobacteria in cystic fibrosis. <emphasis><citetitle>Semin Respir Crit Care Med</citetitle></emphasis> <emphasis role="strong">39:</emphasis>383–391.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0076" role="bibliographyEntry">
            <para>76.<emphasis role="strong">Catherinot E, Roux A-L, Vibet M-A, Bellis G, Ravilly S, Lemonnier L, Le Roux E, Bernède-Bauduin C, Le Bourgeois M, Herrmann JL, Guillemot D, Gaillard J-L, OMA group.</emphasis> 2013. <emphasis><citetitle>Mycobacterium avium</citetitle></emphasis> and <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> complex target distinct cystic fibrosis patient subpopulations. <emphasis><citetitle>J Cyst Fibros</citetitle></emphasis> <emphasis role="strong">12:</emphasis>74–80.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0077" role="bibliographyEntry">
            <para>77.<emphasis role="strong">Aitken ML, Limaye A, Pottinger P, Whimbey E, Goss CH, Tonelli MR, Cangelosi GA, Dirac MA, Olivier KN, Brown-Elliott BA, McNulty S, Wallace RJ Jr.</emphasis> 2012. Respiratory outbreak of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subspecies massiliense in a lung transplant and cystic fibrosis center. <emphasis><citetitle>Am J Respir Crit Care Med</citetitle></emphasis> <emphasis role="strong">185:</emphasis>231–232.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0078" role="bibliographyEntry">
            <para>78.<emphasis role="strong">Bryant JM, Grogono DM, Greaves D, Foweraker J, Roddick I, Inns T, Reacher M, Haworth CS, Curran MD, Harris SR, Peacock SJ, Parkhill J, Floto RA.</emphasis> 2013. Whole-genome sequencing to identify transmission of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> between patients with cystic fibrosis: a retrospective cohort study. <emphasis><citetitle>Lancet</citetitle></emphasis> <emphasis role="strong">381:</emphasis>1551–1560.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0079" role="bibliographyEntry">
            <para>79.<emphasis role="strong">Tettelin H, Davidson RM, Agrawal S, Aitken ML, Shallom S, Hasan NA, Strong M, de Moura VCN, De Groote MA, Duarte RS, Hine E, Parankush S, Su Q, Daugherty SC, Fraser CM, Brown-Elliott BA, Wallace RJ Jr, Holland SM, Sampaio EP, Olivier KN, Jackson M, Zelazny AM.</emphasis> 2014. High-level relatedness among <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subsp. <emphasis><citetitle>massiliense</citetitle></emphasis> strains from widely separated outbreaks. <emphasis><citetitle>Emerg Infect Dis</citetitle></emphasis> <emphasis role="strong">20:</emphasis>364–371.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0080" role="bibliographyEntry">
            <para>80.<emphasis role="strong">Bryant JM, et al.</emphasis> 2016. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. <emphasis><citetitle>Science</citetitle></emphasis> <emphasis role="strong">354:</emphasis>751–757.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0081" role="bibliographyEntry">
            <para>81.<emphasis role="strong">Matsumoto T, Otsuka K, Tomii K.</emphasis> 2015. <emphasis><citetitle>Mycobacterium fortuitum</citetitle></emphasis> thoracic empyema: a case report and review of the literature. <emphasis><citetitle>J Infect Chemother</citetitle></emphasis> <emphasis role="strong">21:</emphasis>747–750.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0082" role="bibliographyEntry">
            <para>82.<emphasis role="strong">Park S, Suh GY, Chung MP, Kim H, Kwon OJ, Lee KS, Lee NY, Koh W-J.</emphasis> 2008. Clinical significance of <emphasis><citetitle>Mycobacterium fortuitum</citetitle></emphasis> isolated from respiratory specimens. <emphasis><citetitle>Respir Med</citetitle></emphasis> <emphasis role="strong">102:</emphasis>437–442.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0083" role="bibliographyEntry">
            <para>83.<emphasis role="strong">Gordon Huth R, Brown-Elliott BA, Wallace RJ Jr.</emphasis> 2011. <emphasis><citetitle>Mycobacterium mageritense</citetitle></emphasis> pulmonary disease in patient with compromised immune system. <emphasis><citetitle>Emerg Infect Dis</citetitle></emphasis> <emphasis role="strong">17:</emphasis>556–558.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0084" role="bibliographyEntry">
            <para>84.<emphasis role="strong">Talati NJ, Rouphael N, Kuppalli K, Franco-Paredes C.</emphasis> 2008. Spectrum of CNS disease caused by rapidly growing mycobacteria. <emphasis><citetitle>Lancet Infect Dis</citetitle></emphasis> <emphasis role="strong">8:</emphasis>390–398.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0085" role="bibliographyEntry">
            <para>85.<emphasis role="strong">Giovannenze F, Stifano V, Scoppettuolo G, Damiano F, Pallavicini F, Delogu G, Palucci I, Rapisarda A, Sturdà C, Pompucci A.</emphasis> 2018. Incidental intraoperative diagnosis of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> meningeal infection: a case report and review of the literature. <emphasis><citetitle>Infection</citetitle></emphasis> <emphasis role="strong">46:</emphasis>591–597.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0086" role="bibliographyEntry">
            <para>86.<emphasis role="strong">Neha P, Prajna L, Gunasekaran R, Appavu SP, Rajapandian SGK, Naveen R, Namperumalsamy Venkatesh P.</emphasis> 2021. Clinical and demographic study of non-tuberculous mycobacterial ocular infections in South India. <emphasis><citetitle>Indian J Med Microbiol</citetitle></emphasis> <emphasis role="strong">39:</emphasis>41–47.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0087" role="bibliographyEntry">
            <para>87.<emphasis role="strong">Brown-Elliott BA, Mann LB, Hail D, Whitney C, Wallace RJ Jr.</emphasis> 2012. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections. <emphasis><citetitle>Cornea</citetitle></emphasis> <emphasis role="strong">31:</emphasis>900–906.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0088" role="bibliographyEntry">
            <para>88.<emphasis role="strong">Pinitpuwadol W, Tesavibul N, Boonsopon S, Sakiyalak D, Sarunket S, Choopong P.</emphasis> 2020. Nontuberculous mycobacterial endophthalmitis: case series and review of literature. <emphasis><citetitle>BMC Infect Dis</citetitle></emphasis> <emphasis role="strong">20:</emphasis>877.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0089" role="bibliographyEntry">
            <para>89.<emphasis role="strong">Moorthy RS, Valluri S, Rao NA.</emphasis> 2012. Nontuberculous mycobacterial ocular and adnexal infections. <emphasis><citetitle>Surv Ophthalmol</citetitle></emphasis> <emphasis role="strong">57:</emphasis>202–235.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0090" role="bibliographyEntry">
            <para>90.<emphasis role="strong">Yeh C-F, Tu T-Y, Wang M-C, Chu C-H, Huang C-Y, Su W-J, Shiao A-S.</emphasis> 2016. Emergence of refractory otomastoiditis due to nontuberculous mycobacteria: institutional exxperience and review of the literature. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">62:</emphasis>739–745.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0091" role="bibliographyEntry">
            <para>91.<emphasis role="strong">Lee M-R, Tsai H-Y, Cheng A, Liu C-Y, Huang Y-T, Liao C-H, Liang S-K, Lee L-N, Hsueh P-R.</emphasis> 2012. Otitis media and otomastoiditis caused by <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis> (<emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subsp. <emphasis><citetitle>bolletii</citetitle></emphasis>). <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">50:</emphasis>3754–3756.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0092" role="bibliographyEntry">
            <para>92.<emphasis role="strong">Wallace RJ Jr, Brown BA, Griffith DE.</emphasis> 1998. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. <emphasis><citetitle>Annu Rev Microbiol</citetitle></emphasis> <emphasis role="strong">52:</emphasis>453–490.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0093" role="bibliographyEntry">
            <para>93.<emphasis role="strong">Brown-Elliott BA, Wallace RJ Jr.</emphasis> 2012. Nontuberculous mycobacteria, p 593–608. <emphasis><citetitle>In</citetitle></emphasis> Mayhall CG (ed), <emphasis><citetitle>Hospital Epidemiology and Infection Control</citetitle></emphasis>, 4th ed. Lippincott Williams &amp; Wilkins, Philadelphia, PA.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0094" role="bibliographyEntry">
            <para>94.<emphasis role="strong">Furuya EY, Paez A, Srinivasan A, Cooksey R, Augenbraun M, Baron M, Brudney K, Della-Latta P, Estivariz C, Fischer S, Flood M, Kellner P, Roman C, Yakrus M, Weiss D, Granowitz EV.</emphasis> 2008. Outbreak of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> wound infections among “lipotourists” from the United States who underwent abdominoplasty in the Dominican Republic. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">46:</emphasis>1181–1188.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0095" role="bibliographyEntry">
            <para>95.<emphasis role="strong">Meyers H, Brown-Elliott BA, Moore D, Curry J, Truong C, Zhang Y, Wallace RJ Jr.</emphasis> 2002. An outbreak of <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis> infection following liposuction. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">34:</emphasis>1500–1507.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0096" role="bibliographyEntry">
            <para>96.<emphasis role="strong">Viana-Niero C, Lima KVB, Lopes ML, Rabello MC, Marsola LR, Brilhante VCR, Durham AM, Leão SC.</emphasis> 2008. Molecular characterization of <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis> and <emphasis><citetitle>Mycobacterium bolletii</citetitle></emphasis> in isolates collected from outbreaks of infections after laparoscopic surgeries and cosmetic procedures. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">46:</emphasis>850–855.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0097" role="bibliographyEntry">
            <para>97.<emphasis role="strong">Hatzenbuehler LA, Tobin-D’Angelo M, Drenzek C, Peralta G, Cranmer LC, Anderson EJ, Milla SS, Abramowicz S, Yi J, Hilinski J, Rajan R, Whitley MK, Gower V, Berkowitz F, Shapiro CA, Williams JK, Harmon P, Shane AL.</emphasis> 2017. Pediatric dental clinic-associated outbreak of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> infection. <emphasis><citetitle>J Pediatric Infect Dis Soc</citetitle></emphasis> <emphasis role="strong">6:</emphasis>e116–e122.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0098" role="bibliographyEntry">
            <para>98.<emphasis role="strong">Singh J, O’Donnell K, Nieves DJ, Adler-Shohet FC, Arrieta AC, Ashouri N, Ahuja G, Cheung M, Holmes WN, Huoh K, Tran L, Tran MT, Pham N, Zahn M.</emphasis> 2021. Invasive <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> outbreak at a pediatric dental clinic. <emphasis><citetitle>Open Forum Infect Dis</citetitle></emphasis> <emphasis role="strong">8:</emphasis>ofab165.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0099" role="bibliographyEntry">
            <para>99.<emphasis role="strong">Matsumoto CK, Chimara E, Ramos JP, Campos CED, De Suza Caldas PC, Lima KVB, Lopes ML, Duarte RS, Leão SC.</emphasis> 2012. Rapid tests for the detection of the <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subsp. <emphasis><citetitle>bolletii</citetitle></emphasis> strain responsible for an epidemic of surgical-site infections in Brazil. <emphasis><citetitle>Mem Inst Oswaldo Cruz</citetitle></emphasis> <emphasis role="strong">107:</emphasis>969–970.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0100" role="bibliographyEntry">
            <para>100.<emphasis role="strong">Leão SC, Viana-Niero C, Matsumoto CK, Lima KV, Lopes ML, Palaci M, Hadad DJ, Vinhas S, Duarte RS, Lourenço MC, Kipnis A, das Neves ZC, Gabardo BM, Ribeiro MO, Baethgen L, de Assis DB, Madalosso G, Chimara E, Dalcolmo MP.</emphasis> 2010. Epidemic of surgical-site infections by a single clone of rapidly growing mycobacteria in Brazil. <emphasis><citetitle>Future Microbiol</citetitle></emphasis> <emphasis role="strong">5:</emphasis>971–980.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0101" role="bibliographyEntry">
            <para>101.<emphasis role="strong">Duarte RS, Lourenço MC, Fonseca LS, Leão SC, Amorim EL, Rocha IL, Coelho FS, Viana-Niero C, Gomes KM, da Silva MG, Lorena NS, Pitombo MB, Ferreira RM, Garcia MH, de Oliveira GP, Lupi O, Vilaça BR, Serradas LR, Chebabo A, Marques EA, Teixeira LM, Dalcolmo M, Senna SG, Sampaio JL.</emphasis> 2009. Epidemic of postsurgical infections caused by <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">47:</emphasis>2149–2155.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0102" role="bibliographyEntry">
            <para>102.<emphasis role="strong">Tiwari TS, Ray B, Jost KC Jr, Rathod MK, Zhang Y, Brown-Elliott BA, Hendricks K, Wallace RJ Jr.</emphasis> 2003. Forty years of disinfectant failure: outbreak of postinjection <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> infection caused by contamination of benzalkonium chloride. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">36:</emphasis>954–962.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0103" role="bibliographyEntry">
            <para>103.<emphasis role="strong">Nunes LS, Baethgen LF, Ribeiro MO, Cardoso CM, de Paris F, De David SMM, da Silva MG, Duarte RS, Barth AL.</emphasis> 2014. Outbreaks due to <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subsp. <emphasis><citetitle>bolletii</citetitle></emphasis> in southern Brazil: persistence of a single clone from 2007 to 2011. <emphasis><citetitle>J Med Microbiol</citetitle></emphasis> <emphasis role="strong">63:</emphasis>1288–1293</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0104" role="bibliographyEntry">
            <para>104.<emphasis role="strong">Ivan M, Dancer C, Koehler AP, Hobby M, Lease C.</emphasis> 2013. <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis> abscesses associated with biomesotherapy, Australia, 2008. <emphasis><citetitle>Emerg Infect Dis</citetitle></emphasis> <emphasis role="strong">19:</emphasis>1493–1495.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0105" role="bibliographyEntry">
            <anchor id="ch0049s0030s0004a0005"/>
            <para>105.<emphasis role="strong">Galmés-Truyols A, Giménez-Duran J, Bosch-Isabel C, Nicolau-Riutort A, Vanrell-Berga J, Portell-Arbona M, Seguí-Prat B, Gumá-Torá M, Martí-Alomar I, Rojo-Arias MÁ, Ruiz-Veramendi M.</emphasis> 2011. An outbreak of cutaneous infection due to <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> associated to mesotherapy. <emphasis><citetitle>Enferm Infecc Microbiol Clin</citetitle></emphasis> <emphasis role="strong">29:</emphasis>510–514.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0106" role="bibliographyEntry">
            <para>106.<emphasis role="strong">Baker AW, Lewis SS, Alexander BD, Chen LF, Wallace RJ Jr, Brown-Elliott BA, Isaacs PJ, Pickett LC, Patel CB, Smith PK, Reynolds JM, Engel J, Wolfe CR, Milano CA, Schroder JN, Davis RD, Hartwig MG, Stout JE, Strittholt N, Maziarz EK, Saullo JH, Hazen KC, Walczak RJ Jr, Vasireddy R, Vasireddy S, McKnight CM, Anderson DJ, Sexton DJ.</emphasis> 2017. Two-phase hospital-associated outbreak of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis>: investigation and mitigation. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">64:</emphasis>902–911.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0107" role="bibliographyEntry">
            <para>107.<emphasis role="strong">Nagpal A, Wentink JE, Berbari EF, Aronhalt KC, Wright AJ, Krageschmidt DA, Wengenack NL, Thompson RL, Tosh PK.</emphasis> 2014. A cluster of <emphasis><citetitle>Mycobacterium wolinskyi</citetitle></emphasis> surgical site infections at an academic medical center. <emphasis><citetitle>Infect Control Hosp Epidemiol</citetitle></emphasis> <emphasis role="strong">35:</emphasis>1169–1175.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0108" role="bibliographyEntry">
            <para>108.<emphasis role="strong">Dupont C, Terru D, Aguilhon S, Frapier J-M, Paquis M-P, Morquin D, Lamy B, Godreuil S, Parer S, Lotthé A, Jumas-Bilak E, Romano-Bertrand S.</emphasis> 2016. Source-case investigation of <emphasis><citetitle>Mycobacterium wolinskyi</citetitle></emphasis> cardiac surgical site infection. <emphasis><citetitle>J Hosp Infect</citetitle></emphasis> <emphasis role="strong">93:</emphasis>235–239.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0109" role="bibliographyEntry">
            <para>109.<emphasis role="strong">Doucette K, Fishman JA.</emphasis> 2004. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">38:</emphasis>1428–1439.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0110" role="bibliographyEntry">
            <para>110.<emphasis role="strong">Al-Anazi KA, Al-Jasser AM, Al-Anazi WK.</emphasis> 2014. Infections caused by non-tuberculous mycobacteria in recipients of hematopoietic stem cell transplantation. <emphasis><citetitle>Front Oncol</citetitle></emphasis> <emphasis role="strong">4:</emphasis>311.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0111" role="bibliographyEntry">
            <para>111.<emphasis role="strong">Longworth SA, Daly JS, AST Infectious Diseases Community of Practice.</emphasis> 2019. Management of infections due to nontuberculous mycobacteria in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. <emphasis><citetitle>Clin Transplant</citetitle></emphasis> <emphasis role="strong">33:</emphasis>e13588.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0112" role="bibliographyEntry">
            <para>112.<emphasis role="strong">Sampaio JL, Chimara E, Ferrazoli L, da Silva Telles MA, Del Guercio VM, Jericó ZV, Miyashiro K, Fortaleza CM, Padoveze MC, Leão SC.</emphasis> 2006. Application of four molecular typing methods for analysis of <emphasis><citetitle>Mycobacterium fortuitum</citetitle></emphasis> group strains causing post-mammaplasty infections. <emphasis><citetitle>Clin Microbiol Infect</citetitle></emphasis> <emphasis role="strong">12:</emphasis>142–149.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0113" role="bibliographyEntry">
            <para>113.<emphasis role="strong">Simmon KE, Pounder JI, Greene JN, Walsh F, Anderson CM, Cohen S, Petti CA.</emphasis> 2007. Identification of an emerging pathogen, <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis>, by <emphasis><citetitle>rpoB</citetitle></emphasis> sequencing of clinical isolates collected in the United States. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">45:</emphasis>1978–1980.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0114" role="bibliographyEntry">
            <para>114.<emphasis role="strong">Kannaiyan K, Ragunathan L, Sakthivel S, Sasidar AR, Muralidaran, Venkatachalam GK.</emphasis> 2015. Surgical site infections due to rapidly growing mycobacteria in puducherry, India. <emphasis><citetitle>J Clin Diagn Res</citetitle></emphasis> <emphasis role="strong">9:</emphasis>DC05–DC08.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0115" role="bibliographyEntry">
            <para>115.<emphasis role="strong">Wu T-S, Yang C-H, Brown-Elliott BA, Chao A-S, Leu H-S, Wu T-L, Lin C-S, Griffith DE, Chiu C-H.</emphasis> 2016. Postcesarean section wound infection caused by <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis>. <emphasis><citetitle>J Microbiol Immunol Infect</citetitle></emphasis> <emphasis role="strong">49:</emphasis>955–961.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0116" role="bibliographyEntry">
            <para>116.<emphasis role="strong">Döffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, Espitia-Pinzon C, Barnes N, Bothamley G, Casanova J-L, Longhurst HJ, Kumararatne DS.</emphasis> 2004. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">38:</emphasis>e10–e14.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0117" role="bibliographyEntry">
            <para>117.<emphasis role="strong">Höflich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, Döcke WD, Grütz G, Meisel C, Halle E, Göbel UB, Volk H-D, Suttorp N.</emphasis> 2004. Naturally occurring anti-IFN-gamma autoantibody and severe infections with <emphasis><citetitle>Mycobacterium cheloneae</citetitle></emphasis> and <emphasis><citetitle>Burkholderia cocovenenans</citetitle></emphasis>. <emphasis><citetitle>Blood</citetitle></emphasis> <emphasis role="strong">103:</emphasis>673–675.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0118" role="bibliographyEntry">
            <para>118.<emphasis role="strong">Patel JB, Leonard DGB, Pan X, Musser JM, Berman RE, Nachamkin I.</emphasis> 2000. Sequence-based identification of <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species using the MicroSeq 500 16S rDNA bacterial identification system. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">38:</emphasis>246–251.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0119" role="bibliographyEntry">
            <para>119.<emphasis role="strong">Hase I, Morimoto K, Sakagami T, Ishii Y, van Ingen J.</emphasis> 2017. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">88:</emphasis>308–315.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0120" role="bibliographyEntry">
            <para>120.<emphasis role="strong">Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S.</emphasis> 2007. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">45:</emphasis>421–427.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0121" role="bibliographyEntry">
            <para>121.<emphasis role="strong">Chetchotisakd P, Mootsikapun P, Anunnatsiri S, Jirarattanapochai K, Choonhakarn C, Chaiprasert A, Ubol PN, Wheat LJ, Davis TE.</emphasis> 2000. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">30:</emphasis>29–34.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0122" role="bibliographyEntry">
            <para>122.<emphasis role="strong">Forbes BA, Banaiee N, Beavis KG, Brown-Elliott BA, Della Latta P, Elliott LB, Hall GS, Hanna B, Perkins MD, Siddiqi SH, Wallace RJ Jr, Warren NG.</emphasis> 2008. Laboratory detection and identification of mycobacteria; approved guideline. CLSI document M48-A. CLSI, Wayne, PA.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0123" role="bibliographyEntry">
            <para>123.<emphasis role="strong">Wright PW, Wallace RJ Jr, Wright NW, Brown BA, Griffith DE.</emphasis> 1998. Sensitivity of fluorochrome microscopy for detection of <emphasis><citetitle>Mycobacterium tuberculosis</citetitle></emphasis> versus nontuberculous mycobacteria. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">36:</emphasis>1046–1049.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0124" role="bibliographyEntry">
            <para>124.<emphasis role="strong">Kim K, Lee H, Lee M-K, Lee S-A, Shim T-S, Lim SY, Koh W-J, Yim J-J, Munkhtsetseg B, Kim W, Chung S-I, Kook Y-H, Kim B-J.</emphasis> 2010. Development and application of multiprobe real-time PCR method targeting the <emphasis><citetitle>hsp65</citetitle></emphasis> gene for differentiation of <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species from isolates and sputum specimens. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">48:</emphasis>3073–3080.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0125" role="bibliographyEntry">
            <para>125.<emphasis role="strong">Steindor M, Nkwouano V, Mayatepek E, Mackenzie CR, Schramm D, Jacobsen M.</emphasis> 2015. Rapid detection and immune characterization of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> infection in cystic fibrosis patients. <emphasis><citetitle>PLoS One</citetitle></emphasis> <emphasis role="strong">10:</emphasis>e0119737.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0126" role="bibliographyEntry">
            <para>126.<emphasis role="strong">Caverly LJ, Carmody LA, Haig S-J, Kotlarz N, Kalikin LM, Raskin L, LiPuma JJ.</emphasis> 2016. Culture-independent identification of nontuberculous mycobacteria in cystic fibrosis respiratory samples. <emphasis><citetitle>PLoS One</citetitle></emphasis> <emphasis role="strong">11:</emphasis>e0153876.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0127" role="bibliographyEntry">
            <para>127.<emphasis role="strong">Chae H, Han SJ, Kim S-Y, Ki C-S, Huh HJ, Yong D, Koh W-J, Shin SJ.</emphasis> 2017. Development of a one-step multiplex PCR assay for differential detection of major <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">55:</emphasis>2736–2751.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0128" role="bibliographyEntry">
            <para>128.<emphasis role="strong">Rocchetti TT, Silbert S, Gostnell A, Kubasek C, Campos Pignatari AC, Widen R.</emphasis> 2017. Detection of <emphasis><citetitle>Mycobacterium chelonae, Mycobacterium abscessus</citetitle></emphasis> group, and <emphasis><citetitle>Mycobacterium fortuitum</citetitle></emphasis> complex by a multiplex real-time PCR directly from clinical samples using the BD MAX system. <emphasis><citetitle>J Mol Diagn</citetitle></emphasis> <emphasis role="strong">19:</emphasis>295–302.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0129" role="bibliographyEntry">
            <para>129.<emphasis role="strong">Leo S, Gaïa N, Ruppé E, Emonet S, Girard M, Lazarevic V, Schrenzel J.</emphasis> 2017. Detection of bacterial pathogens from broncho-alveolar lavage by next-generation sequencing. <emphasis><citetitle>Int J Mol Sci</citetitle></emphasis> <emphasis role="strong">18:</emphasis>2011.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0130" role="bibliographyEntry">
            <para>130.<emphasis role="strong">Xie D, Xian Y, You J, Xu W, Fan M, Bi X, Zhang K.</emphasis> 2021. Co-infection pneumonia with <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> and <emphasis><citetitle>Pneumocystis jiroveci</citetitle></emphasis> in a patient without HIV infection diagnosed by metagenomics next-generation sequencing. <emphasis><citetitle>Infect Drug Resist</citetitle></emphasis> <emphasis role="strong">14:</emphasis>879–888.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0131" role="bibliographyEntry">
            <para>131.<emphasis role="strong">Brown-Elliott BA, Wallace RJ Jr.</emphasis> 2012. Enhancement of conventional phenotypic methods with molecular-based methods for the more definitive identification of nontuberculous mycobacteria. <emphasis><citetitle>Clin Microbiol Newsl</citetitle></emphasis> <emphasis role="strong">34:</emphasis>109–115.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0132" role="bibliographyEntry">
            <para>132.<emphasis role="strong">Nash KA, Brown-Elliott BA, Wallace RJ Jr.</emphasis> 2009. A novel gene, <emphasis><citetitle>erm</citetitle></emphasis>(41), confers inducible macrolide resistance to clinical isolates of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> but is absent from <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis>. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">53:</emphasis>1367–1376.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0133" role="bibliographyEntry">
            <para>133.<emphasis role="strong">Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ Jr.</emphasis> 2005. Molecular basis of intrinsic macrolide resistance in clinical isolates of <emphasis><citetitle>Mycobacterium fortuitum</citetitle></emphasis>. <emphasis><citetitle>J Antimicrob Chemother</citetitle></emphasis> <emphasis role="strong">55:</emphasis>170–177.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0134" role="bibliographyEntry">
            <para>134.<emphasis role="strong">Brown-Elliott BA, Nash KA, Wallace RJ Jr.</emphasis> 2012. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">25:</emphasis>545–582.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0135" role="bibliographyEntry">
            <para>135.<emphasis role="strong">Butler WR, Guthertz LS.</emphasis> 2001. Mycolic acid analysis by high-performance liquid chromatography for identification of <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species. <emphasis><citetitle>Clin Microbiol Rev</citetitle></emphasis> <emphasis role="strong">14:</emphasis>704–726.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0136" role="bibliographyEntry">
            <anchor id="ch0049s0030s0004a0006"/>
            <para>136.<emphasis role="strong">Tortoli E, Mariottini A, Mazzarelli G.</emphasis> 2003. Evaluation of INNO-LiPA MYCOBACTERIA v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">41:</emphasis>4418–4420.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0137" role="bibliographyEntry">
            <para>137.<emphasis role="strong">van den Broek T, Janssen NG, Hetem DJ, Bekers W, Kamst M, Fluit AC, van Ingen J, Kusters JG, Rentenaar RJ.</emphasis> 2019. INNO-LiPA DNA line probe assay misidentification of M. smegmatis as <emphasis><citetitle>Mycobacterium fortuitum</citetitle></emphasis> complex. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">95:</emphasis>114858.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0138" role="bibliographyEntry">
            <para>138.<emphasis role="strong">Richter E, Rüsch-Gerdes S, Hillemann D.</emphasis> 2006. Evaluation of the GenoType <emphasis><citetitle>Mycobacterium</citetitle></emphasis> Assay for identification of mycobacterial species from cultures. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">44:</emphasis>1769–1775.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0139" role="bibliographyEntry">
            <para>139.<emphasis role="strong">Russo C, Tortoli E, Menichella D.</emphasis> 2006. Evaluation of the new GenoType <emphasis><citetitle>Mycobacterium</citetitle></emphasis> assay for identification of mycobacterial species. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">44:</emphasis>334–339.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0140" role="bibliographyEntry">
            <para>140.<emphasis role="strong">Huh HJ, Kim S-Y, Shim HJ, Kim DH, Yoo IY, Kang O-K, Ki C-S, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh W-J, Lee NY.</emphasis> 2019. GenoType NTM-DR performance evaluation for identification of <emphasis><citetitle>Mycobacterium avium</citetitle></emphasis> complex and <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> and determination of clarithromycin and amikacin resistance. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">57:</emphasis>e00516–e00519.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0141" role="bibliographyEntry">
            <para>141.<emphasis role="strong">Bouzinbi N, Marcy O, Bertolotti T, Chiron R, Bemer P, Pestel-Caron M, Peuchant O, Guet-Revillet H, Fangous MS, Héry-Arnaud G, Ouedraogo A-S, Bañuls A-L, Godreuil S.</emphasis> 2020. Evaluation of the GenoType NTM-DR assay performance for the identification and molecular detection of antibiotic resistance in <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> complex. <emphasis><citetitle>PLoS One</citetitle></emphasis> <emphasis role="strong">15:</emphasis>e0239146.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0142" role="bibliographyEntry">
            <para>142.<emphasis role="strong">Hall L, Doerr KA, Wohlfiel SL, Roberts GD.</emphasis> 2003. Evaluation of the MicroSeq system for identification of mycobacteria by 16S ribosomal DNA sequencing and its integration into a routine clinical mycobacteriology laboratory. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">41:</emphasis>1447–1453.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0143" role="bibliographyEntry">
            <para>143.<emphasis role="strong">Turenne CY, Tschetter L, Wolfe J, Kabani A.</emphasis> 2001. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">39:</emphasis>3637–3648.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0144" role="bibliographyEntry">
            <para>144.<emphasis role="strong">Clinical and Laboratory Standards Institute.</emphasis> 2018. Interpretive criteria for identification of bacteria and fungi by targeted DNA sequencing. 3rd ed. <emphasis><citetitle>CLSI guideline MM18</citetitle></emphasis>. CLSI, Wayne, PA.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0145" role="bibliographyEntry">
            <para>145.<emphasis role="strong">Tortoli E.</emphasis> 2010. Standard operating procedure for optimal identification of mycobacteria using 16S rRNA gene sequences. <emphasis><citetitle>Stand Genomic Sci</citetitle></emphasis> <emphasis role="strong">3:</emphasis>145–152.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0146" role="bibliographyEntry">
            <para>146.<emphasis role="strong">Ringuet H, Akoua-Koffi C, Honore S, Varnerot A, Vincent V, Berche P, Gaillard JL, Pierre-Audigier C.</emphasis> 1999. <emphasis><citetitle>hsp</citetitle></emphasis>65 sequencing for identification of rapidly growing mycobacteria. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">37:</emphasis>852–857.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0147" role="bibliographyEntry">
            <para>147.<emphasis role="strong">Telenti A, Marchesi F, Balz M, Bally F, Böttger EC, Bodmer T.</emphasis> 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">31:</emphasis>175–178.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0148" role="bibliographyEntry">
            <para>148.<emphasis role="strong">McNabb A, Eisler D, Adie K, Amos M, Rodrigues M, Stephens G, Black WA, Isaac-Renton J.</emphasis> 2004. Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (<emphasis><citetitle>hsp65</citetitle></emphasis>) for routine identification of <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species isolated from clinical sources. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>3000–3011.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0149" role="bibliographyEntry">
            <para>149.<emphasis role="strong">Kim B-J, Lee SH, Lyu MA, Kim SJ, Bai GH, Chae GT, Kim EC, Cha CY, Kook YH.</emphasis> 1999. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (<emphasis><citetitle>rpoB</citetitle></emphasis>). <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">37:</emphasis>1714–1720.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0150" role="bibliographyEntry">
            <para>150.<emphasis role="strong">Lee H, Bang H-E, Bai G-H, Cho S-N.</emphasis> 2003. Novel polymorphic region of the <emphasis><citetitle>rpoB</citetitle></emphasis> gene containing <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species-specific sequences and its use in identification of mycobacteria. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">41:</emphasis>2213–2218.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0151" role="bibliographyEntry">
            <para>151.<emphasis role="strong">Adékambi T, Drancourt M.</emphasis> 2004. Dissection of phylogenetic relationships among 19 rapidly growing <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species by 16S rRNA, hsp65, sodA, recA and rpoB gene sequencing. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>2095–2105.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0152" role="bibliographyEntry">
            <para>152.<emphasis role="strong">Devulder G, de Montclos MP, Flandrois JP.</emphasis> 2005. A multigene approach to phylogenetic analysis using the genus <emphasis><citetitle>Mycobacterium</citetitle></emphasis> as a model. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">55:</emphasis>293–302.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0153" role="bibliographyEntry">
            <para>153.<emphasis role="strong">Zelazny AM, Root JM, Shea YR, Colombo RE, Shamputa IC, Stock F, Conlan S, McNulty S, Brown-Elliott BA, Wallace RJ Jr, Olivier KN, Holland SM, Sampaio EP.</emphasis> 2009. Cohort study of molecular identification and typing of <emphasis><citetitle>Mycobacterium abscessus, Mycobacterium massiliense</citetitle></emphasis>, and <emphasis><citetitle>Mycobacterium bolletii</citetitle></emphasis>. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">47:</emphasis>1985–1995.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0154" role="bibliographyEntry">
            <para>154.<emphasis role="strong">Zelazny AM, Calhoun LB, Li L, Shea YR, Fischer SH.</emphasis> 2005. Identification of <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species by <emphasis><citetitle>secA1</citetitle></emphasis> sequences. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">43:</emphasis>1051–1058.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0155" role="bibliographyEntry">
            <para>155.<emphasis role="strong">Stackebrandt E, Frederiksen W, Garrity GM, Grimont PAD, Kämpfer P, Maiden MCJ, Nesme X, Rosselló-Mora R, Swings J, Trüper HG, Vauterin L, Ward AC, Whitman WB.</emphasis> 2002. Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology. <emphasis><citetitle>Int J Syst Evol Microbiol</citetitle></emphasis> <emphasis role="strong">52:</emphasis>1043–1047.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0156" role="bibliographyEntry">
            <para>156.<emphasis role="strong">Kim HY, Kim BJ, Kook Y, Yun YJ, Shin JH, Kim BJ, Kook YH.</emphasis> 2010. <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis> is differentiated from <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> and <emphasis><citetitle>Mycobacterium bolletii</citetitle></emphasis> by erythromycin ribosome methyltransferase gene (<emphasis><citetitle>erm</citetitle></emphasis>) and clarithromycin susceptibility patterns. <emphasis><citetitle>Microbiol Immunol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>347–353.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0157" role="bibliographyEntry">
            <para>157.<emphasis role="strong">Blauwendraat C, Dixon GLJ, Hartley JC, Foweraker J, Harris KA.</emphasis> 2012. The use of a two-gene sequencing approach to accurately distinguish between the species within the <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> complex and <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis>. <emphasis><citetitle>Eur J Clin Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">31:</emphasis>1847–1853.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0158" role="bibliographyEntry">
            <para>158.<emphasis role="strong">Kim H-Y, Kook Y, Yun Y-J, Park CG, Lee NY, Shim TS, Kim B-J, Kook Y-H.</emphasis> 2008. Proportions of <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis> and <emphasis><citetitle>Mycobacterium bolletii</citetitle></emphasis> strains among Korean <emphasis><citetitle>Mycobacterium chelonae-Mycobacterium abscessus</citetitle></emphasis> group isolates. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">46:</emphasis>3384–3390.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0159" role="bibliographyEntry">
            <para>159.<emphasis role="strong">Macheras E, Roux A-L, Bastian S, Leão SC, Palaci M, Sivadon-Tardy V, Gutierrez C, Richter E, Rüsch-Gerdes S, Pfyffer G, Bodmer T, Cambau E, Gaillard J-L, Heym B.</emphasis> 2011. Multilocus sequence analysis and <emphasis><citetitle>rpoB</citetitle></emphasis> sequencing of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> (<emphasis><citetitle>sensu lato</citetitle></emphasis>) strains. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>491–499.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0160" role="bibliographyEntry">
            <para>160.<emphasis role="strong">Wuzinski M, Bak AK, Petkau A, B Demczuk WH, Soualhine H, Sharma MK</emphasis>. 2019. A multilocus sequence typing scheme for <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> complex (MAB-multilocus sequence typing) using whole-genome sequencing data. <emphasis><citetitle>Int J Mycobacteriol</citetitle></emphasis> <emphasis role="strong">8:</emphasis>273–280.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0161" role="bibliographyEntry">
            <para>161.<emphasis role="strong">Heller LC, Jones M, Widen RH.</emphasis> 2008. Comparison of DNA pyrosequencing with alternative methods for identification of mycobacteria. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">46:</emphasis>2092–2094.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0162" role="bibliographyEntry">
            <para>162.<emphasis role="strong">Tuohy MJ, Hall GS, Sholtis M, Procop GW.</emphasis> 2005. Pyrosequencing as a tool for the identification of common isolates of <emphasis><citetitle>Mycobacterium</citetitle></emphasis> sp. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">51:</emphasis>245–250.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0163" role="bibliographyEntry">
            <para>163.<emphasis role="strong">Chikamatsu K, Aono A, Hata H, Igarashi Y, Takaki A, Yamada H, Sakashita K, Mitarai S.</emphasis> 2018. Evaluation of PyroMark Q24 pyrosequencing as a method for the identification of mycobacteria. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">90:</emphasis>35–39.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0164" role="bibliographyEntry">
            <para>164.<emphasis role="strong">Arnold C, Barrett A, Cross L, Magee JG.</emphasis> 2012. The use of <emphasis><citetitle>rpoB</citetitle></emphasis> sequence analysis in the differentiation of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> and <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis>: a critical judgement in cystic fibrosis? <emphasis><citetitle>Clin Microbiol Infect</citetitle></emphasis> <emphasis role="strong">18:</emphasis>E131–E133.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0165" role="bibliographyEntry">
            <para>165.<emphasis role="strong">Mather CA, Rivera SF, Butler-Wu SM.</emphasis> 2014. Comparison of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocols. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">52:</emphasis>130–138.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0166" role="bibliographyEntry">
            <para>166.<emphasis role="strong">Buckwalter SP, Olson SL, Connelly BJ, Lucas BC, Rodning AA, Walchak RC, Deml SM, Wohlfiel SL, Wengenack NL.</emphasis> 2016. Evaluation of matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species, <emphasis><citetitle>Nocardia</citetitle></emphasis> species, and other aerobic actinomycetes. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>376–384.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0167" role="bibliographyEntry">
            <para>167.<emphasis role="strong">Rodríguez-Sánchez B, Ruiz-Serrano MJ, Ruiz A, Timke M, Kostrzewa M, Bouza E.</emphasis> 2016. Evaluation of MALDI biotyper mycobacterial library v3.0 for identification of nontuberculous mycobacteria. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>1144–1147.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0168" role="bibliographyEntry">
            <para>168.<emphasis role="strong">van Belkum A, Welker M, Erhard M, Chatellier S.</emphasis> 2012. Biomedical mass spectrometry in today’s and tomorrow’s clinical microbiology laboratories. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">50:</emphasis>1513–1517.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0169" role="bibliographyEntry">
            <anchor id="ch0049s0030s0004a0007"/>
            <para>169.<emphasis role="strong">Saleeb PG, Drake SK, Murray PR, Zelazny AM.</emphasis> 2011. Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionization–time of flight mass spectrometry. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">49:</emphasis>1790–1794.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0170" role="bibliographyEntry">
            <para>170.<emphasis role="strong">Leyer C, Gregorowicz G, Mougari F, Raskine L, Cambau E, de Briel D.</emphasis> 2017. Comparison of Saramis 4.12 and IVD 3.0 Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of mycobacteria from solid and liquid culture media. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">55:</emphasis>2045–2054.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0171" role="bibliographyEntry">
            <para>171.<emphasis role="strong">Body BA, Beard MA, Slechta ES, Hanson KE, Barker AP, Babady NE, McMillen T, Tang YW, Brown-Elliott BA, Iakhiaeva E, Vasireddy R, Vasireddy S, Smith T, Wallace RJ Jr, Turner S, Curtis L, Butler-Wu S, Rychert J.</emphasis> 2018. Evaluation of the Vitek MS v3.0 matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of <emphasis><citetitle>Mycobacterium</citetitle></emphasis> and <emphasis><citetitle>Nocardia</citetitle></emphasis> species. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">56:</emphasis>e00237–e18.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0172" role="bibliographyEntry">
            <para>172.<emphasis role="strong">Wilen CB, McMullen AR, Burnham CA.</emphasis> 2015. Comparison of sample preparation methods, instrumentation platforms, and contemporary commercial databases for identification of clinically relevant mycobacteria by matrix-assisted laser desorption ionization–time of flight mass spectrometry. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">53:</emphasis>2308–2315.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0173" role="bibliographyEntry">
            <para>173.<emphasis role="strong">Adams LL, Dionne K, Fisher S, Parrish N.</emphasis> 2016. A rapid, standardized protein extraction method using adaptive focused acoustics for identification of mycobacteria by MALDI-ToF MS. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">86:</emphasis>284–288.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0174" role="bibliographyEntry">
            <para>174.<emphasis role="strong">O’Connor JA, Lynch-Healy M, Corcoran D, O’Reilly B, O’Mahony J, Lucey B.</emphasis> 2016. Improved matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS)-based identification of <emphasis><citetitle>Mycobacterium</citetitle></emphasis> spp. by use of a novel two-step cell disruption preparatory technique. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>495–496.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0175" role="bibliographyEntry">
            <para>175.<emphasis role="strong">Rotcheewaphan S, Lemon JK, Desai UU, Henderson CM, Zelazny AM.</emphasis> 2019. Rapid one-step protein extraction method for the identification of mycobacteria using MALDI-TOF MS. <emphasis><citetitle>Diagn Microbiol Infect Dis</citetitle></emphasis> <emphasis role="strong">94:</emphasis>355–360.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0176" role="bibliographyEntry">
            <para>176.<emphasis role="strong">bioMérieux SA.</emphasis> 2018. User Manual Supplements VITEK MS v3.2 Knowledge Base 161150-925-A. bioMérieux SA, Marcy-l’Etoile, France.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0177" role="bibliographyEntry">
            <para>177.<emphasis role="strong">Bruker Daltonik GmbH.</emphasis> 2019. <emphasis><citetitle>Release Notes MBT Mycobacterial Library V6.0</citetitle></emphasis>. Document no. 5032543 Revision C. Bruker Daltonik, Bremen, Germany.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0178" role="bibliographyEntry">
            <para>178.<emphasis role="strong">Lévesque S, Dufresne PJ, Soualhine H, Domingo M-C, Bekal S, Lefebvre B, Tremblay C.</emphasis> 2015. A side by side comparison of Bruker Biotyper and VITEK MS: utility of MALDI-TOF MS technology for microorganism identification in a public health reference laboratory. <emphasis><citetitle>PLoS One</citetitle></emphasis> <emphasis role="strong">10:</emphasis>e0144878.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0179" role="bibliographyEntry">
            <para>179.<emphasis role="strong">Balada-Llasat JM, Kamboj K, Pancholi P.</emphasis> 2013. Identification of mycobacteria from solid and liquid media by matrix-assisted laser desorption ionization–time of flight mass spectrometry in the clinical laboratory. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">51:</emphasis>2875–2879.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0180" role="bibliographyEntry">
            <para>180.<emphasis role="strong">Yoo IY, Shim H-J, Yun SA, Kang O-K, Chung Y-N, Kim T-Y, Lee H, Kim J, Park Y-J, Huh H-J, Lee N-Y.</emphasis> 2021. Evaluation of the ASTA MicroIDSys matrix-assisted laser desorption ionization time-of-flight mass spectrometry system for identification of mycobacteria directly from positive MGIT liquid cultures. <emphasis><citetitle>Int J Infect Dis</citetitle></emphasis> <emphasis role="strong">102:</emphasis>172–177.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0181" role="bibliographyEntry">
            <para>181.<emphasis role="strong">Lotz A, Ferroni A, Beretti J-L, Dauphin B, Carbonnelle E, Guet-Revillet H, Veziris N, Heym B, Jarlier V, Gaillard J-L, Pierre-Audigier C, Frapy E, Berche P, Nassif X, Bille E.</emphasis> 2010. Rapid identification of mycobacterial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionization–time of flight mass spectrometry. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">48:</emphasis>4481–4486.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0182" role="bibliographyEntry">
            <para>182.<emphasis role="strong">Miller E, Cantrell C, Beard M, Derylak A, Babady NE, McMillen T, Miranda E, Body B, Tang Y-W, Vasireddy R, Vasireddy S, Smith T, Iakhiaeva E, Wallace RJ Jr, Brown-Elliott BA, Moreno E, Totty H, Deol P.</emphasis> 2018. Performance of Vitek MS v3.0 for identification of <emphasis><citetitle>Mycobacterium</citetitle></emphasis> species from patient samples by use of automated liquid medium systems. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">56:</emphasis>e00219–e18.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0183" role="bibliographyEntry">
            <para>183.<emphasis role="strong">Huang T-S, Lee C-C, Tu H-Z, Lee SS-J.</emphasis> 2018. Rapid identification of mycobacteria from positive MGIT broths of primary cultures by MALDI-TOF mass spectrometry. <emphasis><citetitle>PLoS One</citetitle></emphasis> <emphasis role="strong">13:</emphasis>e0192291.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0184" role="bibliographyEntry">
            <para>184.<emphasis role="strong">Moreno E, Miller E, Miller E, Totty H, Deol P.</emphasis> 2018. A novel liquid media mycobacteria extraction method for MALDI-TOF MS identification using VITEK<superscript>®</superscript> MS. <emphasis><citetitle>J Microbiol Methods</citetitle></emphasis> <emphasis role="strong">144:</emphasis>128–133.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0185" role="bibliographyEntry">
            <para>185.<emphasis role="strong">Luo L, Liu W, Li B, Li M, Huang D, Jing L, Chen H, Yang J, Yue J, Wang F, Chu H, Zhang Z.</emphasis> 2016. Evaluation of matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subspecies according to whole-genome sequencing. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>2982–2989.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0186" role="bibliographyEntry">
            <para>186.<emphasis role="strong">Fangous MS, Mougari F, Gouriou S, Calvez E, Raskine L, Cambau E, Payan C, Héry-Arnaud G.</emphasis> 2014. Classification algorithm for subspecies identification within the <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> species, based on matrix-assisted laser desorption ionization–time of flight mass spectrometry. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">52:</emphasis>3362–3369.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0187" role="bibliographyEntry">
            <para>187.<emphasis role="strong">Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B.</emphasis> 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">33:</emphasis>2233–2239.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0188" role="bibliographyEntry">
            <para>188.<emphasis role="strong">Zhang Y, Rajagopalan M, Brown BA, Wallace RJ Jr.</emphasis> 1997. Randomly amplified polymorphic DNA PCR for comparison of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> strains from nosocomial outbreaks. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">35:</emphasis>3132–3139.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0189" role="bibliographyEntry">
            <para>189.<emphasis role="strong">Zhang Y, Yakrus MA, Graviss EA, Williams-Bouyer N, Turenne C, Kabani A, Wallace RJ Jr.</emphasis> 2004. Pulsed-field gel electrophoresis study of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> isolates previously affected by DNA degradation. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>5582–5587.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0190" role="bibliographyEntry">
            <para>190.<emphasis role="strong">Howard ST, Newman KL, McNulty S, Brown-Elliott BA, Vasireddy R, Bridge L, Wallace RJ Jr.</emphasis> 2013. Insertion site and distribution of a genomic island conferring DNA phosphorothioation in the <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> complex. <emphasis><citetitle>Microbiol Read</citetitle></emphasis> <emphasis role="strong">159:</emphasis>2323–2332.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0191" role="bibliographyEntry">
            <para>191.<emphasis role="strong">Wong YL, Ong CS, Ngeow YF.</emphasis> 2012. Molecular typing of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> based on tandem-repeat polymorphism. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">50:</emphasis>3084–3088.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0192" role="bibliographyEntry">
            <para>192.<emphasis role="strong">Cangelosi GA, Freeman RJ, Lewis KN, Livingston-Rosanoff D, Shah KS, Milan SJ, Goldberg SV.</emphasis> 2004. Evaluation of a high-throughput repetitive-sequence-based PCR system for DNA fingerprinting of <emphasis><citetitle>Mycobacterium tuberculosis</citetitle></emphasis> and <emphasis><citetitle>Mycobacterium avium</citetitle></emphasis> complex strains. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">42:</emphasis>2685–2693.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0193" role="bibliographyEntry">
            <para>193.<emphasis role="strong">Ripoll F, Pasek S, Schenowitz C, Dossat C, Barbe V, Rottman M, Macheras E, Heym B, Herrmann JL, Daffé M, Brosch R, Risler J-L, Gaillard JL.</emphasis> 2009. Non mycobacterial virulence genes in the genome of the emerging pathogen <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis>. <emphasis><citetitle>PLoS One</citetitle></emphasis> <emphasis role="strong">4:</emphasis>e5660.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0194" role="bibliographyEntry">
            <para>194.<emphasis role="strong">Sekizuka T, Kai M, Nakanaga K, Nakata N, Kazumi Y, Maeda S, Makino M, Hoshino Y, Kuroda M.</emphasis> 2014. Complete genome sequence and comparative genomic analysis of <emphasis><citetitle>Mycobacterium massiliense</citetitle></emphasis> JCM 15300 in the <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> group reveal a conserved genomic island MmGI-1 related to putative lipid metabolism. <emphasis><citetitle>PLoS One</citetitle></emphasis> <emphasis role="strong">9:</emphasis>e114848.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0195" role="bibliographyEntry">
            <para>195.<emphasis role="strong">Sapriel G, Konjek J, Orgeur M, Bouri L, Frézal L, Roux A-L, Dumas E, Brosch R, Bouchier C, Brisse S, Vandenbogaert M, Thiberge J-M, Caro V, Ngeow YF, Tan JL, Herrmann JL, Gaillard JL, Heym B, Wirth T.</emphasis> 2016. Genome-wide mosaicism within <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis>: evolutionary and epidemiological implications. <emphasis><citetitle>BMC Genomics</citetitle></emphasis> <emphasis role="strong">17:</emphasis>118.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0196" role="bibliographyEntry">
            <para>196.<emphasis role="strong">Tan JL, Ng KP, Ong CS, Ngeow YF.</emphasis> 2017. Genomic comparisons reveal microevolutionary differences in <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subspecies. <emphasis><citetitle>Front Microbiol</citetitle></emphasis> <emphasis role="strong">8:</emphasis>2042.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0197" role="bibliographyEntry">
            <para>197.<emphasis role="strong">Lipworth S, Hough N, Leach L, Morgan M, Jeffery K, Andersson M, Robinson E, Smith EG, Crook D, Peto T, Walker T.</emphasis> 2018. Whole-genome sequencing of predicting clarithromycin resistance in <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis>. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">63:</emphasis>e01204–e01218.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0198" role="bibliographyEntry">
            <anchor id="ch0049s0030s0004a0008"/>
            <para>198.<emphasis role="strong">Bachmann NL, Salamzade R, Manson AL, Whittington R, Sintchenko V, Earl AM, Marais BJ.</emphasis> 2020. Key transitions in the evolution of rapid and slow growing mycobacteria identified by comparative genomics. <emphasis><citetitle>Front Microbiol</citetitle></emphasis> <emphasis role="strong">10:</emphasis>3019.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0199" role="bibliographyEntry">
            <para>199.<emphasis role="strong">Harris KA, Underwood A, Kenna DTD, Brooks A, Kavaliunaite E, Kapatai G, Tewolde R, Aurora P, Dixon G.</emphasis> 2015. Whole-genome sequencing and epidemiological analysis do not provide evidence for cross-transmission of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> in a cohort of pediatric cystic fibrosis patients. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">60:</emphasis>1007–1016.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0200" role="bibliographyEntry">
            <para>200.<emphasis role="strong">Everall I, Nogueira CL, Bryant JM, Sánchez-Busó L, Chimara E, Duarte RDS, Ramos JP, Lima KVB, Lopes ML, Palaci M, Kipnis A, Monego F, Floto RA, Parkhill J, Leão SC, Harris SR.</emphasis> 2017. Genomic epidemiology of a national outbreak of post-surgical <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> wound infections in Brazil. <emphasis><citetitle>Microb Genom</citetitle></emphasis> <emphasis role="strong">3:</emphasis>e000111.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0201" role="bibliographyEntry">
            <para>201.<emphasis role="strong">Redondo N, Mok S, Montgomery L, Flanagan PR, McNamara E, Smyth EG, O’Sullivan N, Schaffer K, Rogers TR, Fitzgibbon MM.</emphasis> 2020. Genomic analysis of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> complex isolates collected in Ireland between 2006 and 2017. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">58:</emphasis>e00295–e20.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0202" role="bibliographyEntry">
            <para>202.<emphasis role="strong">Davidson RM, Hasan NA, Epperson E, Benoit JB, Kammlade SM, Levin AR, Calado de Moura V, Hunkins J, Weakly N, Beagle S, Sagel SD, Martiniano SL, Salfinger M, Daley CL, Nick JA, Strong M.</emphasis> 2021. Population genomics of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> from United States cystic fibrosis care centers. <emphasis><citetitle>Ann Am Thorac Soc</citetitle></emphasis> <emphasis role="strong">18:</emphasis>1960–1969.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0203" role="bibliographyEntry">
            <para>203.<emphasis role="strong">Davidson RM, Hasan NA, Reynolds PR, Totten S, Garcia B, Levin A, Ramamoorthy P, Heifets L, Daley CL, Strong M.</emphasis> 2014. Genome sequencing of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> isolates from patients in the United States and comparisons to globally diverse clinical strains. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">52:</emphasis>3573–3582.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0204" role="bibliographyEntry">
            <para>204.<emphasis role="strong">Doyle RM, Rubio M, Dixon G, Hartley J, Klein N, Coll P, Harris KA.</emphasis> 2020. Cross-transmission is not the source of new <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> infections in a multicenter cohort of cystic fibrosis patients. <emphasis><citetitle>Clin Infect Dis</citetitle></emphasis> <emphasis role="strong">70:</emphasis>1855–1864.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0205" role="bibliographyEntry">
            <para>205.<emphasis role="strong">Minias A, Żukowska L, Lach J, Jagielski T, Strapagiel D, Kim S-Y, Koh W-J, Adam H, Bittner R, Truden S, Žolnir-Dov</emphasis>č <emphasis role="strong">M, Dziadek J.</emphasis> 2020. Subspecies-specific sequence detection for differentiation of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> complex. <emphasis><citetitle>Sci Rep</citetitle></emphasis> <emphasis role="strong">10:</emphasis>16415.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0206" role="bibliographyEntry">
            <para>206.<emphasis role="strong">Yoshida M, Sano S, Chien J-Y, Fukano H, Suzuki M, Asakura T, Morimoto K, Murase Y, Miyamoto S, Kurashima A, Hasegawa N, Hsueh PR, Mitarai S, Ato M, Hoshino Y.</emphasis> 2021. A novel DNA chromatography method to discriminate <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subspecies and macrolide susceptibility. <emphasis><citetitle>eBioMedicine</citetitle></emphasis> <emphasis role="strong">64:</emphasis>103187.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0207" role="bibliographyEntry">
            <para>207.<emphasis role="strong">Wolinsky E.</emphasis> 1979. Nontuberculous mycobacteria and associated diseases. <emphasis><citetitle>Am Rev Respir Dis</citetitle></emphasis> <emphasis role="strong">119:</emphasis>107–159.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0208" role="bibliographyEntry">
            <para>208.<emphasis role="strong">Clinical and Laboratory Standards Institute.</emphasis> 2003. Susceptibility testing of mycobacteria, Nocardia, and other aerobic actinomycetes. Approved standard. CLSI document M24-A. CLSI, Wayne, PA.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0209" role="bibliographyEntry">
            <para>209.<emphasis role="strong">Clinical and Laboratory Standards Institute.</emphasis> 2011. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes: Approved standard. 2nd ed. CLSI document M24-A2.CLSI, Wayne, PA.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0210" role="bibliographyEntry">
            <para>210.<emphasis role="strong">Clinical and Laboratory Standards Institute.</emphasis> 2018. Susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes. 3rd ed. CLSI standard document, M24. CLSI, Wayne, PA.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0211" role="bibliographyEntry">
            <para>211.<emphasis role="strong">Brown-Elliott BA, Hanson K, Vasireddy S, Iakhiaeva E, Nash KA, Vasireddy R, Parodi N, Smith T, Gee M, Strong A, Barker A, Cohen S, Muir H, Slechta ES, Wallace RJ Jr.</emphasis> 2015. Absence of a functional <emphasis><citetitle>erm</citetitle></emphasis> gene in isolates of <emphasis><citetitle>Mycobacterium immunogenum</citetitle></emphasis> and the <emphasis><citetitle>Mycobacterium mucogenicum</citetitle></emphasis> group, based on <emphasis><citetitle>in vitro</citetitle></emphasis> clarithromycin susceptibility. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">53:</emphasis>875–878.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0212" role="bibliographyEntry">
            <para>212.<emphasis role="strong">Brown-Elliott BA, Vasireddy S, Vasireddy R, Iakhiaeva E, Howard ST, Nash KA, Parodi N, Strong A, Gee M, Smith T, Wallace RJ Jr.</emphasis> 2016. 2015. Utility of sequencing the <emphasis><citetitle>erm</citetitle></emphasis>(41) gene in isolates of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis> subsp. <emphasis><citetitle>abscessus</citetitle></emphasis> with low and intermediate clarithromycin MICs. <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">53:</emphasis>1211–1215. Erratum <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">54:</emphasis>1172.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0213" role="bibliographyEntry">
            <para>213.<emphasis role="strong">Nash KA.</emphasis> 2003. Intrinsic macrolide resistance in <emphasis><citetitle>Mycobacterium smegmatis</citetitle></emphasis> is conferred by a novel <emphasis><citetitle>erm</citetitle></emphasis> gene, <emphasis><citetitle>erm</citetitle></emphasis>(38). <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">47:</emphasis>3053–3060.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0214" role="bibliographyEntry">
            <para>214.<emphasis role="strong">Nash KA, Andini N, Zhang Y, Brown-Elliott BA, Wallace RJ Jr.</emphasis> 2006. Intrinsic macrolide resistance in rapidly growing mycobacteria. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">50:</emphasis>3476–3478.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0215" role="bibliographyEntry">
            <para>215.<emphasis role="strong">Hanson KE, Slechta ES, Muir H, Barker AP.</emphasis> 2014. Rapid molecular detection of inducible macrolide resistance in <emphasis><citetitle>Mycobacterium chelonae</citetitle></emphasis> and <emphasis><citetitle>M. abscessus</citetitle></emphasis> strains: a replacement for 14-day susceptibility testing? <emphasis><citetitle>J Clin Microbiol</citetitle></emphasis> <emphasis role="strong">52:</emphasis>1705–1707.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0216" role="bibliographyEntry">
            <para>216.<emphasis role="strong">Kaushik A, Ammerman NC, Martins O, Parrish NM, Nuermberger EL.</emphasis> 2019. <emphasis><citetitle>In vitro</citetitle></emphasis> activity of new tetracycline analogs omadacycline and eravacycline against drug-resistant clinical isolates of <emphasis><citetitle>Mycobacterium abscessus</citetitle></emphasis>. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">63:</emphasis>e00470–e19.</para>
          </listitem>
          <listitem id="ch0049s0030s0004li0217" role="bibliographyEntry">
            <para>217.<emphasis role="strong">Brown-Elliott BA, Wallace RJ Jr.</emphasis> 2021. <emphasis><citetitle>In vitro</citetitle></emphasis> susceptibility testing of omadacycline against nontuberculous mycobacteria. <emphasis><citetitle>Antimicrob Agents Chemother</citetitle></emphasis> <emphasis role="strong">65:</emphasis>e01947–e20.</para>
          </listitem>
        </itemizedlist>
        <anchor id="ch0049s0030s0004a0009"/>
        <beginpage pagenum="675"/>
      </sect2>
    </sect1>
  </chapter>
